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1.1. Intermediate filament proteins 
The cytoskeleton of all metazoan cells contains three major types of filament systems: the 
actin microfilaments (MFs), the microtubules (MTs), and the intermediate filaments (IFs). 
The name “intermediate filaments” comes from their diameter (10-12nm) being intermediate 
of that from MTs (25nm) and MFs (7-10nm). The network of the three filament systems is 
responsible for the mechanical integrity of the cell and is critically involved in processes such 
as cell division, plasticity and motility. In vivo IFs function in close association with 
cytoskeletal components such as motor proteins and plakin-type cross bridging proteins. 
IFs harbour unique structural features, which make them different from other filament 
systems: First, the elementary unit of an IF is an elongated (45nm) and thin (2-3nm) rod-like 
dimer. In contrast to that, elementary units of MF and MT are globular proteins consisting of 
actin monomers and αβ-tubulin heterodimers, respectively. Second, assembled IFs have no 
polarity: they are oriented in “up” and “down” direction along the same filament. In contrast 
to that, actin MFs and MTs are polar. This polarity allows active transport of motor proteins, 
such as myosin and kinesin, along these filaments. Third, in vivo IFs appear to be the most 
dynamic filament type: assembly and disassembly can occur along the whole filament not 
only at the ends, as it is the case in MFs and MTs (S.V.Strelkov, 2003).  
The intermediate filament protein family was classified into five different major 
subtypes as listed in the table below. The classification is based on comparison of amino acid 
sequences.  
Table 1.1: Intermediate filament proteins: groups I-IV are considered (predominantly) 
cytoplasmic, while the lamins (group V) are found in the nuclei of all cell types.. 
Type Protein Size 
(kDa) 
Site of expression 
I Acidic keratins 40–60 Epithelial cells 
 (~15 proteins)   
II Neutral or basic keratins 50–70 Epithelial cells 
 (~15 proteins)   





53 Muscle cells 
 Glial fibrillary acidic 
protein 
51 Glial cells 
 Peripherin 57 Peripheral neurons 
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IV Neurofilament proteins   
 NF-L 67 Neurons 
 NF-M 150 Neurons 
 NF-H 200 Neurons 
 Α-Internexin 66 Neurons 
V Nuclear lamins 60–75 Nuclear lamina of all cell types 
VI Nestin 200 Stem cells of central nervous system 
 
The classification of the intermediate filament protein nestin is quite controversial. Some 
authors count it to class III, because of its amino acid sequence, but according to its gene 
organisation it also may fit into class IV. However, it is, like synemin, unable to form 
filaments on its own, and in the table above it is listed in class VI. 
Despite the diversity of intermediate filament proteins in size and amino acid 
sequence, the various intermediate filament proteins share a common structural organization, 
which is shown in figure 1.1.1. 
 
 
Fig.1.1.1: The structural organization of an intermediate filament protein (from “The Cell 
a molecular approach”2nd edition;Geoffrey M.Cooper, 2000) 
Figure 1.1.1 shows a typical monomer of a type III intermediate filament protein. The central 
alpha(α)-helical rod domain is needed for filament assembly. The amino(N)-terminal and 
carboxy(C)-terminal portions are highly variable among the different subtypes and determine 
the specific functions of the intermediate filament proteins. In case of desmin the N-terminus 
can interact with a variety of other proteins and DNA (Tolstonog et al. 2005; Costa et 
al.2004). Desmin was found to interact with other IF-proteins, with nebulin, plectin, dynein, 
the myogenic regulator protein myoD and DNA.  In addition to that, the N-terminus contains 
specific serine residues (phosphorylation sites), which might be of importance in the control 
of the cell cycle and probably even in development. (Höllrigl et al. 2007) Together, these 
findings and the variety of its in-vitro interaction partners suggest that desmin is more than 
just a mechanically important structural protein.  
Another classification of intermediate filament proteins is made with respect to their 
assembly properties. Here three different classes were described: Group I consisting of acidic 
and basic keratins, group II with desmin and other mesenchymal, muscle, or neuronal IF 
proteins, and group III, built by the nuclear lamins. Only the members of the same assembly 
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group are able to co-assemble in a productive manner. Most of the assembly studies have 
been done on vimentin (Herrmann and Aebi, 1998b). Although vimentin and desmin exhibit 
high amino acid sequence identity and may co-assemble with each other, they differ in some 
aspects: Desmin filaments are thicker and assemble much faster than vimentin (Herrmann et 
al., 1999). In vitro studies of IF assembly showed, as first step, the formation of a parallel 
coiled-coil dimer, then two dimers associate in a half-staggered, anti-parallel manner to form 
a tetramer. These tetrameric units are the smallest stable soluble complexes found in vitro. 
Within seconds, they associate laterally to form a so-called “unit-length filament” (ULF). 
ULFs measure about 58 nm in length and 16 nm in diameter. In the next step ULFs anneal 
longitudinally to form loosely packed filaments. Within minutes after initiation of assembly, 
these loosely packed filaments undergo a process of “radial compaction”. The radial 
compaction reduces filament diameter to about 14 nm (in desmin). Finally, a mature apolar 
filament is obtained. Apolarity results, according to data obtained from chemical cross-
linking, from the fact that individual dimers alternate their orientation along the filament and 
associate in a heads-to-tails manner (Bär H. et al., 2004). 
 
 
Fig.1.1.2: The Modular arrangement of IF protein monomers in filament assembly: Two IF 
protein monomers wind around each other in a head to head orientation. The resulting 
dimers associate with another dimer in a heads to tails orientation and form a tetramer. The 
tetramers further assemble into proto-filaments, where N-terminal heads always face C-
terminal tails. (“The Cell a molecular approach”2nd edition; Cooper, 2000) 
1.2. About “Desmin” 
Desmin protein was purified first almost at the same time by J.V.Small and A.Sobieszek and 
by E.Lazarides and B.D.Hubbard in 1976 (Lazarides & Hubbard 1976; Small & Sobieszek 
1977). Lazarides and Hubbard purified a 50 kilo Dalton (kDa) protein from chicken gizzard 
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(smooth muscle). They also succeeded to produce antibodies against it and used them for 
indirect immunofluorescence staining. The immunofluorescence staining located the protein 
in muscle. However, to indicate the proteins most obvious function, the discoverers termed it 
after the greek word “δεσμόs”, which means “bond” or “link”. The desmin gene was 
characterized in 1984 (Capetanaki et al.1984), its transcriptional regulation by the myogenic 
transcription factors MyoD, myogenin, MRF4, and Myf5 was elucidated in 1993 (Li et al. 
1993) and knockout animals were generated in 1996 (Milner et al. 1996). Nowadays, research 
on desmin is more focussed on desmin-associated disease such as desminopathy or desmin-
related myopathy.   
Desmin is a muscle specific type III intermediate filament (IF) protein. It is one of the 
earliest known myogenic markers and it is occurring exclusively in muscle and endothelial 
cells. As a cytoplasmic protein it plays a crucial role in the maintenance of cellular 
architecture. In muscle cells there are other IF proteins such as nestin, peripherin, and 
vimentin, besides the ubiquitous lamins, but in contrast to desmin, they are all not unique to 
muscle (Costa et al. 2004). The desmin protein connects the sarcomeres, which are the 
contractile elements of a muscle cell, along so-called Z-lines (or Z-discs). In addition to that, 
desmin interconnects myofibrils to form muscle fibers and anchors myofibrils to the inner 
portion of the cell membrane (sarcolemma) and to the outer portion of the nuclear membrane. 
It also serves to connect neighbouring cells via desmosomes (in cardiac muscle) or costameres 
(in skeletal muscle) and therefore contributes to inter-cellular  mechanical integrity. 
Figure1.2.1: 
A) The organization of a skeletal 
muscle. (from “The Cell a 
molecular approach”2nd edition; 
Cooper, 2000) 
B) The intracellular location of 
desmin intermediate filaments 
(from Bär et al.2004) 
  
  Figure 1.2.1A: The organization of a skeletal muscle as a bundle of muscle fibers. Each of 
these muscle fibers consists of interconnected myofibrils. The myofibrils are formed by 
syncytic cells, which contain sarcomeres. The sarcomeres are the contractile units in a muscle 
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cell. B) A schematic drawing of the localization of Intermediate filaments in muscle cells. It 
depicts the IF proteins cellular localization and its interaction partners (from Review in 
Journal of Structural Biology Vol 148, Bär et al. 2004); Desmin filaments are shown as pink 
lines. 
 
Fig.1.2.1C: The structure of a sarcomere: (from “The Cell a molecular approach”2nd 
edition; Cooper, 2000). The sarcomeres contain actin and myosin filaments in a staggered 
array. Z-lines mark the regions where the sarcomeres are in contact. Desmin interconnects 
the sarcomeres and the myofilaments at the Z-lines.  
 
The sarcomeres, which are the contractile subunits in a muscle cell, consist of actin and 
myosin filaments. During muscle contraction the actin and myosin filaments slide along each 
other. This leads to a reversible shortening of each sarcomere along a muscle. One sarcomere 
measures about 2.3µm in length. The ends of the sarcomeres are defined by the so-called Z-
discs. Here desmin filaments interconnect the sarcomeres as it is mentioned above. The 
sarcomeres contain several distinc regions: The “I-band”, which consists of actin filaments 
only whereas the dark “A-band”(A stands for anisotropic) contains both, the actin and the 
myosin filaments. At the “H zone”the myosin filaments are anchored at the midline (M line).  
 
 
Fig.1.2.2: Desmin in maintenance of 
structural integrity of myocytes: 
Desmin as a component of a muscle cell 
serves for stability structural integrity and 
interconnection of cellular compartements 
and cells in a tissue. (Goldfarb et al. 2008) 
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1.3. The biochemical aspects of desmin 
The human desmin protein is encoded by a single copy gene (des), located on chromosome 
band 2q35. It encompasses nine exons within an 8.4 kilobases (kb) region and codes for 476 
amino acids. The gene is highly conserved among the vertebrate species. The human desmin 
protein weights 52 kDa and has an isoelectric point (pI) at 5.4 (Costa et al.2004). 
Desmin, like all IF proteins, is very resistant to chemical denaturation. After 
homogenization of myofibrils, desmin filaments are highly enriched in the insoluble high-salt-
resistant residue, which is a characteristic property of all IFs. To solubilize this fraction of 
cytoplasmic proteins, high concentration of denaturing agents, like 8 M urea or 6 M guanidine 
hydrochloride is needed. Upon removal of denaturing agents, IFs can completely be re-
natured. In short, IFs are very stable proteins, which are able to self re-assemble in the 
appropriate ionic strenght after chemical denaturation. This fact unfortunately impairs 
extensive study of desmin’s structural traits. So, only little information from crystallographic 
studies is available, and most knowledge comes from studies of vimentin, which is very 
similar to desmin in its amino acid sequence, structural traits and folding behaviour. (Bär et 
al.2004) 
In accordance with its function, the desmin molecule is organized into three domains: 
a highly conserved alpha(α)-helical core of 308 amino acid residues flanked by globular 
amino(N)- and carboxy(C)-terminal (“head” and “tail”) structures as shown in figure 1.3. The 
α-helical core maintains a seven residue (heptad) repeat pattern with a typical sequence of 
hydrophobic and hydrophilic amino acids. This heptad repeat structure guides two 
polypeptides into formation of a homo-polymeric coiled-coil dimer, the elementary unit of an 
intermediate filament. The heptad periodicity within the helical rod is interrupted in several 
places. This led to determination of the four consecutive helical segments 1A, 1B, 2A, and 
2B, which are connected by short non-helical linker regions (L1, L12, and L2). The segments 
1A and 2B contain highly conserved regions that are very important in association of two 
dimers to form tetramers. The 2B segment located at the C-terminal part of the desmin core 
domain contains a discontinuity in the heptad repeat pattern, a so called “stutter”. The 
“stutter” is an obligate feature of all IF proteins and its position is absolutely conserved. 
Experimental “straightening out” of the stutter by addition of three amino acids would restore 
the heptad pattern but leads to inability of this “stutterless” molecule to anneal into longer 
filaments. 
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Another thoroughly examined structure is the 405-YRKLLEGEESRI-416 motif at the C-
terminal end of the 2B helix. Here the coiled-coil structure loosens and the α-helices gradually 
separate, eventually bending away from each other. In vitro data demonstrated that this motif 
directs the proper formation of tetramers and controls the number of segments per filament 
cross section. 
The desmin C-terminal “tail” is involved in longitudinal “heads-to-tails” tetramer 
assembly and control of lateral packing, stabilization and elongation of the filament structure. 
However, the tails major function seems to be interacting with other cytoskeletal proteins to 
establish a cytoplasmic intermediate filament network. (Bär et al.2004) 
 
Fig1.3.: A model of an intermediate filament dimer (Strelkov et al. 2003).  
Originally this picture was shown as a model for vimentin, but the two type III IFs exhibit 
high amino acid sequence identity and the modular arrangement of α-helical structure is 
shared by desmin. It is mainly built by a series of coiled-coils. Periodicity is interrupted at 
several sites, which led to determination of four consecutive α-helical segments (1A, 1B, 2A, 
and 2B).The segments 1A and 1B together form coil 1, 2A and 2B form coil 2. The α-helical 
segments are interconnected by relatively short linkers (L1, L12, and L2). The regions shown 
in purple are highly conserved and are critically involved in dimer-dimer interaction. 
 
Desmin- like all type III intermediate filaments- can form homopolymers and heteropolymers. 
It normally interacts with many other structural proteins, including intermediate filament 
associated proteins (IFAPs), which cross-link desmin filaments to a dense network that 
anchors the cytoskeleton. Mutated desmin is thought to be impaired in its interaction with 
these proteins, and in consequence to trigger disease. 
Desmin usually is phosphorylated at several distinct serine residues. The 
phosphorylation is thought to regulate polymerisation of desmin. Signaling molecules such as 
cAMP-dependent kinase and protein-kinase C were shown to increase the state of 
phosphorylation of desmin and to interfere with the filament assembly (Kitamura et al., 
1989). In consequence of desmin over-phosphorylation, changes in the structure of the 
filament network were observed (Huang X. et al., 2002). Moreover, Aurora-B kinase, which 
phosphorylates serine and threonine residues, was shown to be engaged in phosphorylation of 
desmin at the cleavage furrow during cytokinesis, probably to serve for proper segregation of 
desmin filaments to daughter cells.  
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1.4. Development of the heart 
 
The heart is part of the circulatory system, together with the blood cells, and a system of 
blood vessels. It serves to nourish the developing vertebrate embryo. The heart is the first 
functional organ in the developing organism. The circulatory system is built from the lateral 
plate mesoderm. The lateral plate mesoderm itself divides into two separate regions: the first 
is the dorsal somatic (parietal) mesoderm, which underlies the ectoderm. The second is the 
ventral splanchnic (visceral) mesoderm, which overlies the endoderm. The heart itself is 
built from two regions of splanchnic mesoderm, one at each side of the body. The splanchnic 
mesodermal regions, which will form the heart, are influenced by their surrounding tissue. 
The presumptive heart cells originate from a region, which is close to the primitive streak and 
lateral to the node. The cells of the cardiogenic mesoderm migrate anteriorly between the 
ectoderm and the endoderm towards the midline of the embryo. The direction of migration 
seems to be implied by the foregut endoderm. This is assumed, because of the finding, that 
when the cardiac region endoderm is rotated with respect to the rest of the embryo, the 
direction of migration of the cardiogenic mesodermal cells is reversed. It is thought that 
fibronectin is the factor responsible for the direction of the migration. The endodermal factor 
fibronectin most probably provides the cardiogenic mesoderm cells with a concentration 
gradient to move along. In 1988, Linask and Lash showed that antibodies against fibronectin 
stop this migratory process, while antibodies against other extra-cellular matrix proteins had 
no influence on the migration of cardiogenic mesoderm cells. The presumptive heart cells 
receive inductive signals from the endoderm and the primitive streak. One of these inductive 
signals is the TF Cerberus, another might be BMP2. Together, these TFs induce the 
synthesis of the Nkx 2.5 TF in the migrating mesodermal cells. Nkx 2.5 is a critical protein in 
the specification of the presumptive heart field. It instructs the mesoderm to become cardiac 
tissue and induces the activation of other heart-relevant TFs, like the GATA family and the 
MEF2 family members. Working together, these TFs activate the gene expression of cardiac 
muscle-specific proteins, like atrial natriuretic factor (ANF), α myosin heavy chain 
(αMHC), and cardiac actin. (Gilberts Developmental Biology 6th edition) 
As the presumptive heart cells of the cardiogenic mesoderm are still migrating towards 
midline, they begin to express N-cadherin, which makes them to join in an epithelium. This 
epithelium is the myocardium. 
N-cadherin is a calcium-dependent binding factor, which serves a role in various 
developmental processes, like in migration. In addition to that, it serves a role in cell-cell 
contacts, at the desmosomes. The cadherins, in general, often function in cell-cell contacts at 
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adherens junctions. In development during embryonic morphogenesis they provide cells, 
which carry cadherin, with polarity. It may also function in signal transduction. Some of the 
migrating cardiogenic cells downregulate the expression of N-cadeherin and delaminate from 
the myocardial epithelium, to form the endocardium. The myocardium will form the heart 
muscle itself, while the endocardium will produce the heart valves. In addition to that, the 
endocardium will secrete proteins, that stimulate the growth of the myocardium and it will 
regulate the innervation of the cardiac tissue. (Gilberts Developmental Biology 6th edition) 
 
 
Fig.1.4.1: Shows the formation of the chick heart from the lateral plate mesoderm. 
(Gilberts “Developmental Biology” 6th edition)  
Schematic drawing of the formation of the chick heart from the splanchnic lateral plate 
mesoderm. The endocardium forms the inner lining of the heart, the myocardium forms the 
heart muscles. Transverse sections through the heart-forming region of the chick embryo are 
shown at (A) 25 hours, (B) 26 hours, (C) 28 hours, and (D) 29 hours. 
 
The inward folding of the splanchnic mesoderm during neurulation, leads to the convergence 
of the endocardial primordia. Finally, these primordia further develop to heart tubes, which 
fuse to one endocardium. By week three of human gestation, the fusion of the two heart tube 
primordia occurs. While the paired primordia still are fusing, the pulsation of the heart begins. 
The pacemaker of the initial contractions is the sinus venosus. Here the contractions begin, 
and are continued in a wave-like manner along the heart tube. The heart is able to pump blood 
even before the system of valves has established. The heart muscle cells have an own inherent 
ability to continue beating, even if they are isolated from the body. In the context of an 
embryo the contractions of the heart become regulated by electrical stimuli from the medulla 
oblongata via the vagus nerve. (Gilberts Developmental Biology 6th edition) 
In a five week human embryo the heart is a two chambered tube, with one atrium and 
one ventricle. Thereafter, the heart undergoes a looping, which converts the original anterior-
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posterior polarity to a right-left polarity. Thus, the portion of the heart, which was designated 
to become the right ventricle, lies anterior to the portion, which was designated to become the 
left ventricle. The looping of the heart tube is dependent on the left-right patterning proteins 
Nodal and Lefty-2. Nodal and Lefty-2 are two paracrine factors in the lateral plate mesoderm 
of the left side of the embryo. The expression of these two factors is ascribed to the left-ward 
motion of the cilia on the nodal cells. Nodal itself activates the pitx-2 gene, which codes for a 
product, which activates left sided properties in tissue. (Gilberts Developmental Biology 6th 
edition) 
In the heart primordium, Nkx 2.5 regulates the expression of Hand1 and Hand2 
transcription factors. Initially, the expression of the Hand proteins seems to be uniformly 
distributed in the heart tube. Later when the looping begins, the Hand1 protein becomes 
restricted to the left ventricle and the Hand2 protein becomes restricted to the right ventricle. 
Another TF, critical for heart looping, is Pitx-2. It is activated at the left side of the lateral 
plate mesoderm only, and it is assumed that it also regulates the expression of proteins, such 
as extra cellular matrix protein flectin, which in turn is thought to regulate the physical 
tension of the heart tissue on the different sides. The TFs Nkx 2-5 and MEF2C activate the 
Xin gene. The Xin protein is thought to mediate cytoskeletal changes in the heart tissue, 
which are essential for the looping of the heart tube. (Gilberts Developmental Biology 6th 
edition) 
The separation of the atrium from the ventricle is achieved when the cells express 
several TFs, which are restricted to either the anterior side or the posterior side of the embryo. 
The partition of the heart tube is accomplished, when the cells of the myocardium express a 
factor, which drives the cells of the endocardium to detach and to migrate between these two 
layers to build the cardiac jelly. In humans this leads to the formation of the endocardial 
cushion, which divides the heart tube into the right and the left atrioventricular channels.  
The formation of the septa usually occurs in the seventh week of human development. When 
the septa are formed, the heart is a four chambered structure, as shown in figure 1.4.2. In the 
four chambered heart, the pulmonary artery is connected to the right ventricle, and the aorta is 
connected to the left ventricle. (Gilberts Developmental Biology 6th edition) 
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Fig.1.4.2: The formation of the heart chambers. (Gilberts Developmental Biology 6th 
edition) 
(A) Diagrammatic cross section of the chambers of the human heart at 4.5 weeks. The septa 
of the atrium and the ventricle are growing towards the endocardial cushion. 
(B) Diagrammatic cross section of the human heart during the third month of gestation. 
Before the first breath, the blood can cross from the right side of the heart to the left side 
through openings in the atrial septa. The first breath causes these openings to close, and the 
newborn’s circulation and oxygen supply now depends on the lung.  
 
Fig.1.5.3: Summary of the developmental events in the formation of the heart. 
The correlation between the morphological stage and the transcription factors present in the 
nucleus of the heart precursor cells. Cardioblasts are the committed heart precursor cells 
when they contain Nkx2-5 and GATA family proteins. These proteins convert the cardioblasts 
into cardiomyocytes (heart muscle cells), which express the cardiac muscle-specific proteins. 
The cardiomyocytes join together to form the cardiac tube. Under the influence of the Hand 
proteins, Xin, and Pitx-2, the heart loops and the chambers are formed. (Gilberts 
Developmental Biology 6th edition) 
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Molecular signals in heart development 
Very few of the genes involved in cardiac morphogenesis are restricted to the cardiac 
mesoderm. Many signalling molecules, that control cardiac development, are found in 
numerous other cell types than mesodermal precursors of muscle. To achieve transcriptional 
specificity in a certain cell type at a given time, it is necessary to interpret the intercellular and 
intracellular signals combined with local cellular identity. Therefore, to understand how 
gradients and thresholds of signals are coupled with combinatorial interactions among 
transcriptional regulators on individual transcriptional modules remains a major challenge for 
the future. Equally important are the additional layers of regulation that are imposed on the 
cis-regulatory information and its associated TFs. For example, alterations in chromatin 
conformation, and epigenetic mechanisms, such as DNA-methylation, play key roles in the 
interpretation of DNA sequence information. In addition to that, there are protein-protein 
interactions among transcriptional activators and repressors that do not bind DNA directly. 
These are also involved in modulating the activities of TFs, which are directly bound to DNA. 
The convergence of these different regulatory strategies provides the rich diversity of gene 
expression patterns that serve as the basis for development. 
There are four major signalling pathways involved in the induction of the cardiogenic 
program. (Gilberts Developmental Biology 6th edition) 
The first signalling pathway acts via BMPs- the bone morphogenetic proteins. BMPs 
are expressed in the endoderm of the cardiogenic region as well as in ectoderm and cardiac 
mesoderm itself. The inductive signal for cardiac development is Sonic hedgehog (Shh) from 
the node. Shh positively influences BMP signalling and the activation of cardiogenic TFs. A 
role of BMPs in cardiomyogenesis was implied, because the application of BMPs on explants 
of cardiac mesoderm and non-cardiogenic tissue activates the expression of the early cardiac 
markers, such as Nkx2.5, GATA4, Tbx2 and MHC. In addition to that, the inhibition of BMP 
signalling blocks nkx2.5 gene expression and cardiac differentiation. If BMP-soaked beads are 
placed to head mesoderm Nkx 2.5 is induced ectopically in this tissue. In bmp2 knock out 
mice the development of the heart completely fails and a dominant inhibition of BMP 
signalling inhibits cardiogenesis. (Gilberts Developmental Biology 6th edition) 
Downstream of BMP and TGFβ signalling Smad proteins act as effectors. The Smad 
proteins are transcription factors (TFs), which transduce extracellular signals from TGFβ-
receptor family members. Smad 1, 3 and 5 are regulated by BMPs during cardiac induction. 
The BMP-Smads appear to directly activate early cardiac TF genes, including nkx2.5. 
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The second major signalling pathway, which is involved in the induction of the 
cardiogenic program, acts via WNTs and β-catenin. Wnts are secreted glycoproteins, which 
are expressed in the dorsal neural plate and act repressive on cardiogenesis. The ectopic 
expression of Wnt antagonists can overcome the repressive effect of the dorsal neural plate on 
cardiogenesis. For example, the Wnt antagonists of the Dickkopf and Frizzled-like families are 
expressed in the node and in the endoderm, which surrounds the cardiac mesoderm. These 
antagonists can activate cardiogenesis in non-cardiogenic mesoderm in the frog and chick 
embryo. The ectopic application of Wnt-antagonists leads to the formation of ectopic beating 
heart tubes in the frog. Thus the elimination of Wnt/β catenin signalling is essential for 
cardiogenesis. The balance of Wnts and their antagonists seems to shape the cardiac field. 
The TF, β-catenin, is one of the best characterized effectors of the Wnt signaling pathway. 
The stabilization of cytoplasmic β-catenin within the canonical Wnt pathway, allows for its 
translocation to the nucleus. In the nucleus it associates with TFs of the TCF/LEF family and 
activates the expression of target genes. Normally, in the absence of Wnt signals, the GSK3β, 
a serine/threonine kinase, serves to destabilize β-catenin. When GSK3β is overexpressed, it 
can also initiate cardiogenesis in non-cardigenic mesodermal explants of Xenopus laevis. 
The targeted inactivation of β-catenin in the node, the notochord and the endoderm of 
developing mice, was found to lead to ectopic formation of hearts along the anterior-posterior 
axis. (Gilberts Developmental Biology 6th edition) 
The third major signalling pathway, which is involved in the induction of the 
cardiogenic program, acts via WNTs and the c-Jun-N-terminal Kinase (JNK). In contrast to 
the Wnt/β-catenin pathway, which is inhibitory for cardiogenesis, there is a non-canonical 
Wnt/JNK pathway, which is essential for cardiac induction in the frog and chick embryo. 
Upon the activation of JNK and the small GTPases RhoA and cdc42, Wnt 11 is expressed in 
the mesoderm. Wnt 11 and has been implicated in regulation of cell polarity and movement 
during gastrulation. In frogs, the ectopic expression of Wnt 11 or activation of protein kinase 
C (PKC) and JNK induces a cardiogenic phenotype. In contrast to that, the inhibition of Wnt 
11, PKC or JNK inhibits endogenous or induced cardiogenesis. Wnt 11 also was shown to 
inhibit the canonical Wnt/β-catenin pathway, and therefore to silent the repressive signals 
from Wnt/β-catenin pathway. The Wnt-inhibitors of the Dickkopf and Frizzled family 
stimulate the Wnt/JNK pathway at the same time as they block Wnt/β-catenin signalling. 
Thus, the activation of Wnt/JNK signalling by factors expressed in endoderm and mesoderm 
promotes cardiogenesis. In contrast to that, the inhibitory Wnts from the neural plate help to 
limit the extension of the cardiac fields. (Gilberts Developmental Biology 6th edition) 
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The fourth major signalling pathway, which modules cardiogenesis, acts via the 
fibroblast growth factor (FGF) family of signalling molecules. Explant experiments revealed 
that FGF-4 in combination with BMP-2 can induce cardiac differentiation in non-cardiac 
mesodermal explants. The FGF signal is required transiently to induce the cardiac fate in non-
cardiac cells, but it is also required to sustain the expression of Nkx2.5 and Serum Response 
Factor (SRF) genes. In another study in mouse and chick embryos, the inducing mesoderm 
was excised and FGF-8 was applied ectopically. The ectopic application of FGF-8 prevented 
the loss of cardiac gene expression. Furthermore, the expression of cardiac markers is 
expanded when FGF-8 soaked beads are placed lateral to heart fields. FGF-8 only has a 
cardiogenic effect in presence of BMP signalling and the fgf8 gene appears to lie downstream 
of BMPs. (Gilberts Developmental Biology 6th edition) 
The signalling pathways described above are highly interconnected and cross-talk to each 
other. There are positive regulatory circuits as well as negative regulatory circuits. 
The gene of our interest, nkx 2.5, also lies downstream of BMP signalling.
The nkx 2.5 gene is a vertebrate orthologue of the Drosophila tinman (tin) gene. It is one of 
the first genes expressed in the developing heart of early stage vertebrate embryos. In the 
mouse, nkx-2.5 is one of the initial markers of the cardiogenic region and is expressed in the 
heart throughout development and in the adult. In addition to that, nkx 2.5 is expressed in the 
developing pharyngeal arches, the spleen, the thymus, the thyroid, the stomach and the 
tongue. Likewise to tin, nkx 2.5 gene expression is regulated by a complex series of positive 
and negative regulatory circuits. The nkx 2.5 gene is known to be regulated by TFs, which 
bind to a 505 bp regulatory element, that contains multiple GATA, NKE, bHLH, HMG and 
HOX consensus binding sites. This 505 bp regulatory element was shown to be sufficient for 
gene activation in the cardiac crescent and in the heart outflow tract, pharynx and spleen by 
reporter gene assays with the lacZ gene. If the paired GATA sites within this element are 
mutated, the activation of nkx 2.5 is eliminated in transgenic embryos. The dependence of this 
nkx-2.5 regulatory element on GATA sites for gene activity is evidence for a GATA-
dependent regulatory mechanism controlling nkx-2.5 gene expression. As there are not only 
GATA binding sites on the distal regulatory element, it is most likely a combinatorial 
interaction of multiple factors, which is responsible for the initial activation of nkx 2.5 in the 
cardiac, thyroid and spleen primordial (Searcy et al.1998). 
18 
1.5. Desmin in cardiomyogenesis 
In all types of mature striated muscle, desmin links individual myofibrils laterally at the level 
of Z-discs. In addition to that, it connects the contractile apparatus with mitochondria 
(Capetanaki et al.2002; Milner et al.2000), the nucleus, the sarcolemma, the T-tubules, and 
the post-synaptic areas of motor end plates. Last but not least, desmin is also found to be 
concentrated at myotendinous junctions of skeletal muscle and at the desmosomes of cardiac 
muscle (Bär et al. 2004). In mammalian skeletal muscle, desmin is one of the first marker 
proteins for muscle, where it is detected in the somites and myoblasts (Herrmann et al. 1989; 
Kaufman and Foster 1988). 
  
Fig.1.5.1: Transgenic mice deficient in desmin. 
Representative developmental stages of transgenic mice deficient in desmin (des::lac Z) are 
shown in figure 1.5.1: The desmin gene was heterozygously or homozygously disrupted by an 
E.coli lacZ gene (Li et al. 1997). Therefore the sites where desmin would be expressed can be 
easily located in β-galactosidase staining. (A) Shows the formation of the myotome in 
heterozygous des+/lac Z+ mouse at day 11 p.c. (B) Shows the formation of the myotome in 
homozygous des-/- (lacZ+/+) mouse at day 11 p.c.: Tissue areas, which are stained in blue, 
correspond to sites, where the expression of the desmin gene normally takes place (h=heart, 
dm=dermomyotome, hl=hind limb, hg=hind gut). More intensive blue staining in (B) is due to 
homozygosity in the lacZ gene. (C) Shows the growth of muscle in mice, aged 13.5 days p.c. 
and (D) day 15 p.c. Both pictures show normal formation of muscle, although desmin gene 
expression is homozygously replaced by lac Z. (ld= latissimus dorsi, cm=cutaneous maximus) 
 
In mouse the desmin protein first appears at day 8.25 post coitum (pc) in the neurectoderm, 
where it is transiently co-expressed with keratin, vimentin, and nestin. At day 8.5 pc the 
protein localizes to the heart rudiment and by day 9 to 9.5 it forms longitudinal filaments 
associated with the Z-disc within the somites. During early differentiation of mammalian 
skeletal and cardiac muscle, desmin is transiently co-expressed with keratin, vimentin, and 
nestin. Later in development the protein has been described to co-localize with synemin and 
paramin (Capentanki et al.1984). During skeletal muscle differentiation, the expression of the 
desmin gene precedes the expression of all other muscle specific genes. It even precedes the 
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expression of transcriptional regulators for muscle differentiation, the myoD family members, 
with the exeption of the myogenic factor 5 (myf5). Transcripts of myf5 could be detected as 
early as day 8 pc in the myotome, which is in contrast to desmin transcripts appearing at day 9 
pc. Due to the fact that the expression of the myf5 gene is preceding the expression of desmin 
and because the expression of the desmin gene is preceding the expression of myoD family 
members, it has been proposed that myf5 may be involved in the initial activation of the 
desmin gene and on the other hand, that desmin might play a regulatory role in myogenic 
development as well. However, the next myogenic marker to appear in developing mouse 
embryos is myogenin at day 8.5 pc (or 9pc), followed by myoD at day 10 pc and finally 
MRF4. The desmin gene contains various cis-acting elements in its 5´- flanking region, such 
as several GC-boxes, three myoD- binding sites (E-boxes), one MEF2 binding site, and a 
region with homology to an M-CAT motiv. Co-transfection studies of myoD, myogenin, 
MRF4, and myf5 with a desmin-CAT construct revealed that the desmin gene is 
transactivated in 10T ½ fibroblast (Li et al.1993). Therefore, it is assumed that these factors 
transactivate desmin at different stages during development, alone or in combination. Studies 
with myoD-/- myoblasts showed that the desmin gene expression is 55-fold higher in wild type 
myoblasts than in the myoD-/- myoblasts. This supports the idea that the myogenic 
transcription factor, myoD, is one of the major regulators of desmin gene expression. The 
desmin gene is most probably regulated by myoD via the E-boxes (myoD-binding sites) in the 
5’-flanking region of desmin gene (Asakura et al., 2007). To further investigate the role of 
desmin in myogenic development and differentiation, several in vitro studies were done in the 
past decades. For instance, antisense RNA-technology was used in C2C12 myoblasts. The 
desmin antisense RNA interferes with desmin gene expression, which in the C2C12 myoblasts 
blocked the fusion of myoblasts and the formation of myotubes. Furthermore, the antisense-
RNA negatively interfered with the normal induction of the muscle specific gene expression. 
In addition to that, the desmin antisense-RNA downregulated the expression of the myogenic 
helix-loop-helix (HLH) regulators of transcription myoD and myogenin (Capetanaki et 
al.1997). In another in vitro experiment embryonic stem cells (ESC) were used to investigate 
the consequences of a lack of functional desmin. In this study ESC with wildtype alleles of 
desmin and ESC with homozygously or heterozygously mutated alleles of desmin were used. 
The ESC were allowed to differentiate in vitro in an embryoid body (EBs) model, which 
normally recapitulates the in vivo cardiac, skeletal and smooth muscle myogenesis of mouse 
embryos. The ESC/EB study revealed that skeletal myogenesis in desmin null mutant EBs 
was totally inhibited. The inhibition of skeletal myogenesis was manifested by the absence of 
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myotube formation, the absence of any contracting movement, and the absence of myogenic 
marker expression, such as myoD, myogenin, myf5, and myosin heavy chain. Formation of 
smooth muscle tissue also was completely missing in the absence of desmin. On the other 
hand, no obvious effect on cardiac differentiation could be observed, as desmin null EBs were 
still able to develop fields of beating cardiomyocytes. The data of this in vitro study suggests 
that desmin is indispensable for skeletal and smooth muscle development, but in contrast 
seems to be negligible for cardiac differentiation.  
However, the in vitro data is not supported by in vivo experiments. Desmin knockout 
mice were generated in 1996 by D.J.Milner and colleagues. The desmin null mice were 
viable, which implicates that prenatal muscle development can take place in the absence of 
desmin. These mice display no obvious anatomical defects, when compared to wild type or 
heterozygous littermates. Capetanaki and colleagues (1997) ascribed the absence of any 
obvious anatomical defects in desmin null mice to compensatory mechanisms. To prove this 
hypothesis, the expression levels of other IF genes were analysed, but there was no unusual 
maintenance or up-regulation of gene expression detected, that could serve for compensation. 
As myofibrils are properly assembled in desmin null mice, it is obvious that desmin is not 
necessary for assembly and initial lateral alignment of myofibrils, as it was originally 
suggested by Hill and colleagues (1986). An analysis of muscle from desmin null mice has 
shown that the absence of desmin does not influence the localization or expression levels of 
some individual myofibrillar proteins. A comparison of the localization and expression levels 
of α-actinin, cardiac troponin, nebulin and myosin heavy chain proteins in desmin null and 
desmin wildtype mice showed no significant difference (Capetanaki et al.1997).  
In mice the expression of the desmin gene becomes visible at day 7.25 p.c. (Kuisk et 
al.1996) in murine pre-cardiac mesoderm, emanating from brachyury and goosecoid 
expressing mesodermal precursors. In embryoid bodies (EBs), desmin mRNA was detected at 
day 5 (Weitzer et al.1995), before cardiomyogenesis takes place. Later in development, 
desmin is also expressed in skeletal and smooth muscle cells and it is known to influence 
myogenesis at the transcriptional level by modulating the basic helix-loop-helix (bHLH) TF 
genes myogenin, myoD, and myf5 (Li et al.1994; Weitzer et al.1995). In-vivo and in-vitro 
studies revealed that desmin is dispensable for cardiomyogenesis (Weitzer et al.1995; Li et 
al.1996; Milner et al.1996). Initially, transgenic mice which lack a functional desmin gene 
develop normal. Later, these mice develop lesions in cardiac muscle (Li et al.1996; Milner et 
al.1996) which are accompanied by the disorganization of myofibrils, intercalated discs, and 
mitochondria (Capetanaki et al. 2002).  
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However, the early expression of desmin in pre-cardiac mesoderm and its influence on 
transcription of early myogenic transcription factor genes in skeletal muscle (Li et al.1994; 
Weitzer et al.1995), suggests a role for desmin in very early developmental processes like 
cardiomyogenic commitment and differentiation. 
To test the hypothesis that desmin affects very early developmental processes, in-vitro 
cardiomyogenesis was observed in EBs. The EBs had been generated from four different 
murine ESC lines, which divert in their alleles of the desmin gene. The first ESC line, which 
was used to generate EBs, carries the normal wild-type alleles of the desmin gene (des+/+). 
The second ESC line, which was used to generate EBs, holds an additional wild-type allele of 
the desmin gene and therefore is expressing desmin ectopically (des+/+ desect). The third ESC 
line, carries disrupted alleles of the desmin gene (des-/-) and therefore does not produce any 
functional desmin (Weitzer et al. 1995). The fourth ESC line, carries an amino-terminally 
truncated version of desmin (desΔ1-48/Δ1-48), which leads to the production of N-terminally 
truncated desmin Δ1-48 protein (Höllrigl et al. 2002). These ESC were subjected to in-vitro 
differentiation in the embryoid body (EB) hanging drop model. Usually, in wild-type (WT) 
EBs clusters of beating cardiomyocytes appear at day 7. Interestingly, in the des+/+ desect  EBs 
the onset of cardiomyogenesis took place one day prior compared to the WT EBs, as shown in 
figure 1.5.2.A. The development of beating cardiomyocytes from the des-/-  ESC, which were 
differentiated in the EB hanging drop model, was delayed by about one day compared to WT 
ESC. In addition to the delay of cardiomyogenesis in the des-/- EBs, the clusters of beating 
cardiomyocytes were smaller, as shown in figure 1.5.2.C.  
The EBs, which were generated from desΔ1-48/Δ1-48 ESC, poorly developed small 
clusters of beating cardiomyocytes with a delay of two days, compared to WT EBs (Hofner et 
al.; 2007). In addition to that, the data demonstrates that the expression of the N-terminally 
truncated desmin (desmin ∆1-48) is more disadvantageous to cardiomyogenesis than the 
absence of desmin (desmin-/-). From these results it is reasonable to propose a regulatory role 
for desmin in commitment and early differentiation of cardiomyocytes. 
In the same piece of work, Hofner and colleagues investigated the influence of desmin 
on the morphology of cardiomyocytes. Therefore, EBs which were derived from in-vitro 
differentiation of ESC of the respective genotypes, were subjected to immunofluorescence 
imaging (data not shown). The EBs had been stained with specific antibodies for cardiac 
troponin T (cTnT) and desmin. The immunofluorescence staining revealed that, compared to 
des+/+ EBs, the size of clusters of cardiomyocytes in EBs from des-/- ESC was decreased 
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significantly. In contrast to that, the EBs derived from des+/+ desect ESC showed very large 
areas of cardiomyocytes, which completely covered the central area of the EBs. The desΔ1-
48/Δ1-48 EBs showed similar reduced areas of cTnT-staining as the des-/- EBs. This 
demonstrates a dominant-negative effect of desminΔ1-48 on cardiomyogenesis. Further, this 
suggests that differentiation and proliferation of ESC towards a cardiac fate is severely 
disturbed by the presence of an amino-terminally truncated version of the desmin protein. The 
constitutive desmin expression in the des+/+ desect ESC, in EB differentiation model led to the 
observation that these EBs develop larger and more interconnected clusters of beating 
cardiomyocytes. In addition to that, these clusters show increased rates of synchronous 
contraction compared to the wild-type EB-clusters, as it is shown in figure 1.5.2.B.
  
Fig.1.5.2ABC: EB in vitro differentiation study (Hofner et al.; 2007) 
A) Compared developmental time course of beating cardiomyocytes in EBs. Note that the 
development of beating cardiomyocytes in EBs from des+/+ desect ESC is one day ahead (day 
6), compared to the wild-type (day 7). The expression of desΔ1-48/Δ1-48 is more 
disadvantageous for cardiomyogenesis, than the complete absence of desmin (des-/-).  
B) The initial increase in clusters of beating cardiomyocytes per day. (Hofner et al.;2007). 
The acceleration of development to beating cardiomyocytes by desmin is demonstrated. 
C) The extent of cardiomyogenesis from ESC of the different genotypes. (Hofner et al. 2007) 
The size of the bars refer to the ability of ESC of the four different genotypes to develop into 
cardiomyocytes. More than 85% of the des+/+ ESC contrasted by less than 30% of des∆1-48/∆1-
48 ESC contribution to cardiomyogenesis. 
 
After the observation of the reported morphological and physiological changes, the effect of 
differential desmin expression was further investigated on a molecular level. Therefore, total 
mRNA was purified from EBs of the four different ESC at day 0 to day8 of in-vitro 
differentiation. The mRNA was reverse transcribed and used to assess the levels of 
mesodermal- and cardiac- marker genes in a semi-quantitative PCR. In wild-type EBs, desmin 
transcripts were detected at the beginning of mesoderm development around day 4 of in-vitro 
differentiation, as shown in figure 1.5.3A. Interestingly, the absence of desmin in EBs from 
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des-/- ESC had a weak negative effect on the expression of the mesodermal TF gene 
brachyury and a significant delay in the expression of the mlc1ν gene. The constitutive 
expression of the truncated desminΔ1-48 protein caused a downregulation of the mesodermal 
TF genes brachyury and goosecoid. In addition to that, the expression of the cardiac TF genes 
nkx 2.5 and mef2C is completely abolished between day 4 and day 6. The expression of the 
cardiac specific marker gene mlc1ν was delayed by two days. The marker gene of skeletal 
muscle development, mhcα, was unaffected.  
Furthermore, the constitutive overexpression of desmin in des+/+ desect ESC seemed to 
promote differentiation of ESC. This promotion of ESC differentiation became evident, 
because the stemness factor gene oct 3/ 4 was downregulated and the expression of brachyury 
and goosecoid, two primitive mesodermal markers, and the expression of the early cardiac TF 
nkx2.5 was reported to be significantly increased (Hofner et al.; 2007). Nkx 2.5 together with 
T-box transcription factors are known to synergistically promote cardiogenesis (Bruneau et 
al. 2002). The ability of desmin to directly bind to DNA via its N-terminus was shown in 
2003 by Li and colleagues and in 2005 by Tolstonog and colleagues. The fact that desmin is 
able to directly bind to DNA, allows for the suggestion of a regulatory role for desmin in 
cardiomyogenesis.   
The findings from Hofner and colleagues, as shown in figure 1.5.3ABC, strengthened 
the hypothesis that desmin influences cardiomyogenesis by direct or indirect interaction with 
regulatory elements within heart relevant transcriptional circuits. 
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Fig.1.5.3.: The influence of desmin on the expression of mesodermal and cardiac markers 
(Hofner et al.; 2007
  
   
 
A) Shows the mRNA levels of the genes 
as indicated.The levels of desmin 
expression are shown. Oct 3/4 is a 
stemness factor, which is expressed at 
high levels in undifferentiated 
embryonic stem cells. Oct 3/4 
expression ceases in course of 
differentiation. Brachyury is known 
as a mesodermal TF. Nkx 2.5 is a 
cardiac TF. GAPDH expression 
levels were used for internal 
normalization of the template cDNA. 
B) Demonstrates the up-regulation and 
down-regulation of brachyury 
expression in des+/+ desect EBs and 
desminΔ1-48/ Δ1-48EBs respectively 
relative to des+/+ EBs. 
C) Demonstrates the up-regulation and 
the downregulation of the cardiac TF 
nkx 2.5 expression in des+/+ desect 
EBs and desminΔ1-48/ Δ1-48EBs 




The hypothesis that desmin influences cardiomyogenesis is further strengthened by the data, 
which is presented in the work of Höllrigl and colleagues from 2007 and shown in figure 
1.5.4. From previous experiments, the scientists had learned that the expression of desminΔ1-
48 in ESC elicits a severe phenotype in in-vitro differentiated EBs. It was already known 
before, that the amino-terminus of intermediate filament proteins influences their assembly 
and can interact with a variety of other proteins and with DNA, and that it therefore might be 
essential, but still the severity of the phenotype was surprising.  
At the N-terminus of native intermediate filament proteins of type III, there are specific serine 
residues, which might be reversibly phosphorylated during the cell cycle or during 
developmental processes. Usually, the phosophorylation of serine or threonine residues is 
accomplished by kinases, like the protein kinases A and C, the small kinase cdc42, the Rho-
dependent kinase, and many others. To elucidate the significance of desmin and especially the 
N-terminal serine residues in more than just structural means, Höllrigl and colleagues 
performed a series of mutations in the N-terminal region of the desmin protein. The serine 
residues 6,7, and 8 of the desmin protein were heterozygously mutated to alanine in ESC 
(des+/S6,7,8A).
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In parallel, the serine residues 31 and 32 were mutated heterozygously to alanine in ESC 
(des+/S31,32A). Both mutant variants of the desmin gene were expressed under the control of 
the native desmin promoter. Upon the exchange of the indicated serine residues by alanine, 
these affected residues are no more phosphorylated by kinases. The hetero-zygously mutated 
ESCs were allowed to differentiate in-vitro in the EB hanging drop model. The heterozygous 
expression of the mutant desminS6,7,8A variant resulted in delayed cardiomyogenesis and 
reduced proliferation, as reported by Höllrigl and colleagues in 2007 (Höllrigl et al.; 2007). In 
addition to that, the expression of this mutant desmin variant affects myofibrillogenesis and 
results in altered morphology of cardiomyocytes (data not shown). Furthermore, the 
expression of desminS6,7,8A led to the downregulation of the TF genes brachyury, 
goosecoid, nkx2.5, and mef2C , as it is shown in figure 1.5.4. Höllrigl and colleagues 
demonstrated, that with the onset of desmin expression in the pre-cardiac mesoderm of 
embryoid bodies, the mutant desminS6,7,8A variant caused a delay in the onset of the 
expression of the mesodermal transcription factor genes brachyury and goosecoid. The 
expression of nodal, a gene of the TGF-β family, which is specifically expressed in 
mesoderm, was partially and temporally down-regulated. In contrast to that, the expression of 
the stemness factor oct3/4 in the primitive ectoderm was not affected. In parallel to the 
observed delay of cardiomyocyte development in EBs, which were generated from des+/S6,7,8A 
ESC, the expression of the early myocardial TF nkx2.5 was delayed significantly. The 
expression of mef2C was found to be completely blocked at day 6 and partially blocked at day 
8. The expression of the myosin light chain gene (mlc1ν) was partially delayed. In contrast, 
the expression of the genes coding for mhcα and vimentin was not affected significantly. The 
mhcα and vimentin proteins are not restricted to cell types, which express the mutant 
desminS6,7,8A. In summary, the timing and the degree of the expression of the myocardial 
TFs nkx2.5 and mef2C was much more affected by the expression of the mutant 
desminS6,7,8A variant, than the expression of the mesodermal TFs brachyury and goosecoid.  
The degree of the delay in the expression of the TF genes brachyury, goosecoid, nkx2.5 and 
mef2C in des+/S6,7,8A  EBs relative to des+/+ EBs (1.0) is shown in figure 1.5.4B. 
These results suggest that the expression of the mutant desminS6,7,8A variant specifically 
affects mesodermal cells with a cardiac fate.          
In contrast, the expression of the mutant desminS31,32A variant did not show the 
same impact on the expression of myocardial TFs, as it was observed for the expression of the 
mutant desminS6,7,8A variant. Consequently, desminS6,7,8A but not desminS31,32A 
severely interferes with the molecular mechanisms, which are involved in the transcriptional 
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control of the TF genes, which guide the commitment of the mesoderm to the cardiomyogenic 
lineage. 
Further, the expression of the mutant desminS6,7,8A variant seemed to cause 
increased apoptosis of presumptive mesoderm and differentiating cardiomyocytes. The 
cardiomyocytes, which remained viable, were lacking myofibrils. These results suggest an 
important role for temporarily phosphorylated serine residues 6,7, and 8 in the amino-terminal 
portion of desmin protein. The phosphorylation of serine 6,7, and 8 might be instrumental for 
the commitment and the proliferation of cardiomyocytes. In contrast to that, the expression of 
the mutant desminS31,32A variant, had no significant effect on the onset of the 
cardiomyogenesis. The desminS31,32A EBs showed a very mild phenotype with smaller 
fields of beating cardiomyocytes as compared to the wild-type desmin EBs of the same 
developmental stage. Thus, the serine residues 31 and 32, which are not targeted by kinases, 
seem to be less important for the proper function of desmin. In the past, the phosphorylation 
of analogous serine or threonine residues in other intermediate filament proteins was shown to 
regulate the disassembly of the intermediate filament proteins during mitosis (Izawa et 
al.2005). Thus, it is most likely, that the mutant desminS6,7,8A variant elicits the phenotype, 
which was described above, due to the irreversible aggregation of desmin intermediate 
filament protein. Indeed, Höllrigl and colleagues reported that they had found aggregated 
desmin in immunofluorescence microscopy of EBs, which express the mutant desminS6,7,8A 
variant. The cardiomyocytes of these EBs were completely lacking myofibrils and typically 
assembled intermediate filament protein. These cardiomyocytes were also reported to show 
aberrant morphology and to contain irregularly shaped cytoplasmic material, which was 
reminiscent of the aggresomes, which were observed in desmin-related cardiomyopathies 
(Goldfarb et al.2008).  
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Figure 1.5.4: The molecular consequences of the expression of the mutant desmin variants 
(desS6,7,8A and desS31,32A).(from Höllrigl et al., 2007) 
(A) Results of semi-quantitative RT-PCR (Höllrigl et al.2007). 
(B) Timing of the expression of the TF genes brachyury, goosecoid, nkx2.5 and mef2C. The 
presented values are set relative to their expression in wild-type des+/+ EBs(1.0). The degree 
of the delay in the expression of these TFs is visualized. 
 
From the data of Höllrigl and colleagues work (2007) and previous experiments, it was 
concluded that desmin in general and in particular its amino-terminus, plays a vital role in the 
commitment of the mesoderm to the cardiomyogenic lineage, in the early differentiation of 
cardiomyocytes and in the generation of myofibrils. The embryoid body model of in-vitro 
differentiation again was proven to be a powerful tool to study early developmental processes. 
1.6. Desminopathy 
In the past years, a subset of myopathies was found, which is characterized by the presence of 
abnormal extensive accumulations of granular and filamentous aggregates in the contractile 
elements of a muscle cell, the sarcomeres. Because of the pre-dominant occurance of desmin 
in these aggregates, the described myopathies were named “desminopathies” (DM) or 
“desmin-related myopathies” (DRM). Affected patients exhibit a slowly progressive skeletal 
muscle weakness associated with cardiomyopathy. The cardiomyopathy is manifested by 
conduction blocks, arrhythmias, and chronic heart failure resulting in sudden premature death. 
First symptoms appear in the second or third decade of life. Usually, skeletal muscle 
weakness is progressive, often ascending from distal to proximal limb muscles, finally 
affecting the trunk, and eventually leading to respiratory failure. However, the 
intrasarcoplasmic aggregates, which are characteristic of DRM, do not only contain desmin, 
but also αβ-crystallin, dystrophin, actin, ubiquitin, synemin, syncoilin, nestin, plectin, and 
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vimentin. The aggregates are found as multifocal cytoplasmic inclusions or spheroid bodies, 
or as disseminated granulo-filamentous material. Additionally, histological observation 
showed myofibrillar disarray and loss of sarcomere integrity in affected tissue. This ultimately 
leads to muscle cell death in an apoptotic or necrotic pathway, further causing fatty 
degeneration and calcification.  
Disease-associated Mutations 
 
Fig.1.6.1: Schematic representation of structural organization of desmin protein and 
predicted positions of disease-causing mutations. (Goldfarb et al. 2008) 
 
To date 42 pathogenic mutations in the desmin gene could be identified (Goldfarb et al. 
2008). The number of patients is rapidly increasing because of the rising awareness of this 
frequently miss-diagnosed disease. DRM is associated with either autosomal dominant or 
recessive inheritance. So far 37 miss-sense mutations, three small in-frame deletions, and 
deletion of exon 3, which is caused by mutated donor and acceptor splice sites in the desmin 
gene, have been described as disease-causing. The majority of the mutations (22) were found 
in the conserved 2B α-helical segment, some additional mutations (10) could be identified in 
the tail domain of desmin protein, and five mutations were located to the head domain. 
Interestingly, so far no mutations in 1A and 2A segments were found. However, in some 
cases of DRM the desmin gene was found unaffected, but instead a mutation in αβ-crystallin, 
which serves as a chaperone for the desmin protein, could be identified. Filament and network 
assembly studies indicate that most, but not all disease-causing mutations make desmin 
assembly-incompetent and able to disrupt a pre-existing filamentous network in a dominant 
negative way. However, it is remarkable that even point mutations often lead to severe 
alterations in desmin filament structure and assembly, finally giving way to diseased tissue. 
To date there are three different mechanisms discussed, which may lead to disturbed desmin 
homeostasis and therefore to a pathologic phenotype. The first is a compromised assembly of 
the mutant protein. The second mechanism is summarized as “altered biophysical properties” 
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of the mutant protein, which eventually leads to an increased susceptibility to stress-induced 
filament break-down and increased proteolysis. Both kinds of disturbance are caused by 
mutations in the α-helical segments, which are crucial to proper folding of desmin units and 
assembly of the filaments. The third mechanism regards the ability of the assembled protein 
filaments to interact with cellular binding partners. The interaction ability of mutant protein 
may be severely impaired, which in consequence may lead to degradation of the impaired 
protein (in our case desmin) and its segregation into protein granules. This was shown to be 
the case with desmin mutant in the non-helical tail segment. In DM or DRM most probable it 
is a combination of all three mechanisms, not a single cause, which leads to a diseased 
phenotype in individual patients. This suspicion is supported by increasing evidence that most 
severe cases of desminopathies are caused by a combination of mutations in two or more 
relevant genes (e.g. αβ-crystallin, desmin, and lamin A/C). The interference of mutant desmin 
in filament-formation was tested in in vitro filament formation experiments, generation of 
ordered cytoskeletal arrays and assays for the ability to integrate into an existing cytoskeletal 
network in various cell lines. Analysis of filament assembly behaviour demonstrates that 
some desmin mutants do not prevent filament assembly. Some other mutations interfere with 
the assembly process at distinct stages and these are classified into three groups: 1) mutations 
that compromise the longitudinal annealing properties; 2) mutants with enhanced 
adhesiveness leading to filament aggregation; and 3) mutants showing rapid disintegration of 
assembly precursors. However, mutations in desmin are responsible for inadequate supply of 
normal functional desmin. Toxic aggregates containing mutant misfolded desmin and debris 
of other myofibrillar and ectopically expressed proteins accumulate in the myofibers and 
eventually lead to their destruction. In addition to the toxic accumulation of mutant protein 
species, mutant desmin was shown to hamper normal interactions with other cytoplasmic 
proteins. 
The genetic background of desminopathy: autosomal recessive inheritance  
So far, three autosomal recessive (AR) desmin mutations are known. Patients who are carriers 
had the earliest onset of disease and the fastest progression of illness. A patient homozygous 
for a deletion of seven amino acids in the 1B helix (Arg173-Glu179del) developed 
generalized muscle weakness and atrophy, predominantly in the distal muscles of the upper 
extremities. In the same patient atrioventricular block required urgent implantation of a 
permanent pacemaker. In addition to that, the patient suffered from intestinal malabsorption. 
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The progression of disease led to cardiac and respiratory failure and intestinal pseudo-
obstruction at the patient’s age of 28 years. 
In another family three siblings were compound-heterozygous for the Ala360Pro and 
Asn393Ile substitution mutations in the desmin gene. In all three, a complete heart block 
required implantation of a permanent pacemaker at the patient’s ages of two, nine and ten 
years. Between the ages 20 and 24 years, all three developed progressive muscle weakness 
and wasting in the extremities and trunk, weakness in the neck and facial muscles, swallowing 
and breathing difficulties. Finally, all three died due to congestive heart failure at the age of 
28, 30 and 32 years. Histopathologic analysis revealed intramyofiber accumulation of 
amorphous desmin immunoreactive material with characteristic subsarcolemmal distribution. 
Interestingly, several older members of the same family carrying either the Ala360Pro or the 
Asn393Ile mutation did not show any signs of muscle or heart disease. (Goldfarb et al.2008) 
Resuming, there is increasing evidence that certain mutations in the desmin cause serious 
problems in individuals who carry that mutation.    
In Vitro studies  
In vitro studies of desmin knock down in C2C12 myoblasts gave some insight into desmin’s 
function. The C2C12 myoblasts were treated with antisense RNA of desmin. The use of 
antisense RNA interfered with desmin gene expression in the C2C12 myoblasts and led to 
blockade of myoblast fusion and formation of myotubes. In addition, desmin antisense RNA 
treatment interfered with the normal induction of muscle specific gene expression, including 
the myogenic helix-loop-helix (HLH) regulators of transcription myoD and myogenin 
(Capetanaki et al., 1997).  
Another in vitro experiment was done with embryonic stem cells (ESC), which 
differed in their desmin alleles. In this study ESC with wild type desmin allele and 
heterozygously or homozygously mutated desmin alleles were allowed to differentiate in an 
embryoid body (EB) model. These EBs normally recapitulate the in vivo skeletal, smooth and 
cardiac myogenesis. This in vitro study revealed that desmin null EBs showed totally 
inhibited skeletal myogenesis, which was manifested by the absence of myotube formation 
and the absence of myogenic marker expression, such as myogenin, myoD, myf5, and myosin 
heavy chain. In addition to that, formation of smooth muscle was also completely absent in 
the desmin null EBs (Weitzer et al. 1995). In contrast to that, cardiac differentiation occurred 
and fields of beating cardiomyocytes could be observed. In summary, the data of the EB in 
vitro study suggests that desmin is indispensable for skeletal and smooth muscle development, 
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but in contrast seems to be negligible for cardiac differentiation (Capetanaki et al., 1997). 
However, the in vitro data is not supported by in vivo experiments.  
The animal model 
Desmin null mice were generated in 1996 by Milner D.J. and colleagues. The knock-out mice 
are viable, fertile and develop all three types of muscle tissue. In comparison to wild type 
litter mates the desmin null mice appear normal and do not show any anatomical defects. 
Though the mice appear normal, they have defects in their muscle structural organization. In 
the second week after birth, the desmin null mice appear more lethargic than their wild type 
and heterozygous litter mates. Dissections from these mice showed extensive calcium 
deposits in the myocardium and signs of degeneration. Histological and electron microscopic 
analysis revealed the appearance of a general loss of cardiomyofiber tension, with areas of 
disruption and disorganization of cardiac myofibers. In contrast to that, dissections from 
neonates did not show the same signs of degeneration and calcification. However, electron 
microscopy of desmin null ventricular muscle revealed that several myofibers demonstrated 
severely disrupted architecture. In contrast to wild type fibers, which display laterally aligned 
myofibrils and packed mitochondria, the desmin null myofibrils have lost their lateral 
alignment and often show disrupted myofibrils, particularly in the position of the intercalated 
discs. The loss of myofibrillar anchorage to the plasma membrane is one of the hallmarks of 
the observed defects in desmin null mice. Furthermore, the mitochondria have lost their shape 
and organization, and often appear to be “swollen”. (Capetanaki et al.1997) 
 
  
Fig.1.6.2: The muscle architecture in wild type (wt) and desmin null (-/-) mice (Capetanaki 
et al.1997). Transmission electron microscopy of cardiac muscle from desmin wt and null 
mice is shown above. Wt muscle (left) shows aligned arrays of myofibrils terminating and 
inserting into intercalated discs. Myofibrils are occasionally interrupted by packed strands of 
mitochondria. In desmin null muscle (right) myofibrils are disorganized and separated from 
the sarcolemma, hypercontracted, and damaged. The mitochondria are disorganized and 
abnormal in size and shape. 
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Histological examination of desmin null mice skeletal muscle of the tongue, leg and 
diaphragm revealed similar defects in the integrity and organization of the myofibers, but to a 
lesser extent than it was seen in the cardiac muscle. The abnormalities that were observed 
ranged from loss of myofiber tension, ragged and disorganized myofibers with less 
discernible striation to loss of stable nuclear positioning and indications of degeneration. 
Cross sections of skeletal muscle from desmin null and wild type mice also demonstrate that 
in mice lacking desmin, many fibers are ragged in appearance, of smaller diameter, and are 
less closely packed, when compared to wild type muscle. Among the different skeletal 
muscles, tongue is most affected by myofiber disruption and disintegration. The diaphragm 
also is severely affected. Less affected are muscles of the thigh and the long muscles of the 
back. This pattern shows that in desmin null mice more active skeletal muscles are more 
affected by myofiber disruption than less active ones. Histological analysis of smooth muscle 
revealed similar defects. The abnormalities in the smooth muscle of desmin null mice include 
loose organization of smooth muscle cells, and loss of the normal elongated nuclear shape. In 
summary the effects of the absence of desmin are most severe in the myocardium, with 
smooth muscle seemingly least affected and skeletal muscle exhibiting damage that is 
intermediate in severity. However, only a fraction of the cell population in a given muscle 
tissue is defective. Together, the findings of Y.Capetanaki, D.J. Milner, G.Weitzer and 
colleagues (Capetanaki et al. 1997; Milner et al. 1996; Weitzer et al. 1995) suggest that in 
vivo desmin is not absolutely necessary for the formation and assembly of myofibrils, but they 
rather indicate that it is required for maintenance of cellular integrity and possibly for repair 
and regeneration after mechanical damage. Muscle that is deficient in desmin seems to be 
more fragile than wild type muscle and seems to be more easily damaged by contractile 
activity. 
Another animal model brought more insight into formation of protein aggregates. 
Transgenic mice expressing a human mutation p.Arg173-Glu179del in the desmin gene show 
accumulation of chimeric intracellular aggregates of desmin and other cytoskeletal proteins in 
the myocardium. Such inclusions are not seen in knock-out mice, supporting the hypothesis 
that mutant misfolded proteins may act as seeds in the formation of these protein aggregates 
in desminopathies. The protein aggregates disrupt the continuity and overall organization of 
the desmin network throughout the cell. These aggregates appear as electron-dense 
granulofilamentous structures proximal to the nucleus and in the inter-myofibrillar space. 
Missfolded desmin protein seems to escape proteolytic breakdown and attracts other 
   33 
cytoskeletal proteins into insoluble high molecular weight chimeric aggregates that grow and 
finally have toxic effects on the tissue (Goldfarb et al. 2008).   
Conclusions from the two existing models 
The in vitro and in vivo studies introduced above indicate that desmin and in general the IF 
network is vital for the maintenance of cellular integrity and architecture of muscle cells, but 
not for myogenic commitment, differentiation or fusion of myoblasts in vivo. The IFs together 
with extracellular- and nuclear matrix proteins build up a network that extends throughout the 
muscle fibers. This network is thought to serve in coordination of contraction and relaxation, 
in strengthening the muscle, in transmission of mechanical forces and mechano-chemical 
signals throughout the muscle fiber, to the nucleus, other cellular organelles and the entire 
muscle in a coordinated fashion (Capetanaki et al. 1997). Ablation of the desmin gene 
expression demonstrated that functional desmin protein is crucial to the architectural and 
functional integrity of striated muscle. Mice lacking desmin showed a multisystem disorder, 
involving cardiac, skeletal, and smooth muscle. Histological and electron microscopic 
analysis in both heart and skeletal muscle tissue revealed severe disruption of muscle 
architecture and degeneration. Structural abnormalities included loss of lateral alignment of 
myofibrils and abnormal mitochondrial organization. These defects appear most severe in the 
heart, which exhibited progressive degeneration and necrosis of the myocardium, 
accompanied by extensive calcification. The consequences range from cardiomyocyte 
hypertrophy and chamber dilatation to heart failure. Chamber dilation is characterised by 
extensive myocyte death, fibrosis and calcification of the myocardium (Li et al.1996; Milner 
et al.1996). Abnormalities of smooth muscle included hypoplasia and degeneration. However, 
the detailed mechanism by which desmin deficiency leads to heart failure remains elusive, but 
one important hint may be the finding of disturbed mitochondrial behaviour, distribution and 
function in desmin-deficient mice (Capetanaki et al.2002). According to a study from Milner 
D.J. (Milner et al.2000) mitochondrial abnormalities appear prior to any other obvious effect 
in desmin-deficient mice. Mitochondria are despite their important role in a cells respiratory 
cycle, the central executioners in apoptotic and non-apoptotic cell death. Activation of pro-
death signal transduction cascades or damage pathways can perturb the mitochondrial 
membrane integrity. This may lead to the activation of the mitochondrial permeability 
transition pore (mtPTP) complex and/or to the activation of Bcl-2-Bax complex or the 
activation of caspases. In both cases, the cells “decision to die”, directly affects its 
mitochondria and is executed by these organelles. In des-deficient mice, “swollen” 
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mitochondria were observed. This might be a consequence of permeabilization of the 
mitochondrial inner and outer membrane (IM/ OM). The permeabilization of the OM will 
release proteins from the intermembrane space, such as cytochrome C, certain pro-caspases, 
adenylate kinase 2, and apoptosis-inducing factor. The permeabilization of the IM leads to 
dissipation of the intra-mitochondrial proton gradient, release of small solutes, such as 
calcium and glutathione, and to an influx of water and sucrose, that eventually may cause 
swelling of mitochondria. The permeabilization of the OM and IM can be triggered by a 
variety of apoptotic second messengers, including different members of the Bcl-2-family, like 
Bax, Bac, and Bid. The function and the localization of the different Bcl-2-family members is 
further influenced by signaltransduction molecules, including phosphatases, kinases, and 
caspases. Another non-protein factor, which mediates important “decisions” in mitochondria 
and concomittant in the cell, is calcium (Ca2+). Ca2+-homeostasis is mainly executed by 
mitochondria. On one hand, excessive intracellular Ca2+ contributes to a final common 
pathway of cytotoxic events, leading to formation of reactive oxygen species (ROS) and cell 
death. On the other hand, Ca2+ is a major signaling molecule, that stimulates for instance Ca2+-
sensitive enzymes in the Krebs cycle (pyruvate dehydrogenase (DH), isocitrate DH, and 
oxoglutarate DH), which allow the cell to adapt to increased need of energy. However, studies 
on the IF cytoskeleton have shown its importance for normal mitochondrial behaviour and 
function. Whether the abnormal behaviour of mitochondria is triggered by the lack of a 
functional IF network and the disturbance of Ca2+ -homeostasis is a consequence, or the latter 
is the leading cause, remains elusive. 
 
   
 
Fig.1.6.3: Desmin- null cardiac muscle. TEM pictures of the extensive mitochondrial 
proliferation and degeneration in desmin- null cardiac muscle (Capetanaki Y., 2002) (A) 
Cardiac muscle of wild type mice, with normal ultrastructure, laterally aligned myofibrils, 
and strands of mitochondria between myofibrils. (B) Cardiac muscle of exercised desmin-null 
mice, with severe mitochondrial proliferation and swelling. 
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Amino acid deletions or substitutions due to miss-sense mutations in the desmin gene 
may lead to aberrant filament assembly and function or to changes in filament turnover rates. 
Unfortunately, the detailed mechanisms, which lead to pathologic phenotypes, are still 
unclear. It is speculated that, compromised assembly of desmin protein and altered 
biophysical properties of the mutated protein may lead to increased susceptibility to stress-
induced filament break down and increased proteolysis. Another speculation is that altered 
desmin protein may be impaired in its interaction options with potential cellular binding 
partners, and thus is prone to degradation or segregation into protein granules (Bär et al. 
2004). 
A desmin null mutation in mouse model gives rise to a cardiomyopathy which early in 
post-natal life is seen as lysis of individual cardiomyocytes. This lysis is followed by invasion 
of the affected region by macrophages, and development of varying degrees of calcification 
and fibrosis. Disruption of the sacolemma, probably at the intercalated discs, seems to be a 
main event preceding cardiomyolysis, whereas myofibrillar disorganization due to a lack of 
intermyofibrillar desmin filaments seems to be of less significance (Thornell et al.1997).Once 
regional myolyis has occurred, the entire myocardium will be weakened, because in mammals 
the cardiomyocytes do not regenerate. The heart lacks the equivalents of skeletal muscle 
satellite cells. Therefore, as fibroblasts invest, replace dying cardiomyocytes, and secrete 
extra-cellular matrix components, fibrosis occurs (Thornell et al.1997). Thus, the advanced 
degeneration of the myocardium in des-/- mice, the calcification and fibrosis do not seem to be 
specific for the des-/- cardiomyopathy, but rather seem to be a result of a general repair 
process. This explains why the same hallmarks of myolysis, myocyte degeneration, 
calcification and fibrosis, as they were observed in the des-/- animals, were also found in 
animals that express normal desmin (Reichenbach et al. 1969). 
1.7. Clinical manifestation of desminopathy  
Desminopathy originally was described as skeletal and cardiac myopathy. It is characterized 
by bilateral weakness in distal leg muscles spreading proximally, or as proximal muscle 
weakness spreading distally and eventually leading to weel-chair-dependence. The weakness 
may involve extremities, trunk, neck flexors and facial muscles. In some variants of the 
disease patients experience dizziness, syncopal (short loss of consciousness) and fainting 
episodes associated with conduction blocks. These conditions require implantation of a 
permanent pace maker. Since the desminopathy ten years ago was defined as an independent 
pathology, many new affected families were identified. In a review from Goldfarb and 
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colleagues (Goldfarb et al.2008) 65 affected families with 98 patients are mentioned. 
Constantly increasing knowledge and rising awareness enables a more precise definition of 
clinical manifestations and diagnostic criteria.  
The pattern of inheritance was reliably established in 52 families with desminopathy. 
It was autosomal dominant in 32 of them and recessive in three families. Seventeen patients 
had sporadic onset with de novo mutations. The age of onset in autosomal dominant inherited 
desminopathy is between 14 and 48 years, while patients with recessive mutations develop the 
disease in their childhood or adolescence. The analysis of the clinical manifestations led to 
characterization of distinct, sometimes overlapping forms of desminopathy:  
Progressive skeletal myopathy 
A progressive uncomplicated form of skeletal muscle weakness was observed in 13 patients 
from six families. Initial symptoms were bilateral distal muscle weakness in the lower 
extremities, which later spread to proximal leg muscles, upper extremities, and neck flexors. 
Muscle biopsy showed abnormal accumulation of desmin-immunoreactive deposits in muscle 
fibers. As causative agent two different mutations were identified. The first was an amino acid 
substitution from asparagine to aspartate at residue 342. The second was a deletion of three 
amino acids from Glu359 to Ser361 (Goldfarb et al.2008).  
Respiratory dysfunction 
Respiratory dysfunction causes nocturnal hypoventilation with oxygen desaturation and 
eventually day time respiratory failure. The context between a disorder of a muscle specific 
protein and respiratory dysfunction is made by the diaphragm. The diaphragm, unlike other 
skeletal muscles, is functioning in an environment in which forces can be transmitted in both, 
longitudinal and transversal, directions in each respiratory cycle. Here desmin can serve as 
visco-elastic element to dissipate forces in both planes, because it is the only (known) 
molecule that has dual orientation. The critical significance of desmin in the respiratory cycle 
is most likely reflected by the fact that in the diaphragm the content of desmin is 38% higher 
compared to biceps femuris muscle. However, respiratory dysfunction combined with skeletal 
muscle weakness was observed in 10 patients from 5 families. The illness was caused by a 
missense mutation in desmin (i.e. a shift from alanine 357 to proline). Cardiac abnormalities 
were not observed in these patients. Muscle biopsies showed variation in fiber size and 
furthermore, intra-cytoplasmic eosinophilic patches, which in immuno-cytochemistry turned 
out to be desmin deposits. Moreover, deposits of desmin were seen in the subsarcolemmal 
space between myofibrils in electron microscopy. (Goldfarb et al.2008)  
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Cardiomyopathy 
Primary cardiomyopathies are classified pathophysiologically as dilated cardiomyopathy 
(DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and 
arrythmogenic right ventricular cardiomyopathy (ARCM). DCM is characterized by an 
increased ventricular chamber size and reduced systolic output. The disease pattern of RCM 
results from all processes that lead to stiffening of the myocardium. Infiltration and fibrosis 
lead to impaired ventricular filling and reduced diastolic volume, although wall thickness and 
cavity size appear normal. Out of 34 patients with cardiomyopathy, 18 were diagnosed with 
DCM, 10 with RCM, and 6 with HCM. As the heart conduction system is rich in desmin, a 
frequent feature in desminopathy patients is atrioventricular conduction abnormality. This 
condition often requires urgent implantation of a permanent pacemaker. Skeletal myopathy 
followed by cardiomyopathy was observed in 32 patients from 20 families. Cardiomyopathy 
alone with no signs of skeletal myopathy was seen in 19 patients from 15 families. (Goldfarb 
et al.2008)  
Correlation between a genotype and a phenotype in desminopathy 
Routine genetic screening gave convincing evidence that distinct clinical phenotypes of 
desminopathy resulted from different mutations. Cardiomyopathy, smooth muscle myopathy, 
respiratory dysfunction, neuropathy, facial paralysis or cataracts may be present in some 
cases, but absent in others. Phenotypic manifestations in members of the same family were 
concordant, with few exceptions. This observation suggests that the type and location of the 
mutation within the desmin gene most likely influences the resulting phenotype. For instance, 
patients carrying mutations in the 2B segment tend to show primarily skeletal muscle 
pathology, while those carrying mutations in the 1B and tail domains predominantly develop 
a more ominous cardiac disease. Moreover, there is a clear tendency for the age of onset to be 
four to ten years earlier and with faster progression in patients with cardiomyopathy as an 
early feature of disease. (Goldfarb et al., 2008)     
Table1.7: Clinical phenotypes of desminopathy caused by mutations located in the different 
functional domains of desmin protein. (Goldfarb et al. 2008)  
 
38 
1.8. Working hypothesis and design of this thesis 
From previous studies, we knew that the proper expression of the desmin protein is vital for 
cardiomyogenesis, although transgenic des-/- mice develop a functional heart and are viable.  
To further investigate desmin’s influence on cardiomyogenesis, two major experimental 
branches were designed. The first branch serves to prove a potential physical interaction of 
the desmin protein and regulatory elements in the genomic DNA. Therefore, a chromatin 
immuno-precipitation (ChIP) was performed with EBs of different developmental stages. In 
ChIP, residual proteins are reversibly cross-linked to the genomic(g) DNA. The gDNA is 
shredded by sonication. The proper sonication of the gDNA is an important step, because 
finally the ChIP samples are analysed by PCR for the presence of specific bands. Incomplete 
sonication of the ChIP samples might result in false-positive signals in later PCR. After the 
sonication, the samples are incubated with antibodies, which are specific for the protein of 
interest. Then protein A-coupled sepharose beads are added to hold the Fc-portion of the 
antibodies. The samples undergo a series of washing steps with different buffers to wash away 
unbound DNA, residual salts, and traces of RNA. In parallel, a “whole-amount” (input) 
sample is prepared. The input samples reflect the total amount of DNA, which is present in 
the sample before the series of washing steps. Finally, the crosslink between DNA and protein 
is reversed and the DNA is purified by phenol-chloroform extraction. The samples are used 
for ChIP-PCRs. These PCRs allow for amplification and therefore for visualization of the 
genomic regions, which physically interact with the protein of interest. Therefore, as it is 
mentioned above, the sonication is a vital step in this proecedure, because incomplete 
sonication may lead to the purification of a DNA fragment, which had bound the protein of 
interest at another site than the genomic element of interest.  
As the second experimental model we chose a luciferase reporter assay system. This 
reporter assay system was designed to see if desmin is not only able to bind to DNA, but also 
to interact with regulatory genomic elements, such as the nkx 2.5 promoter and the minimal 
cardiac enhancer (Lien et al.1999). Therefore, desmin was co-expressed with plasmids, which 
contain the firefly luciferase reporter gene under the control of the nkx 2.5 promoter or the 
minimal cardiac enhancer element additionally. The Dual Luciferase Reporter Assay® 
(Promega) provides a system, which allows for validation of such interactions. To introduce 
the luciferase reporter plasmids and other plasmids into eukaryotic cells, two different 
methods of transfection were engaged. First, the calcium phosphate precipitation-method was 
used. This method is useful for transient transfections. It works by a mechanism, in which the 
DNA associates with calcium-phosphate crystals and is taken up by endocytosis. Second, 
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Lipofectamin 2000 (Invitrogen) was used to transiently transfect eukaryotic cells. The 
Lipofectamine 2000 seems to give better transfection efficiencies and the results are more 
reproducible. 
These two methods may demonstrate that desmin interferes with cardiomyogenesis on 
the transcriptional level by binding to promoter and enhancer elements of transcription factor 
genes, which are crucial in cardiomyogenesis, and that desmin alters the expression of such 
TF genes.  
2. Results and discussion  
2.1. The interaction of desmin with the 5’UTR of nkx 2.5 
2.1.1 The nkx 2.5 gene  
The murine nkx 2.5 gene is located on chromosome 17. The nkx 2.5 promoter region and the 
minimal cardiac enhancer region are critical to murine heart development (Searcy et al.1998; 
Lien et al.1999). The locations of the nkx 2.5 gene, its promoter region and a minimal cardiac 
enhancer region are shown in figure 2.1.1. The arrows indicate the binding sites of specific 
primer pairs, which were used in ChIP PCRs. The specific primer pairs were chosen to 
amplify the nkx 2.5 promoter region and the minimal cardiac enhancer region. Primer pairs, 
which bind to regions adjacent to these two well characterized genomic elements, were used 
as negative controls, as shown in figure 2.1.4. 
      
Fig.2.1.1: Schematic drawing of the mouse nkx 2.5 gene and its upstream regions. 
Primer binding sites are indicated as arrows. Minimal cardiac enhancer (white box), nkx2.5 
promoter (grey box), nkx 2.5 exons 1 and 2 (black boxes). Primer pairs: distal 2 (D2), distal 1 
(D1), proximal 2 (P2) and proximal 1 (P1). 
2.1.2 Interaction of desmin with the nkx2.5 promoter region  
2.1.2.1 Desmin is able to bind to the nkx 2.5 promoter 
To assess the binding of desmin to the nkx 2.5 promoter region during early 
cardiomyogenesis, des+/+ embryonic stem cells (ESC) were aggreagted to form embryoid 
bodies (EBs). In EBs some cells autonomously undergo cardiomyogenesis starting with the 
development of brachyury-positive primitive mesoderm around day 3 after aggregation. 
Finally, the autonomous cardiomyogenesis in EBs results in the development of fully 
differentiated and functional cardiomyocytes between day 7 and 11. The EBs of different 
developmental stages (day 5 to 9) were subjected to chromatin-immuno-precipitation. The 
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method is described in detail in the methods chapter 4.2.8. Input samples (In) reflect the 
whole gDNA, which is present in the sample prior to the selective purification in the immuno-
precipitation (IP). Desmin (des) samples contain gDNA fragments, which were bound by 
desmin and were selectively purified in presence of desmin-specific antibodies. Mock 
samples were prepared in presence of pre-immune sera from mice or without the addition of 
specific antibodies, respectively. The Mock samples should serve as negative controls. 
Histone H3 samples were prepared in presence of specific antibodies to histone H3. The 
Histone H3 samples should serve as positive controls. In all ChIP PCRs an internal PCR 
negative control was included, with sterile distilled water as “template” (data not shown). In 
the following demonstrations only PCR results were included, when the internal negative 
control was free of contamination. 
 
Fig.2.1.2.1A: Summary of ChIP PCR results from des+/+ EBs.  
The ChIP PCR samples were prepared from desmin wild type (des+/+) embryoid bodies of 
different developmental stages (days 5-9 of EB development, as indicated). (In) Input 
samples; (Des) desmin samples; Mock: negative control; Histone H3 (Hist) 
 








day 5 day 6 day 7 day 8 day 9
desmin bound 0 3 3 2 1
total number of
replicates 10 10 10 10 6
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By performing ChIP PCRs with des +/+ embryoid bodies, we found that desmin binds to the 
nkx 2.5 promoter, at day 6, day 7, day 8 and once at day 9, but not at day 5 of in-vitro 
differentiation.  Interestingly, the binding of desmin to the nkx 2.5 promoter at day 6 
corresponds to the timing of in vitro cardiomyogenesis. Usually, in des+/+ EBs first signs of 
beating cardiomyocytes may be observed around day 6.    
The histone H3 samples were chosen as positive controls, because in theory the 
histone H3 component is ubiquitously and unselectively bound to transcriptionally and 
synthetically inactive chromatin.  Therefore, we expected to find PCR bands in all the histone 
H3 samples. As it is shown above this expectation was not fulfilled. One might speculate that 
the lack of bands could be due to the onset of transcriptional activity, which is enabled by 
loosening of the tight histone packing. This loss of histone packing prior to the observation of 
first beating cardiomyocytes in day 6 embryoid bodies would perfectly go along with the 
onset of nkx 2.5 gene expression. 
A striking throwback of the presented results is the presence of PCR bands in the 
mock samples. In the beginning of this thesis, these samples were prepared without specific 
antibodies, later a pre-immune serum was used instead. They were included as negative 
controls and were expected to show no PCR bands. The reason why the Mock samples 
showed PCR bands might be found in the use of protein A-coupled sepharose beads. These 
protein A-coupled sepharose beads need to be blocked with salmon or herring sperm DNA, as 
we found out after a couple of experiments with positive mock samples. However, as the time 
frame of a diploma thesis is too short to repeat all experiments, here the complete data set is 
shown, including the results of sub optimal procedures. 
2.1.2.2 Amino-terminally truncated desmin fails to bind to the nkx 2.5 
promoter 
The N-terminus of desmin is known to be vital for cardiomyogenesis and for DNA-binding 
(Tolstonog et al.2005; Höllrigl et al 2007, Hofner et al. 2007). The expression of an N-
terminally truncated variant of desmin protein was shown to severly interfer with 
cardiomyogenesis in the EB model. When desΔ1-48des Δ1-48 ESC are in-vitro differentiated in 
the EB model, they develop delayed smaller and less interconnected fields of beating 
cardiomyocytes compared to des+/+ EBs (Hofner et al.2007). The desΔ1-48des Δ1-48 EBs were 
included in the ChIP experiments to demonstrate the absence of desmin binding to chromatin, 
when the N-terminal portions, which are vital for DNA-binding and interaction, are missing. 
Therefore, in-vitro differentiated ESC, which ectopically express N-terminally truncated 
desmin (desΔ1-48des Δ1-48), were subjected to ChIP procedure. The ChIP samples were used for 
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PCR with primers, which serve to specifically amplify the nkx 2.5 promoter. Input samples 
(In) reflect the whole gDNA, which is present in the sample prior to the selective purification 
in immuno-precipitation (IP). Desmin (des) samples contain selectively purified gDNA 
fragments, which were bound by desmin-specific antibodies. Mock samples were prepared in 
presence of pre-immune sera from mice or without the addition of specific antibodies, 
respectively. The mock samples are negative controls. Histone H3 samples were prepared in 
presence of specific antibodies to histone H3. The Histone H3 samples serve as positive 
controls. In all ChIP PCRs an internal PCR negative control was included, with sterile 
distilled water as “template” (data not shown). In the following demonstration only PCR 
results were included, when the internal negative control was free of contamination. 
 
Fig.2.1.2.2A: Summary of ChIP PCR results from desΔ1-48des Δ1-48EBs. 
(In) input samples; (Des) desmin samples; Mock: negative control. Histone H3 (Hist) are 
positive controls.  
 
Fig.2.1.2.2B: Shows a columnar diagram of the nkx 2.5 promoter ChIP PCR results with des 
Δ1-48 des Δ1-48 EBs. 
Due to the findings of my colleagues A.Höllrigl and M.Hofner in 2007, we expected the 
embryoid bodies, which ectopically express an N-terminally truncated desmin variant, to be 
unable to bind to DNA. The N-terminus of desmin is known to be vital for cardiomyogenesis 









day 5 day 6 day 7 day 8 day 9 day
10
desmin bound 2 1 1 0 0 0
total number of replicates 7 7 7 5 5 5
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To explain the observed DNA-binding from des∆1-48, there may be two theories. The first 
would be that desmin harbours an alternative DNA-binding site despite the N-terminal. The 
second would be that something went wrong in the ChIP procedure and that the PCR bands 
derive from contamination of the ChIP samples themselves. From the ChIP results, it is 
impossible to say if there is an alternative DNA-binding site in the desmin protein apart from 
the N-terminal, which leads to the unexpected rare positive result. Most likely, the bands in 
the desmin samples of day 5, day 6 and day 7, are artefacts, because this result occurred only 
once in all the ChIP samples. Likewise as the positive bands in the mock samples, this is most 
likely the result of the improper blocking of protein A-coupled sepharose beads or DNA 
contamination of the ChIP samples.  In conclusion, we doubt that the positive signal from the 
N-terminally truncated desmin is an image of the real condition during the differentiation of 
des ∆1-48/∆1-48 embryonic stem cells. We further assume that the truncated version of desmin 
(des ∆1-48/∆1-48) is unable to bind to the nkx 2.5 promoter. 
2.1.2.3 Ectopically expressed desmin binds to the nkx 2.5 promoter earlier 
during in-vitro differentiation of cardiomyocytes 
Embryonic stem cells, which ectopically express desmin (des +/+/ect), underwent in-vitro 
differentiation in the embryoid body model. In addition to the input, desmin, histone H3 and 
the mock samples, c-Myc samples were included as positive controls. C-Myc binds to E-
boxes, which are numerous in the 5’UTR of the nkx 2.5 gene (at least eight). E-boxes are 
common elements in promoter and enhancer sequences. The consensus sequence of E-boxes 
is CANNTG. The E-boxes serve as binding sites for transcription factors, which contain a 
basic-helic-loop-helix structural motif.  
 
Fig.2.1.2.3A: Summary of ChIP PCR results from des+/+ desect EBs of different developmental 
stages (as indicated). Input samples (In), Desmin (Des), C-Myc samples were included as 
positive controls. “Without antibody” (negative control). Histone H3(positive control)  
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Fig.2.1.2.3B: Shows a columnar diagram of the nkx 2.5 promoter ChIP PCR results with 
des+/+ des ect EBs. 
The ChIP PCR from des +/+/ect EBs revealed that desmin is bound to the nkx 2.5 promoter at 
day 5, 6, and 7 but not at day 8 of EB development. The binding of ectopically expressed 
desmin at day 5 is perfectly in line with the fact that des +/+/ect EBs develop beating 
cardiomyocytes one day earlier compared to wild type des +/+ EBs. 
The bands in the “without antibody” samples are most probably derived from unspecific 
bindings between un-blocked sepharose beads and gDNA. As it was already mentioned 
above, the un-blocked beads were used accidentally in the beginning of this thesis. Later, the 
experiment was repeated with blocked sepharose beads. This helped to reduce unwanted 
bands, but sometimes even led to the complete lack of bands in PCR from specifically 
purified samples.   
2.1.2.4 Desmin-deficient embryoid bodies as a negative control  
The ChIP experiment dataset is rounded up by the inclusion of embryoid bodies from desmin-
deficient (des -/-) ESC. These des -/- EBs develop beating cardiomyocytes, but several days 
later, compared to the desmin wild type EBs. In addition to that, the des -/- EBs develop 
smaller fields of beating cardiomyocytes, which are also less interconnected. On one hand, the 
following dataset was included for the means of completeness. On the other hand, it was a 









day 5 day 6 day 7 day 8 day 9
desmin bound 5 4 4 0 0
total number of
replicates 7 7 7 4 4
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Fig.2.1.2.4A: Summary of ChIP PCR results from des-/- embryoid bodies. 
 Input samples (In), Desmin (des) samples, C-Myc samples as positive controls, “Without 
antibody” as negative controls. Histone H3 as positive controls. 
  
Fig.2.1.2.4B: Shows a columnar diagram of the nkx 2.5 promoter ChIP PCR results with des -
/- EBs. 
The figures 2.1.2.4AB nicely show the presence of the nkx 2.5 promoter DNA in the input 
samples, but the lack of bands in the anti-desmin samples. The weak positive result from day 
7 des -/- EBs is most probably derived from a contamination of unknown source. The bands 
from the “without antibody” samples again most probably result from the use of unblocked 
sepharose beads, which can lead to unspecific binding of gDNA. Fortunately, un-specific 
bindings were not found in the anti-desmin samples. 
2.1.3 Interaction of desmin with a „minimal cardiac enhancer“ region 
The minimal cardiac enhancer was characterized in experiments from Lien and colleagues in 
1999 (Lien et al.1999). The scientists cloned sequences of the 5’ untranslated region of the 
nkx 2.5 gene upstream of the lacZ gene to find important cis-acting elements. The cloned 




















desmin bound 0 0 1 0 0 0
total number of replicates 6 6 6 4 4 4
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transgene could be monitored by β-galactosidase staining. The transgenic mice were screened 
for β-galactosidase staining. Further, organ-specific expression of the lacZ  reporter in the 
transgenic mice was matched to the different cloned sequences. The cardiac-specific region of 
the 5’UTR of the nkx 2.5 gene was named the “cardiac enhancer”. To further delimit the 
boundaries of the cardiac enhancer, a series of 5’and 3’deletion was created and tested for 
cardiac-activity in transgenic mice. This study revealed that two separable regions of the nkx 
2.5 5’UTR positively influence cardiac activity. The first is located between positions -9435 
and -8922 of the nkx2.5 5’UTR , whereas the second is located between positions -8039 and -
7353. The cardiac specific region -9435 to -8922 was defined as the minimal cardiac 
enhancer, because it alone exhibited cardiac activity. In contrast, the second region (-8039 to -
7353) was shown to be unable to confer cardiac expression alone, but was able to enhance the 
expression of the minimal cardiac enhancer (-9435 to -8922) (Lien et al.1999). 
To test the potential of desmin to interact with this minimal cardiac enhancer region, 
we designed ChIP primers (MCE1107 2 fwd and rev). The sequence of these primers is 
shown in a list in chapter 3.5.  
2.1.3.1 Desmin is able to bind to the minimal cardiac enhancer 
Wild type ESC were aggregated to EBs, as it is described above and in the methods chapter 
4.1.6. The EBs were subjected to chromatin immune-precipitation as described in detail in 
chapter 4.2.8. Input samples (In) reflect the whole gDNA amount, which is present in the 
sample prior to the selective purification in the immune-precipitation (IP). Desmin (des) 
samples contain selectively purified gDNA fragments, which were bound by desmin-specific 
antibodies. Mock samples were prepared in presence of pre-immune serum or without the 
addition of specific antibodies. The mock samples serve as negative controls. Histone H3 
samples were prepared in presence of specific antibodies to histone H3. The Histone H3 
samples serve as positive controls. Transcriptionally and synthetically inactive chromatin is 
tighly wrapped around histones. Therefore, histone H3 should be unseclectively bound to the 
minimal cardiac enhancer, unless this region is highly transcriptionally active. 
In all ChIP PCRs an internal PCR negative control was included, with sterile distilled 
water as “template” (data not shown). In the following demonstration only PCR results were 
included, when the internal PCR negative control was free of contamination. 
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Fig.2.1.3.1A: Summary of ChIP PCR results from des+/+ embryoid bodies. Input samples (In). 
Desmin (Des) samples. Mock samples serve as negative controls. Histone H3 samples as 
positive controls.  
 
Fig.2.1.3.1B: Shows a columnar diagram of the minimal cardiac enhancer ChIP PCR results 
with des+/+ EBs. 
In the results which are presented in figures 2.1.3.1AB, wild type desmin (des +/+) is bound to 
the minimal cardiac enhancer at day 5, day 6, and day 7 of EB development.  As the day 9 
EBs were included only once in the experiment, it may be doubted that the positive signal 
depicts the real state during EB development, but however, this result was included for the 
means of data completeness. In case of the data, which is shown here, the mock negative 

















desmin bound 1 2 1 0 1
total number of replicates 5 5 3 3 1
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2.1.3.2 Amino-terminally truncated desmin might harbour an alternative DNA 
binding site 
Embryonic stem cells, which ectopically express an amino-terminally truncated variant of the 
desmin gene (des ∆1-48/∆1-48) were aggregated to form embryoid bodies (EBs). These EBs were 
subjected to ChIP as described in detail in chapter 4.2.8. Input samples (In) reflect the whole 
gDNA amount, which is present in the sonicated sample prior to selective purification in 
presence of specific antibodies. Desmin (Des) samples were selectively purified in the 
presence of specific antibodies to desmin protein. Histone H3 samples were purified in the 
presence of specific antibodies to the histone H3 component. The histones are bound to 
transcriptionally and synthetically inactive chromatin, and therefore serve as positive controls. 
 
Fig.2.1.3.2A:  Shows a representative summary of ChIP PCR results. The ChIP PCR samples 
were prepared from des ∆1-48/∆1-48 embryoid bodies. 
 
Fig.2.1.3.2B: Shows a columnar diagram of the minimal cardiac enhancer ChIP PCR results 
with des ∆1-48/∆1-48 EBs. 
In general it is known that the amino-terminal region of the desmin protein harbours domains, 
which are capable of interacting with other proteins or DNA (Tolstonog et al.2005). 
Therefore, we expected the des ∆1-48/∆1-48 EBs to reveal no binding of desmin to the minimal 
cardiac enhancer region. Nevertheless, the results from ChIP of des ∆1-48/∆1-48 EBs are quite 
similar to the results from the des +/+ EBs. This implicates that there might be an alternative 
DNA binding domain within the desmin protein, besides the already known one. 






day 5 day 6 day 7
desmin bound 1 2 0
total number of
replicates 4 4 2
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draw any serious conclusions, the experiments would have to be repeated several times to 
create a greater data set.  
2.1.3.3 Ectopically expressed desmin shows strong binding to the minimal 
cardiac enhancer  
 
Fig.2.1.3.3A: Summary of ChIP PCR results from des+/+/ect embryoid bodies. 
 
Fig.2.1.3.3B: Shows a columnar diagram of the minimal cardiac enhancer ChIP PCR results 







day 5 day 6 day 7 day 8 day 9
desmin bound 7 5 5 0 0
total number of replicates 10 10 8 1 1
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Ectopically expressed desmin (des +/+/ect) shows strong presence at the minimal cardiac 
enhancer region. Unfortunately, due to a mistake in data filing the quality of some of the gel 
pictures is really bad, and the bands are hardly visible. Another throwback in the presented 
data is again the high prevalence of bands from mock samples. So in summary it is hard to say 
if the interaction of desmin with the minimal cardiac enhancer is an artefact or an image of the 
real situation in developing EBs.  
Finally, I want to state that the samples from des +/+/ect EBs and des-/- EBs were prepared in the 
very beginning of this thesis. By and by I was able to improve my ChIP skills, which is 
visible in form of the results presented above from the nkx 2.5 promoter ChIP. The data from 
des +/+/ect EBs and des-/- EBs minimal cardiac enhancer ChIP is shown anyway, although it 
might distort the overall impression.  
2.1.3.4 Samples from desmin-deficient embryoid bodies demonstrate 
inaccuracy in sample processing  
ESC, which do not express desmin (des-/-), were aggregated to form EBs. The EBs were 
subjected to ChIP as it is described in detail in chapter 4.2.8. The des-/- EBs were included as 
negative controls of the ChIP experiment. By the inclusion of ChIP samples from des-/- EBs 
we wanted to demonstrate the specifity of the ChIP results, which were shown so far. The 
samples from des-/- EBs, which were selectively purified in presence of desmin-specific 
antibodies, were expected to be free of DNA. As these cells do not express desmin, the 
desmin (Des) ChIP samples should not reveal any bands from ChIP PCR.  
  
Fig.2.1.3.4A: ChIP PCR results from des-/- embryoid bodies. Input (In) samples: gDNA prior 
to IP, Desmin (Des), Mock samples: pre-immune serum or without the addition of specific 
antibodies (negative control). Histone H3 (positive control), c-Myc (positive controls).   
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Fig.2.1.3.4B: Shows a columnar diagram of the minimal cardiac enhancer ChIP PCR results 
from des -/- EB samples. 
The results which are shown in figure 2.1.3.4AB, demonstrate that the ChIP protocol still 
contained some inaccuracy. Besides the use of unblocked protein A-coupled sepharose beads, 
the sonication of the samples could be a major source for DNA contamination of the original 
samples. As the samples were all sonicated at the same sonicator it might be that some gDNA 
remained on the sonicator after cleaning it with distilled water and 70% ethanol. Especially in 
the beginning of this thesis, the samples were treated in a way, which makes this very likely. 
The samples of different genotypes with respect to their desmin alleles were sonicated one 
after the other. The sonicator was cleaned in between, but as repeatedly desmin bands 
appeared in the desmin-deficient (des-/-) samples, the sonication protocol was changed. While 
in the beginning the samples were cooled after one cycle of sonication and another sample 
was sonicated, later the samples of one genotype were sonicated to the end, with continuous 
cooling in a ice-water bath. This reduced the chance of contamination and the efforts of 
cleaning in between each sonication of the samples of different genotypes and saved a lot of 
time. Also the sonication series was accomplished in the following sequence: des -/- EBs of all 
developmental stages were sonicated first, then the des ∆1-48/∆1-48 EBs of all developmental 
stages were sonicated, then the des +/+  EBs were sonicated and finally the des +/+/ect EBs were 
sonicated. In between the sonicator was extensively cleaned with distilled water and 70% 
ethanol, by immersing the sonicator in the liquids. 
However, due to the presence of many bands in anti-desmin samples from des -/- EBs, this 
data set is not satisfying as negative control, but rather leads to question the ChIP procedure. 
2.1.4 Proof of specificity of desmin interaction with the 5’UTR of the nkx 2.5 
gene 
The same ChIP samples, which were used in the ChIP experiment to test desmins ability to 
bind to the nkx 2.5 promoter and the minimal cardiac enhancer, were used to challenge the 
specificity of desmins interaction with these genomic elements. Therefore, ChIP primer pairs, 












day 5 day 6 day 7
desmin bound 5 3 2
total number of replicates 9 10 5
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enhancer (MCE), were designed. These primers were generated for the specific amplification 
of a region located distally of the MCE (D2), a region in between the MCE and the nkx 2.5 
promoter (D1), a region proximally of the nkx 2.5 promoter (P2) and a region proximally of 
the nkx 2.5 exon 1 (P1). The primer pairs P2 and P1 both serve to specifically amplify distinct 
regions between the nkx 2.5 promoter and the nkx 2.5 exon1. The binding sites of the primers 
are indicated in figure 2.1.1. 
The ChIP PCRs with these primers are included to test the specificity of desmin 
binding to the MCE and the nkx 2.5 promoter. If desmin specifically binds these regulatory 
gDNA elements, the ChIP PCRs with primers D1, D2, P1, and P2 are expected to be free of 
any PCR product.  
 
 
          
Fig.2.1.4: Summary of 
ChIP PCR results from the 
regions adjacent to the nkx 
2.5 promoter and the 
minimal cardiac 
enhancer.The binding sites 
of the primers are 
indicated in figure 2.1.1. 
des+/+: wild type EBs, 
des+/+/ect: ectopic desmin 
expression, des∆1-48/∆1-48 : 
N-terminally truncated 




cells (diploma thesis 
W.Weber 2006). 
CTL: untreated control, 
M-LIF: CVPGC treated 
with M-Leukemia 
Inhibitory Factor, SPARC: 
secreted protein, acidic, 
rich in cysteine.  
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The ChIP PCRs with primers, which specifically amplify genomic regions adjacent to the nkx 
2.5 promoter and the minimal cardiac enhancer, revealed that desmin is not bound to these 
gDNA regions, as it is shown in figure 2.1.4. These negative results show that desmin binding 
to the nkx 2.5 promoter and the MCE is specific and restricted to these regulatory elements in 
the 5’UTR of the nkx 2.5 gene.  
2.1.5 Selected issues of ChIP 
In the following, some problems that occurred during the ChIP sampling will be discussed. 
First, the importance of proper sonication will be outlined. Second, as the summarized ChIP 
results show all results that were revealed regardless of their output, a summary of the best 
ChIP results of the nkx 2.5 promoter and the minimal cardiac enhancer (MCE) will be 
presented and discussed.  
2.1.5.1 Sonicated gDNA 
The following figures show the analysis of sonicated genomic DNA (gDNA) on a 0.8% 
agarose gel. The samples were prepared from embryoid bodies of different developmental 
stages, as indicated in the figure. 
 
A)   des+/+ and des ∆1-48/∆1-48 EBs B)    des+/+/ect and des-/- EBs 
Fig.2.1.5.1AB: The analysis of the sonication of gDNA from EBs. These samples are later 
used as the “input” templates for ChIP PCRs. The rectangle marks the ideal degree of 
sonication, which results in gDNA fragments of 400-600 bp.  
 
Prior to the selective purification of genomic DNA fragments, the gDNA is fragmented by 
sonication. After the sonication, the majority of the gDNA fragments should be between 400- 
600 base pairs in size to guarantee for specificity of signals in ChIP PCR, which are obtained 
due to the binding of the protein of interest and selective purification of the samples in 
presence of specific antibodies to the protein of interest. The sonicated samples, which are 
shown in Fig.2.1.5.1A and B were treated the same way. They were all sonicated 18 times 
(90% cycle, 45% output), with the same intensity and duration of the sonication cycles. The 
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pictures above illustrate, that the samples were very inconsistent in their resistance to the 
sonication. While the samples from des +/+ and des ∆1-48/∆1-48 EBs, which are shown in 
Fig.2.1.5.1A, show insufficient fragmentation of the gDNA, the samples from des +/+/ect and 
des -/- EBs, which are shown in Fig.2.1.5.1B, show sufficient fragmentation of the gDNA. In 
the latter, the majority of the gDNA is fragmented to 400-600 base pairs and below. This 
means, that the same number of cycles, with the same settings of output and duration of 
sonication, resulted in a different grade of fragmentation in the samples. The fact, that the 
same sonication treatment of the samples resulted in very inconsistent fragmentation, puts 
emphasis on the throwbacks of this method. To obtain good results, it is critical that the 
majority of the gDNA is fragmented to 400-600 bp. Otherwise the immune-precipitation 
would result in the co-purification of a gDNA fragment, which is bound by the protein of 
interest at another location, than the region of interest. This could lead to “false” positive 
results.  As it is demonstrated by the different grades of sonication in figure 2.1.5.1AB, it is 
difficult to find the repetition of sonication cycles, which results in optimal but not excessive 
fragmentation. The samples, which were prepared from different stages of embryoid body 
development, were inconsistent in their resistance to sonication.  
One of the striking limitations of the ChIP procedure is that the analysis of the proper 
fragmentation of the sonicated ChIP samples has to wait until the “input” samples are 
prepared. After a phenol-chloroform extraction, the “input” samples may be analysed on a 
0.8% agarose gel. If the fragmentation turns out to be incomplete for the following procedure, 
the ChIP sample has to be sonicated again. This was omitted in the presented experiments. So 
the gDNA fragments in the samples were partly longer than 600 base pairs. This might 
contribute to false positive results, if one of these oversized fragments was bound by desmin 
or another protein, which was targeted in the immune-precipitations. 
2.1.5.2 Desmin at the nkx 2.5 promoter  
 
Figure 2.1.5.2: Shows the best results from nkx 2.5 promoter ChIP PCRs.  
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The data, which is shown in figure 2.1.5.2, show a selection of the best results from the nkx 
2.5 promoter ChIP PCRs. The data demonstrate that desmin is bound to the nkx 2.5 promoter 
at day 6, day 7, and day 8 in wild type (des +/+) embryoid bodies. In embryoid bodies, which 
ectopically express an additional desmin allele (des +/+/ect), desmin is bound to the nkx 2.5 
promoter at day 5, day 6, and day 7. These results are in line with the development of beating 
cardiomyocytes in embryoid body (EB) model of in-vitro differentiation. In des +/+ (wild type) 
embryoid bodies, the expression of desmin begins at day 3 and it was detected in semi-
quantitative real time PCR in low levels at day 4 of EB development (Hofner et al.2007). The 
first beating cardiomyocytes in des +/+ (wild type) EBs appear at day 7.  
In des +/+/ect EBs the expression of desmin was detected at day 0 of EB development in 
a semi-quantitative real-time PCR (Hofner et al.2007). The first beating cardiomyocytes 
appear at day 6 of EB development in des +/+/ect EBs.  
The results from the ChIP PCRs implicate that desmin is able to bind to the nkx 2.5 
promoter. The binding of desmin to the nkx 2.5 promoter was proven to be specific in ChIP 
PCRs with primers, which serve to specifically amplify genomic regions adjacent to the nkx 
2.5 promoter, by the absence of PCR products from these ChIP PCRs, as shown in figure 
2.1.4. The binding of desmin disapears at day 8 of EB development in des +/+/ect EBs and at 
day 9 in des+/+ EBs. This suggests that desmin binds to the nkx 2.5 promoter from the onset of 
its expression as long as the majority of this protein is not fully assembled into intermediate 
filaments of the type III. As soon as the intermediate filaments begin to assemble from desmin 
subunits, these subunits are sequestered from the nucleus to take over their role in the 
maintenance of the structural integrity of cardiomyocytes. Therefore, after the development of 
fully differentiated and functional beating cardiomyocytes, the desmin protein no more binds 
to the nkx 2.5 promoter, as the ChIP PCRs revealed. As in the desmin ectopically expressing 
EBs, the desmin protein is available from the very beginning of development, these EBs are 
able to develop beating cardiomyocytes one day prior to the wild type EBs. From this, we 
concluded that the desmin protein units are sequestered one day earlier from the nucleus. 
Therefore, the desmin protein cannot be detected at the nkx 2.5 promoter at day 8 in the 
majority of the des +/+/ect EBs.   
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2.1.5.3 Minimal cardiac enhancer region 
 
 
 Figure 2.1.5.3: Shows the best results from the ChIP PCRs of the minimal cardiac enhancer 
region.  
From the data, which is shown in figure 2.1.5.3, we concluded that the desmin protein more or 
less equally binds to the minimal cardiac enhancer region (Lien et al.1999) as it binds to the 
nkx 2.5 promoter. This means that in wild type (des+/+) EBs desmin binds to the minimal 
cardiac enhancer region at day 6 and at day 7 of EB development. From the ChIP PCR results 
of the minimal cardiac enhancer we found that desmin binding already disappeared at day 8. 
It might be that this absence of desmin binding at day 8 of EB development results from 
earlier sequestering from the MCE, to fullfill its natural role in the maintenance of the 
structural integrity of cardiomyocytes. In line with the results from the nkx 2.5 promoter, des 
+/+/ect EBs revealed that desmin is bound to the minimal cardiac enhancer region at day 5, day 
6, and day 7. The binding of desmin at day 5 of EB development in des +/+/ect EBs, is again one 
day ahead of the des+/+ EBs, which is in line with the observation of earlier development of 
beating cardiomyocytes in these EBs. 
2.2 The cloning strategy of MCE-cis 
The MCE-cis plasmid is a reporter plasmid, which is based on the NKE24 reporter plasmid. 
The NKE24 plasmid was cloned by K.Yutzey (Cincinnati). It is a pGL3b-derived reporter 
plasmid, with the firefly luciferase gene under the control of the nkx 2.5 promoter. The 
MCEcis reporter plasmid contains the sequence of the minimal cardiac enhancer (Lien et al. 
1999) upstream of the firefly luciferase under the control of the nkx 2.5 promoter. It was 
cloned to prove the hypothesis of a physical interaction between desmin and the minimal 
cardiac enhancer region, which arose from the ChIP experiments. 
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Fig.2.2A: NKE24, the firefly luciferase reporter plasmid.  
 
Fig.2.2B: The NKE24-derived MCEcis-plasmid containing 510bp of a minimal cardiac 
enhancer sequence upstream of the nkx2.5 promoter and the luciferase reporter gene. 
The minimal cardiac enhancer region was cloned in maximal possible distance to the nkx 2.5 
promoter to enable alignment of the enhancer with the promoter without destroying important 
regulatory elements within the plasmid. This was reported in various publications to be 
crucial in the enhancement of gene expression. 
2.2.1 Design of primers for the production of the DNA insert 
PCR primers were designed for the production of the minimal cardiac enhancer insert, which 
is flanked by SalI restriction sites: 
SalI fwd: 5’-taatgtcgactctgggtcctaatgc-3’ 
SalI rev:  5’-tattgtcgactcaaggtgcacatga-3’ 
2.2.2 Production of the insert for cloning 
To produce the insert of the minimal cardiac enhancer region for cloning, a PCR with the 
Pyrococcus furiosus polymerase was set up. This type of polymerase harbours proof-reading 
activity and its use reduces the frequency of point mutations in the sequence of the PCR 
product. As a template the genomic DNA of C3H mouse was used. The PCR conditions were 
as indicated in table 2.2.2. The PCR product was analysed on a 1.2% agarose gel. The 530 
base pair PCR product was cut out with a clean and sharp scalpel under short UV-
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illumination. The cut gel slices were dissolved and the PCR products were extracted with a 
Promega Wizard SV Gel extraction kit.  
Temperature Duration Cycles 
95°C 4 min.  
95°C 1 min. 30 sec. x 34 
56.5°C 45 sec. x 34 
72°C 2 min. 30 sec. x 34 
72°C 5 min.  
4°C Infinitely  
 Table 2.2.2: The PCR conditions 
 
Figure 2.2.2: The analysis of the PCR 
product. 
2.2.3 Restriction of the vector backbone and the DNA insert 
The NKE24 backbone vector was cut with Sal I. In a 40µl reaction mix, 4µg vector DNA was 
incubated at 37°C for two hours. Then the vector was dephosphorylated with 2 Units of 
alkaline phosphatase from calf intestine (CIP) at 37°C for 40 minutes. The restriction enzyme 
and the CIP was heat inactivated at 65°C for 20 minutes.  
In parallel, the DNA insert was cut with Sal I to produce compatible ends for later 
ligation with the vector backbone. In a 40µl reaction mix 90ng of the insert were incubated at 
37°C for three hours. The restriction enzyme was heat inactivated at 65°C for 20 minutes. 
The cut DNA fragments were purified from buffers and inactivated enzymes by phenol-
chloroform-isopropanol extraction. The purified DNA was precipitated with a double volume 
of 96% ethanol and 1/10 1M sodium chloride solution at -20°C overnight. The precipitated 
DNA was pelleted by centrifugation at 4°C and 14.000 rpm for 30 minutes. The DNA pellet 
was washed with 70% ethanol and re-hydrated in 30µl sterile distilled Millipore water.  
2.2.4 The ligation of the vector and the insert 
The cut vector and insert were ligated in four different molar ratios: (A) 1:1, (B) 1:3 and (C) 
1:0, where the last (1:0) served as a negative control. Another negative control, were the 
addition of T4 ligase was omitted, was included (D). 100ng cut NKE 24 plasmid DNA was 
combined with the respective amount of insert DNA and T4 ligase. The reaction mixtures 
were incubated at room temperature for three hours and then the ligase was heat inactivated at 
65°C for 30 minutes.  
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2.2.5 The transformation of competent E.coli and screening of transformants 
Competent E.coli XL-1 were transformed with 10µl of each ligation mixture.  
From each transformation 50µl of the suspension was plated to sterile LB+Amp-agar plates. 
On the next day the plates were examined for colonies. From ligations (A) and (B) for clones 
were picked and used to inoculate 4ml LB+amp overnight cultures. The plasmids of the 
selected clones were retrieved by a mini plasmid preparation with the Promega kit.  
The plasmids of the different clones were subjected to restriction analysis with SalI. 
 
Figure 2.2.5A: Restriction analysis of 
MCEcis transformants on a 1% agarose 
gel. 
To screen the clones for the right orientation of the insert, a PCR with specific primers was set 
up. As primers SalI forward and MCEcis reverse were used: 
Sal I fwd 5’-TAATGTCGACTCTGGGTCCTAATGC-3’ 
MCEcis rev 5’-TAAGTGCGGCGACGATAGTCATGC-3’ 
Originally, the Sal I fwd primer was designed to generate the MCE insert for cloning as a 
PCR product. Therefore, this primer anneals inside at the beginning of the cloned sequence. 
The MCEcis rev primer was designed for later sequencing, it anneals outside of the cloned 
sequence. By choosing a primer that anneals inside of the sequence and one that finds 
complementarity in the vector backbone, one can see if the DNA was inserted in the desired 
orientation. If it is oriented the desired way, the PCR gives a product, if the DNA is inserted 
the wrong way, there is no PCR product, because the primers both face the same direction. 
The plasmids served as templates and the PCR conditions were as follows: 
Temperature Duration Cycles 
95°C 5 minutes  
95°C 1 minute x 33 
57°C 30 seconds x 33 
72°C 1 minute x 33 
72°C 2 minutes  
4°C Infinitely    
Figure 2.2.5B: Shows the analysis of the PCR products from PCR screening. Left band: 
597bp, right: 681 bp. 
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The PCR screening of the clones was done in two different set ups: the first was done to 
check the orientation of the insert. Therefore the primers Sal I fwd and MCEcis rev were used 
(as it is indicated in the picture). The use of these primers resulted in a 597 bp product in 
positive clones and in the lack of any product in clones that were negative in the previous 
screening of transformants. The second screening was done to check if the sequencing PCR 
works out. Therefore the primers MCEcis fwd and rev were used. They resulted in positive 
clones in the production of a 681bp product. The PCR product for sequencing has to be 
somewhat larger than the inserted sequence itself, because otherwise the sequence is un-
readable at its borders. Unfortunately, from both PCR reactions the product band is somewhat 
blurred. This might have a couple of reasons, like the too long extension time, acidic 
hydrolysis of DNA in water, or the use of a circular template in these PCRs.  
 However, clone MCEcisA3 was chosen for sequencing. Therefore, a 50ml LB+Amp 
liquid overnight culture was inoculated. The plasmids were retrieved by the midi plasmid 
preparation kit from Promega. The plasmid and the primers MCEcis fwd and rev were sent to 
VBC genomics for sequencing. The sequencing result is shown in figure 2.2.6C aligned (by 
BLAST http://blast.ncbi.nlm.nih.gov/Blast.cgi ) to the sequence of the minimal cardiac 
enhancer as it was published by Lien et al 1997. The alignment of the two sequences revealed 
that the sequence of MCE cis contains five additional bases. These additional bases are 
indicated as red letters in figure 2.2.6C. 
 
Score =  918 bits (497),  Expect = 0.0 
 Identities = 510/515 (99%), Gaps = 5/515 (1%) 
 Strand=Plus/Plus 
 
MCEcis 1    TCTGGGTCCTAATGCGGGTGGCGTCTCTCTTGACAGGCAGCGTTTGGGGACAACAGCGGG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien1    TCTGGGTCCTAATGCGGGTGGCGTCTCTCTTGACAGGCAGCGTTTGGGGACAACAGCGGG  60 
 
MCEcis 61   GAAGGGAGATAAGATGACATACCAGAGCAGATTTGGTGTGCGCGCTGATACTCCTGGCCC  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien61   GAAGGGAGATAAGATGACATACCAGAGCAGATTTGGTGTGCGCGCTGATACTCCTGGCCC  120 
 
MCEcis 121  GACAGGAAACTCGGAGCTATTTAAAAAGGCCCTATCGATTACTTTATCTTCCCCGGAGGA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien121  GACAGGAAACTCGGAGCTATTTAAAAAGGCCCTATCGATTACTTTATCTTCCCCGGAGGA  180 
 
MCEcis 181  AAACTTCTTGCCGAGAGACAAAAGATGTCCCCCTACCTAAAGATACAAGGCCACACAGCA  240 
            ||  | |||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien181  AA--T-CTTGCCGAGAGACAAAAGATGTCCCCCTACCTAAAGATACAAGGCCACACAGCA  237 
 
MCEcis 241  GAGGGTTTGTACAGGCGACGCGCGAGTAGATCCCTGGGAGCGCAGAGACGCCTTTCTACC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien238  GAGGGTTTGTACAGGCGACGCGCGAGTAGATCCCTGGGAGCGCAGAGACGCCTTTCTACC  297 
 
MCEcis 301  GGCAGAGACTGAAGTTTGACTGGAGCGAGGCGGGGCGGAGCCACCTCCCGGTCCCCGTGC  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien298  GGCAGAGACTGAAGTTTGACTGGAGCGAGGCGGGGCGGAGCCACCTCCCGGTCCCCGTGC  357 
 
 
MCEcis 361  ACTCCGGAATTGTGAACGCTCCCGCAAAGTCCCCGCGAGTGTTGTGTTCACACTAATTGG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
MCElien358  ACTCCGGAATTGTGAACGCTCCCGCAAAGTCCCCGCGAGTGTTGTGTTCACACTAATTGG  417 
   61 
 
MCEcis 421  TGTGCCTCTGAGTTCCATCCGTACTcccccccccccccAAGTTTAAATGCTCCTTTTAAG  480 
            ||||||||||||||||||||||||||||||||||||  |||||||||||||||||||||| 
MCElien418  TGTGCCTCTGAGTTCCATCCGTACTCCCCCCCCCCC--AAGTTTAAATGCTCCTTTTAAG  475 
 
MCEcis 481  GGCTTGAGTGTCTGCAGCCGTCATGTGCACCTTGA  515 
            ||||||||||||||||||||||||||||||||||| 
MCElien476  GGCTTGAGTGTCTGCAGCCGTCATGTGCACCTTGA  510 
 
Figure 2.2.5C: Shows the sequencing (VBC gemomics) result of the MCEcis insert. Red 
letters indicate additional bases in the cloned MCE sequence compared to Lien’s MCE. Light 
blue letters highlight GATAA-binding sites. 
The pairwise alignment of the MCE-cis sequencing result and the published MCE (Lien et 
al.1999) sequence revealed that the MCE-cis insert harbours several additional basepairs. At 
position 183 an adenin was inserted, at position 184 a cytosin was inserted and at position 186 
a thymine was inserted into the MCEcis sequence. At the positions 457 and 458 of MCEcis 
two cytosines were inserted. The MCE sequence as it is pulished by Lien et al. 1999 was 
revealed from SV129 mice, whereas the MCE-cis insert for cloning was produced from a 
gDNA template from C3H mouse. As gDNA sequences from C3H mouse are not available 
from the NCBI-gene bank, it remains elusive if the differences in the MCE sequence from 
SV129 mice (Lien et al.1999) and the MCE sequence from C3H mouse results from errors in 
the PCR reaction, from sequencing mistakes or most likely from polymorphism in the 
different mouse genotypes. Fortunately, the crucial GATAA-binding sites were not affected 
by these deviations from the published sequence of MCE. This unaffectedness of vital TF 
binding sites affirms the suspicion that the additional basepairs in the cloned MCE sequence 
derive from genomic polymorphisms. Although, the MCE-cis sequence did not completely 
match the published minimal cardiac enhancer sequence a QIAGEN endotoxin-free plasmid 
preparation was made, because we were not sure about the effect of the base insertions and to 
have a result for the cloning in this thesis. 
2.2.6 Restriction of clone MCE-cisA3 plasmids compared with NKE24 
 
The MCE-cis plasmid from the maxi prep and NKE24 were cut with the restriction enzymes 
XhoI and BamHI. This results in the production of three different DNA fragments in both 
plasmids: Restriction of the MCEcis results in one 4.2 kb fragment, in one 2.4 kb fragment 
and in one 1.9 kb fragment, if the sequence of the minimal cardiac enhancer is cloned 
successfully. If the MCE sequence was not cloned successfully into the MCE-cis plasmid, the 
pattern of restriction bands would be the same as from the restriction of NKE24. The 
restriction of the NKE24 plasmid results in one 3.7 kb fragment, one 2.4 kb fragment and one 
1.9 kb fragment. 
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Figure 2.2.6A: Restriction analysis of the 
NKE24 and the MCEcis luciferase reporter 
plasmids on a 0.8% agarose gel
 
 
Figure 2.2.6B: Shows a physical map of the two luciferase reporter plasmids: MCEcis black 
box: sequence of minimal cardiac enhancer at SalI site (2010bp) and NKE24. The linear 
illustration was chosen to point out the differences in the position of the restriction sites. 
2.3 The cloning strategy of the MCEtrans vector
Figure 2.3: The hypothetical MCEtrans vector.  
We tried to clone the MCEtrans plasmid to see if the minimal cardiac enhancer preferentially 
acts in “trans” meaning that it is able to activate the expression of a luciferase reporter from 
another plasmid (Farr et al.1992). The MCEtrans plasmid itself is not a reporter plasmid, as it 
does not carry the firefly luciferase gene. It is based on a pBluescriptKS+/- vector from 
Stratagene. The pBluescriptKS contains a pUC origin of replication, an F1 origin of 
replication, an ampicillin resistance gene and a lacZ gene. The plasmid was retrieved from 
XL-1 E.coli from the glycerol stocks in a -80°C freezer. Therefore, a mini plasmid preparation 
with the SV Wizard kit from Promega was done from an overnight culture. 
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2.3.1 Restriction of pBluescriptKS 
To prove the identity of the retrieved plasmid, a qualitative restriction was set up. The 
restriction enzymes DraIII and BamHI were used:  
 
Figure 2.3.1A: Shows a physical map of the pBluescriptKS vector. 
 
Figure 2.3.1B: Shows the analysis of the restriction of pBluescript on a 0.8% agarose gel. 
2.3.2 Production of the minimal cardiac enhancer insert for cloning 
The MCE DNA insert for cloning was produced by PCR with Pyrococcus furiosus (Pfu) 
polymerase and C3H mouse gDNA. To generate compatible ends for cloning specific 
primers, which introduce a DraIII and a NotI restriction site into the PCR product, were used: 
DraIII fwd: 5’- TAA TCA CGT AGT GTC TGG GTC CTA ATG C- 3’ 
NotI rev:    5’- TAT TCG CCG GCC GCT CAA GGT GCA CAT GA-3’ 
The PCR conditions were as follows: 
Temperature Duration Cycles  
95°C 5 min.  
95°C 1 min. 30 sec. x 34 
63°C 1 min. 30 sec. x 34 
72°C 2 min. 30 sec. x 34 
72°C 5 min.  
4°C Infinitely  
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Figure 2.3.2: The analysis of 10µl of the Pfu-polymerase PCR products on a 1.2% agarose 
gel (A) and subsequent extraction of the PCR product(B, C). 
One of these PCR products (40µl) was purified from a 1.2% preparative agarose gel, as 
shown in figure 2.3.2B. As shown in figure 2.3.2C, the PCR product was cut out of the gel 
and the DNA insert was purified with the SV Wizard Gel extraction kit from Promega.  
2.3.3 Restriction of pBluescript and the DNA insert 
Therefore, 1000ng of pBluescript and 100ng of the MCE DNA insert were used to set up to 
different double digests with the enzymes DraIII and NotI. The restriction mixes were 
incubated at 4°C overnight. On the next day the mixtures were incubated at 37°C for two 
hours. Then the enzymes were heat inactivated at 65°C for 25 minutes.  
Although, the sticky ends, which are produced in the restriction with DraIII and NotI 
enzymes are incompatible, the vector was de-phosphorylated with calf intestine 
dephosphatase (CIP) to eliminate the chance of self-re-ligation of the vector alone. This was 
done because the cloning of the MCE-trans vector turned out to be more complicated than it 
was expected, in order to eliminate more complications.  
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2.3.4 The ligation of the vector and the DNA insert 
The cut pBluescriptKS vector and the MCE insert DNA were mixed in a molar ratio of 1:3. 
After several failed trials the ligation mixture was finally prepared with 100mM dATP in 
addition to T4 ligase from Promega. The ligation reaction was incubated at room temperature 
for two hours. After the heat inactivation at 65°C for 30 minutes, the reaction was shortly 
cooled on ice. Thereafter, 12µl of the ligation mix was transformed into competent E.coli XL-
1. 50µl and 100µl of the transformant suspension was plated onto LB+Amp agar plates. 
2.3.5 Screenig of the MCEtrans transformants 
  
Figure 2.3.5.1: Shows the analysis of MCEtrans clones after digestion with DraIII and NotI 
restriction enzymes on a 1.2% agarose gel. 
The outcome of this analysis was that none of the clones carried the MCE insert. Most of the 
plasmids were only linearized (e.g clones 1, 3, 4, 12, and 14). Some suffered from DNase 
degradation (e.g. clones 6, 7, 11, and 13). The bright and diffusive bands in the analysed 
samples in figure 2.3.5.1 results from the use of impure bovine serum albumin (BSA), which 
was needed in the restriction. 
After the first attempt of cloning, the screening of the MCEtrans transformants 
revealed a single clone (MCEtrans 4.6), which seems to have a MCE insert of 510 base pairs, 
as it is shown in figure 2.3.5.1 on the left. On the right in figure 2.3.5.1 the analysis of the 
clones from the second attempt is shown. The second attempt of cloning did not reveal a 
clone, which is positive for the MCE sequence. 
However, the clone MCEtrans 4.6 and later the clones from the second cloning trial 
(MCE-trans clones 1-14), were further subjected to a qualitative PCR screening, with primers, 
which were designed for later sequencing of the MCEtrans insert: 
MCEtrans fwd: 5’- GAT AGG GTT GAG TGT TGT TCC AGT TT-3’ 
MCEtrans rev: 5’- ATT ACC GCC TTT GAG TGA GCT GAT A-3’ 
The PCR conditions were as follows: 
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Temperature Duration Cycles 
95°C 5 min  
95°C 1 min x 29 
65°C /alt. 
66°C 
45 sec/ alt. 
30 sec. 
x 29 
72°C 1 min 30 sec x 29 
72°C 2 min  
4°C Infinitely  
 
  
Figure 2.3.5.2: Shows the analysis of the PCR screening of MCE-trans clones on a 1.2% 
agarose gel. Left: Screening of MCE-trans clone 4.6. Right: Screening of MCE-trans clones 
1-14, which were anyway already shown to be negative for the MCE insert in figure 2.3.5.1 
The expected size of the PCR product was for plasmids with MCE insert a fragment of 1066 
bp. For plasmids, that had self-re ligated the expected products size was a fragment of 994 bp. 
For a successfully cut plasmid, which re-ligated without the DraIII-NotI sequence, we 
expected a 551 bp band. 
The only clone that was obtained from the first MCEtrans cloning did not carry the 
MCE sequence. The left picture shows the PCR product, which is produced from the empty 
vector. The initial restriction with DraIII and NotI seems to have been incomplete, so the 
whole cloning procedure was repeated from the very beginning. The right picture in figure 
2.3.5.2 shows the PCR screening after repeated cloning. Unfortunately, the MCEtrans vector 
could not be cloned successfully. 
   67 
2.4 The influence of desmin on the expression of an nkx 2.5-luciferase 
reporter gene 
From the ChIP experiments we found that desmin binds to the nkx 2.5 promoter and to the 
minimal cardiac enhancer region between day 5 and 8 of EB development. To address the 
question why desmin binds to the nkx 2.5 promoter, we choose the Dual Luciferase Reporter 
System (Promega). Therefore, three different cell types were transfected with luciferase 
reporter plasmids and a desmin-expression vector (pBK-RSVcDesmin). The first cell type, 
which was used in transfection, was the 10T ½ fibroblasts. Naturally, the 10 T ½ fibroblasts 
do not express desmin, as it is shown in figure 2.5.6.1. These cells were used to assess the 
changes in luciferase reporter activity upon desmin co-expression. The successful ectopic 
expression of desmin in 10T ½ fibroblasts is also demonstrated in figure 2.5.6.1. The second 
cell type, which was transfected, was the C2C12 myoblasts. These cells express moderate 
levels of desmin, which can be further increased upon differentiation into myotubes in the 
presence of horse serum. In the following experiments undifferentiated C2C12 myoblasts 
were transfected. The third cell type, which was transfected, was primary cardiomyocytes 
from new born mice. The isolation of primary cardiomyocytes is described in chapter 4.1.7.  
As luciferase reporter plasmids the NKE24-reporter vector was used. The NKE24 (nkx 
2.5 pro::luc) contains the firefly luciferase gene downstream of the nkx 2.5 promoter (by 
K.Yutzey; Searcy et al.1998 describes a lacZ variant of the nkx 2.5 promoter reporter). The 
MCEcis vector is based on the NKE24, but carries the minimal cardiac en-hancer sequence 
(Lien et al. 1999) in addition to the nkx 2.5 promoter upstream of the firefly luciferase reporter 
gene. In all transfections the phRL-TK plasmids was included as internal control of 
transfection efficiency. It codes for the renilla reniformis luciferase gene downstream of the 
thymidine kinase (TK) promoter. The plasmids are described in detail in chapter 3.6 and are 
depicted in figure 3.6.1-7. 
Further to assess the impact of desmin knock down at mRNA level on the activity of 
the nkx 2.5 pro::luc reporter and the minimal cardiac enhancer sequence, short hairpin RNA 
expressing plasmids were co-transfected.  
2.4.1 Plasmid-based RNAi 
To study the effect of a desmin knock-down on RNA level in luciferase reporter assays, we 
purchased a plasmid-based RNA interference (pshRNA) set from SA Biosciences. The 
plasmids in this set express short hairpin RNAs (shRNA) and act by RNA interference 
(RNAi) on the cellular gene expression. 
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RNA interference (RNAi) is a term that sums up a variety of processes, which 
naturally occur inside a cell. RNAi processes are initiated by the presence of double stranded 
RNA (dsRNA) molecules. RNAi leads to altered gene expression within the affected cell and 
even in neighbouring cells. RNAi is sequence specific. It can lead to transcriptional silencing, 
mRNA slicing or translational repression of target sequences. In the last years, the use of 
RNAi techniques became a powerful tool in science. RNAi enables a sequence specific, 
transient or conditional knock down of a gene of interest. RNAi experiments in cultured cells 
have become a very fast, easy and clean model to study the function of a gene in transient 
conditional knock down experiments. RNAi effects are mediated by double stranded RNA 
molecules (dsRNA). They naturally occur as a consequence of viral infection or endogenous 
sources. Nowadays, plasmid-based RNAi approaches are used as the vehicle of choice to 
induce RNAi in eukaryotic cells. The RNAi-plasmids code for a 21-nucleotide sequence 
which matchs the sense strand of a target mRNA. Upon the transcription of the RNAi-
sequence, which is encoded on the plasmid, hairpin-structured RNAi molecules, named short 
hairpin RNAs (shRNAs) are formed. A helicase, named Dicer cleaves the shRNAs into 
duplexes of small interfering RNA molecules (siRNAs). The cleaved siRNA duplexes are 
incorporated into the effector complex RISC (RNA-induced silencing complex). The RISC 
basically consists of one siRNA, the complementary target mRNA and a member of 
Argonaute (Ago) protein family. The Ago family proteins contain two major domains, the 
PAZ-domain and the PIWI-domain. The first domain, the PAZ, is also conserved in dicer and 
is an RNA-binding domain (RBD). In consideration of the PAZ domain´s conservation in 
dicer and Ago proteins, it is assumed that the PAZ serves to direct the passing off the siRNA 
strands from dicer to Ago effectors (Song et al.2004). The second domain of Ago proteins, the 
PIWI, shows high similarity to members of RNase H family, which cleave the RNA strand of 
DNA/RNA duplexes. 
However, the shRNAs, microRNAs (miRNAs), and small interfering RNAs (siRNAs) 
function as guide molecules in RNAi and serve for target specificity.  Ultimately, RNAi 
processes can lead to various effects, ranging from RNA cleavage, post transcriptional gene 
silencing (PTGS) to long lasting translational repression and chromatin silencing. The 
miRNAs are a naturally existing large gene-family. The members of miRNA gene family 
normally have key roles in diverse regulatory pathways, including the control of 
developmental timing, haematopoietic cell differentiation, apoptosis, cell proliferation and 
organ development (Kim 2005).  
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2.4.1.1 The murine desmin short hairpin RNA plasmids (pshRNA) 
The pshRNA plasmids were bought from SA Biosciences. The pshRNA are provided as a set 
of four different silencing clones and one negative control plasmid.  Each of the silencing 
plasmids carries a sequence that specifically targets the mRNA of the gene of interest and 
expresses GFP. The negative control contains a random scrambled DNA sequence, which 
does not target the gene of interest. The following sequence shows the murine desmin mRNA 
(NCBI nucleotide database; Accession numbers: NM 010043, GI:33563249). The target sites 
of the pshRNA clones within the desmin mRNA are indicated by bold coloured letters. 
   1 atccactcca gccggctgcc cgcccgctgc ctcctctgtg cgtccgccca gccagcctcg 
  61 tccacgccgc caccatgagc caggcctact cgtccagcca gcgcgtgtcc tcctaccgcc 
 121 gcaccttcgg cggcgccccg ggcttctctc tgggctcccc gctgagctct cccgtgttcc 
 181 ctcgagcagg cttcggtacc aagggctcct cgagttcaat gacatcccgc gtgtaccagg sh3 
 241 tgtcgcgcac gtcgggcggg gctggaggct tggggtcgct gcggtctagc cggctgggga 
 301 ccacccgagc gccatcctat ggcgcgggcg agctgctgga cttctccctg gccgacgctg 
 361 tgaaccagga gttcctggcc acgcgcacca acgagaaggt ggagctgcaa gagctcaatg 
 421 accgcttcgc caactacatc gagaaggtgc gcttcttgga gcagcagaac gccgcgctcg 
 481 ccgccgaggt caaccggctc aagggccgcg aaccgactcg ggtcgccgag ctctacgagg 
 541 aggagatgcg cgagctgcgg cgccaggtgg aggtgctcac caaccagcgc gcccgggtcg 
 601 acgtggagcg tgacaacctg atagacgacc tgcagaggct caaggccaaa ctacaggagg 
 661 aaatccaact aagagaagaa gcagagaaca acttggctgc cttccgagcg gatgtggatg 
 721 cagccactct agctcgtatt gacctggagc gcagaatcga atccctcaac gaggagatcg sh2 
 781 cgttccttaa gaaagtgcat gaagaggaga tccgtgagct tcaggcccag cttcaggaac  
 841 agcaggtcca ggtggagatg gacatgtcca agccggacct cacagctgcc ctcagggaca 
 901 tccgggctca gtatgagacc atcgcggcta agaacatctc tgaggctgaa gaatggtaca sh4 
 961 agtccaaggt ttcagacttg actcaggcag ccaataagaa caacgatgcg ctgcgccaag  
1021 ccaagcagga gatgatggaa taccgacacc agatccagtc ctacacctgc gagattgatg sh1 
1081 ccctcaaggg caccaacgac tccctgatga ggcagatgag ggagctggag gatcgctttg 
1141 ccagcgaggc caatggctat caggacaaca ttgcgcgcct ggaggaggag atccgacacc   
1201 taaaggatga gatggcccgc catctgcgcg agtaccagga cctgctcaat gtgaagatgg 
1261 ccttggatgt ggagatcgcc acctaccgga agctactgga gggcgaggag agcaggatca 
1321 accttcctat ccagaccttc tctgctctca acttccgaga aaccagcccc gagcaaaggg 
1381 gttctgaagt ccataccaaa aagacagtga tgatcaagac cattgagacc cgggatggag 
1441 aggttgtcag cgaggctaca cagcaacaac atgaagtgct gtaagccagg aattcagtgt 
1501 cctggccccg tcctcactgc ctcctgaagc cagcctcttc cactctcgga tatcacaccc 
1561 agccactttt ctccactcac aggctctgac cccccctcac cgatcacccc tttgtggtct 
1621 tcatgctgcc caaccccagg gaacccctca gccacctctg cagaccctcc catgagccct 
1681 ggctattggc aggtgtcaaa gctggctctt aagagagaac ccagctcaag tcatcgccct 
1741 tccccttcca cctttgtgac ccctggctta ggagagggta ccagagaggg tgttgggatc 
1801 tgcagggtca ggaccgagtt tgtggacatc cccagcctgg gtcagagaca gaatgaagcc 
1861 tcagcgagct gagatggaga gtggggggcc tgaaaactgc cctcatggcc cctctctttc 
1921 ccatcgcagc ccaggatggc cttggaaagc gggggctgta agagggaagc ggaaggtgct 
1981 ggatgtggga gcaggagcta cagaaggaga gaggatgggt gaggagctgg agaggaagga 
2041 agagagaggc agagagtggg ctcaggttgg tgggagggta ccacctcccc tgcctgcccc 





Clone 1 : TCCTACACCTGCGAGATTGAT 
Clone 2 : GATCGCGTTCCTTAAGAAAGT 
Clone 3 : CAAGGGCTCCTCGAGTTCAAT 
Clone 4 : GACCATCGCGGCTAAGAACAT 
 
Negative control: ggaatctcattcgatgcatac  no match in murine Desmin mRNA 
(RefSeq. NM_010043 ) 
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Figure 2.4.1.1A: Shows the 2162 bp sequence of the murine desmin mRNA (NCBI nucleotide 
database; Accession numbers: NM 010043, GI:33563249).The target sequences of the 
different pshRNA clones are highlighted in different colours and in bold letters. The random 
sequence of the negative control has no match in the desmin mRNA sequence.  
 
             Figure 
2.4.1.1B: Shows a map of the backbone of 
pshRNA with green fluorescent protein 
(GFP) under the control of a CMV-
promoter (as a tracer). The targeting 
sequences, which form the short hairpin 
RNA, are incorporated in the vector 
between positions 438 and 439 (not shown 
in the map) under the control of the human 
U1 promoter. (U1 is a multigene family of 
small nuclear RNAs).
2.4.1.1.1 The transformation of pshRNA into competent E.coli 
The pshRNA plasmids were introduced into competent E.coli XL-1 by heat-shock 
transformation. Thereafter, 100µl of each reaction was plated on LB+Amp agar plates. (The 
rest was stored at -80°C.) On the next day, one colony of each plate was picked to inoculate a 
5ml liquid LB+Amp starter culture. The starter culture was used to inoculate a 250ml liquid 
LB+Amp overnight culture for QIAGEN endotoxin-free maxi plasmid preparation. 
On the next day, the liquid cultures were used to generate glycerol stocks of the pshRNA 
clones 1-4. The remaining culture was centrifuged for endo-toxin-free maxi prep. The 
plasmids from this preparation are of transfection grade and were subsequently used to 
transfect different eukaryotic cells. 
DNA concentration of the plasmids after maxi prep: 
pshRNA clone1:     [  852.80 ng/µl] 
pshRNA clone 2:    [  910.17 ng/µl] 
pshRNA clone 3:    [1591.71 ng/µl] 
pshRNA clone 4:    [1432.07 ng/µl] 
pshRNA neg.Ctl:    [1110.74 ng/µl] 
2.4.1.1.2 The Quality control and restriction of pshRNA 
To verify the identity of the pshRNA plasmids a diagnostic restriction with PstI was 
performed. The pshRNA-GFP vector is cut in two fragments by PstI if it carries a hairpin 
insert: 4130 base pairs and 1197 base pairs. 
   71 
 
Figure 2.4.1.1.2: The restriction analysis 
of the pshRNA plasmids.
2.4.2 Nkx2.5 promoter-driven Luciferase Expression in transfected 10 T ½ 
Fibroblasts 
First of all we wanted to see if desmin not only binds to the nkx 2.5 promoter and the minimal 
cardiac enhancer (MCE), but also interferes with the activity of these regulatory elements in 
fibroblasts, which have the potential to become myoblasts upon forced expression of MyoD 
(Weintraub et al.1989). Therefore, 10T ½ fibroblasts were transfected with several different 
reporter plasmids. The transfected cells were assayed with Promega’s Dual Luciferase 
Assays. The vectors, which were used in transfections, are listed and explained in the material 
and methods chapter (3.6). In all the different transfections the Renilla reniformis luciferase 
expression plasmid (phRL-TK) from Promega was co-transfected. It served as an internal 
control of transfection efficiency. The data which are listed under “Ratio F/R” come from the 
measured activity of the firefly luciferase divided by the measured activity of the renilla 
luciferase. This procedure is meant to correct possible errors, which arise from different 
transfection efficiency in the samples. The data which is listed under “Renilla luciferase” 
always refers to the activity of the Renilla reniformis luciferase alone. In all the transfections 
the amount of phRL was chosen constant (1:10 of the total DNA concentration), but the 
values of the renilla luciferase activity showed great deviation from sample to sample. 
Therefore, we decided to explore if the expression of the renilla luciferase from the internal 
control phRL-TK (Promega) itself is influenced by the other co-expressed plasmids.  
The activity of firefly luciferase and renilla luciferase was assayed with the Promega Dual 
Luciferase Assay components and was measured in a Berthold Luminometer 48 hours after 
the transfection. The measured values of the same transfection set up were compared with 
each other and were summarized as smaller (<) , equal (=) , or greater (>) than a value 
obtained in presence of the promoter-less pGL3b or NKE24, which carries the firefly 
luciferase under the control of the nkx 2 .5 promoter. A set of data was considered as “equal” 
(=), if the division of the two raw values of reporter activity resulted in a ratio smaller than 
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1.6, because this means that the increase or decrease in reporter activity was less than 0.6. A 
transcription factor, an enhancer or a promoter element should cause a certain x-fold increase 
(factor) in the reporter activity otherwise it does not influence the reporter activity 
significantly. Therefore, a factor of 1.6 was chosen as the minimum, which represents 
“unequal” data. To reveal this factor of increase or decrease, the greater value was always 
divided by the smaller and then related to the context. The following table shows an example 
of the raw data from Luciferase Assay with transfected 10T ½ fibroblasts and the calculation 
of the factor, which is the basis for the classification of the results as “smaller” (<), “equal” 
(=), or “greater” (>): 
 
Plasmid identity Firefly Luc Renilla Luc Ratio F/R*1000 
pGL3b 1400 407990 3.43 





407990/179160= 2.277 20.37/3.43= 5.939 
NKE24 68740 18277850 3.76 









NKE24+Des 123120 110853300 1,111 
NKE24+Des+Kd4 189390 89763600 2,110 








2.4.2.1 The nkx 2.5 promoter drives luciferase expression 
 
Firefly luciferase (∑ 13) Renilla luciferase (∑ 13) Ratio F/R (∑ 13) 
13 pGL3b< NKE24 8 pGL3b< NKE24 11 pGL3b< NKE24 
  0 pGL3b= NKE24 1 pGL3b= NKE24   2 pGL3b= NKE24 
  0 pGL3b> NKE24 4 pGL3b> NKE24   0 pGL3b> NKE24 
Table 2.4.2.1: Comparison of reporter activities from promoter-less pGL3b firefly luciferase 
reporter vector, with the nkx 2.5 promoter-driven firefly luciferase expression (NKE24). 
NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control vector, 
reflects the transfection efficiency. Ratio F/R: normalized reporter activity.  
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Figure 2.4.2.1: The results of the luciferase reporter activities in circular diagrams.  
 
The results , which are shown in figure 2.4.2.1, demonstrate that the nkx 2.5 promoter in the 
NKE24 plasmid is able to drive the expression of downstream firefly luciferase reporter gene 
in 10T ½ fibroblasts. The results from Renilla reniformis luciferase expression show that the 
transfection efficiency in NKE24-transfections was greater, than in pGL3b transfections. This 
is rather a random result than a specific. The data from the ratio of firefly luciferase and 
renilla luciferase (Ratio F/R) serves to correct a possible error in the system, which might 
arise from different transfection efficiencies. The ratio F/R data confirms that the expression 
of the firefly luciferase reporter is activated in presence of the nkx 2.5 promoter. The mean 
fold of luciferase reporter activation from NKE24 is 3.74 with a standart deviation of 1.85. 
The peak fold-increase was found one time with 7.28-fold increase in reporter activity. The 
lowest ratio of NKE24 and pGL3b was found to be 1.14 in one experiment, which obviously 
did not work. 
2.4.2.2 The influence of desmin expression on the promoter-less pGL3b 
The impact of desmin expression on the nkx 2.5 prom::luc reporter (NKE24 and MCE-cis) 
was in the main focus of this thesis. To be sure that any observed effect is due to a specific 
interaction of desmin with the nkx 2.5 promoter, we included a series of co-expression of 
desmin from the pBK-RSV-cDesmin vector with the promoter-less pGL3b. If the expression 
of desmin has no influence on the basic activity of the firefly luciferase from pGL3b the 
results are expected to show a random distribution of pGL3b<pGL3b+Des, pGL3b= 
pGL3b+Des, pGL3b> pGL3b+Des.  
Firefly luciferase (13) Renilla luciferase (13) Ratio F/R (13) 
  0 pGL3b< pGL3b+Des 3 pGL3b< pGL3b+Des 5 pGL3b< pGL3b+Des 
11 pGL3b= pGL3b+Des 6 pGL3b= pGL3b+Des 3 pGL3b= pGL3b+Des 
  2 pGL3b> pGL3b+Des 4 pGL3b> pGL3b+Des 5 pGL3b> pGL3b+Des 
Table 2.4.2.2: Shows the results of the luciferase reporter activities from the promoter-less 
























Figure 2.4.2.2: Shows the results of the luciferase reporter activities in circular diagrams. 
As we expected, the co-expression of desmin has no impact on the basic firefly luciferase 
from pGL3b. This is demonstrated by the great portion of values which are summarized as 
pGL3b= pGL3b+Des. In addition to that, the renilla luciferase activity is neither influenced 
by the co-expression of desmin nor is there any difference in the transfection efficiency with 
or without desmin. The data from the ratio F/R nicely demonstrates the lack of any specific 
effect of desmin on the promoter-less pGL3b, by a distribution of the results close to 1:1:1.   
2.4.2.3 The influence of desmin expression on nkx 2.5 promoter-driven 
luciferase reporter 
The main focus of this thesis was to test the impact of desmin expression on regulatory 
elements, such as the nkx 2.5 promoter. Therefore, the nkx 2.5 pro::luc reporter vector 
(NKE24) was transfected alone or in combination with the desmin-expression vector pBK-
RSV-cDesmin into 10T ½ fibroblasts. The reporter activity, which resulted from the 
transfections, was assayed in the Dual Luciferase Assay system (Promega).  
Firefly luciferase (∑15) Renilla luciferase (∑15) Ratio F/R (∑15) 
1 NKE24< NKE24+Des 0 NKE24< NKE24+Des   2 NKE24< NKE24+Des 
5 NKE24= NKE24+Des 6 NKE24= NKE24+Des 10 NKE24= NKE24+Des 
9 NKE24> NKE24+Des 9 NKE24> NKE24+Des   3 NKE24> NKE24+Des 
Table 2.4.2.3: Shows the results of the luciferase activities from nkx 2.5 promoter-driven 
reporter (NKE24) compared to luciferase reporter activity from the same vector in co-
expression with desmin. NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK 
internal control vector, reflects the transfection efficiency. Ratio F/R: normalized reporter 
activity. Des: ectopic expression of desmin from pBK-RSVcDesmin. 
 
Figure 2.4.2.3: Show circular diagrams of the results of nkx 2.5 promoter-driven reporter 
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The data from above demonstrates that the co-expression of desmin from pBK-RSV-cDesmin 
plasmid either influences both luciferase reporters in an inhibitory manner or simply that the 
transfection efficiency was greater from the NKE24 transfections alone, than in combination 
with desmin. The underlying mechanism remains unknown. However, the firefly luciferase 
alone just gives values without any reference to the efficiency of transfection, and is therefore 
useless. Only the normalized luciferase results (ratio F/R) are valueable. The normalized 
results from luciferase activity (ratio F/R) indicate that in 67% of the samples the co-
expression of desmin from pBK-RSVcDesmin does not  influence the firefly reporter activity 
under the control of the nkx 2.5 promoter. In one of the compared reporter activities from 
NKE24 and NKE24+desmin we found an eight-fold increase of the reporter activity after the 
co-expression of desmin, but most of the other results show that the reporter activity slightly 
decreases (ranging from 1 to 0.5-fold) or stays at the same range. By the term “the same 
range” is meant that the values did not increase or decrease more than 1.6-fold in the reporter 
activity.  
2.4.2.4 The influence of desmin co-expression on the minimal cardiac 
enhancer reporter plasmid 
To test if desmin co-expression results in changes of reporter activity, 10T ½ fibroblasts were 
co-transfected with the MCEcis reporter vector. The MCEcis reporter vector carries the firefly 
luciferase reporter gene under the control of the nkx 2.5 promoter downstream of the minimal 
cardiac enhancer (Lien et al. 1999).  
Firefly luciferase (4) Renilla luciferase (8) Ratio F/R (4) 
0 MCE<MCE+Des 1 MCE<MCE+Des 0 MCE<MCE+Des 
1 MCE=MCE+Des 0 MCE=MCE+Des 4 MCE=MCE+Des 
3 MCE>MCE+Des 7 MCE>MCE+Des 0 MCE>MCE+Des 
Table 2.4.2.4: Shows the results of luciferase reporter activity, which contains the minimal 
cardiac enhancer upstream of the nkx 2.5 promoter-driven firefly luciferase (MCE), under the 
influence of ectopic desmin expression. Renilla luciferase: from phRL-TK, serves as internal 
control of transfection efficiency. Ratio F/R: normalized reporter activity (normalized to 





















Figure 2.4.2.4: Shows circular diagrams of the results shown above. MCE: mce:: nkx 2.5 
pro:: luc. 
Despite the fact that this data set is too small to draw any serious conclusions, it shows the 
same inhibitory effect of desmin co-expression on the luciferase reporters, as we observed 
from NKE24 and NKE24+Desmin at the level of the separate luciferase reporters (firefly and 
renilla). This also might be a consequence of reduced transfection efficiency in combination 
with desmin, than from MCE alone. However, the normalized reporter activity (ratio F/R) 
shows that the co-expressed desmin is not able to serve for addiditional activation of the nkx 
2.5 promoter, which controls the firefly luciferase reporter gene. 
2.4.2.5 The influence of a short hairpin RNA negative control on the luciferase 
reporters  
The short hairpin RNA plasmids were included in this experiment to explore the impact of 
desmin knock down at mRNA level on the expression of the luciferase reporter. We ordered 
pshRNA-GFP constructs from SA Biosciences, to evaluate the transfection efficiencies. Due 
to the fact that so far there was no possibility to see if the transfection has worked, we 
estimated the pshRNA-GFP variant as the most useful to us. The idea behind was to see the 
degree of transfection efficiency already before the luciferase activity was assayed with the 
Dual Luciferase System of Promega. 
The pshRNA clones express an hMGFP- variant, which is an improved synthetic 
version of GFP. The green fluorescent protein (GFP) was originally cloned from Monastrea 
cavernosa. The hMGFP is a codon optimized variant of this naturally existing protein. From 
hMGFP commonly known transcription factor (TF) consensus sites were elimi-nated 
(Promega) from the gfp gene. This reduces or even abolishes the chance that TFs interfere 
with the expression of GFP. The peak excitation wavelength of hMGFP occurs at 505nm and 
the peak emission occurs at 515nm.  
During the process of Dual Luciferase Assay, an ATP-containing beetle luciferin 
substrate (LAR II) is brought in contact with the firefly luciferase. The luciferase enzyme 
oxidizes the luciferin in the substrate to oxyluciferin. This is a reaction, which is accompanied 
by the release of energy in form of light. The emitted light has a wavelength of 530-635nm. 
Although the wavelengths of the light, which is emitted from the firefly luciferase reaction, 
does not match the peak excitation of the hMGFP and although this is very improbable, we 
can not exclude that the emitted light from luciferin oxidation might lead to the excitation of 
GFP or that the presence of GFP interferes somehow with the performance of the Dual 
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Luciferase Assay. This effect is commonly refered to as “crosstalk”. To exclude this threat of 
the experiments, we contacted an agent of Promega, who stated that such interference was not 
observed when they tested this (personal correspondence).  
However, upon the automatic addition of the Stop+Glo® reagent, the light emission 
from firefly luciferase is quenched at least by a factor of 105. The Stop+Glo® reagent not only 
serves to quench the firefly luciferase light reaction, but also contains the renilla luciferase 
substrate (coelenterazine). The renilla luciferase catalyzes the decarboxylation of 
coelenterazine to coelenteramide, which is accompanied by the release of CO2 and energy in 
form of a light shot of 482 nm. The wavelength, which is emitted from the renilla luciferase 
reaction, is quite close to the peak excitation wavelength of hMGFP (505nm). Due to the 
proximity of the wavelengths from renilla luciferase reaction and the GFP excitation, 
interference of the GFP and the renilla signal (crosstalk) might occur. Another consideration 
about the crosstalk of luciferase and GFP is that the overall amount of photons should stay the 
same, regardless if they make the long way round from luciferase to GFP before they reach 
the detector. At the detector of the luminometer single photons with a spectral range of 340-
630 nm are counted. It is unclear if the fluorescence from GFP interferes with the luciferase 
signal and if this further leads to a potentiation of the firefly luciferase signal or to a reduced 
detection of the firefly luciferase signal due to the absorbance of photons by GFP.  
Therefore, the consequence of pshRNA-GFP co-expression was assessed empirical. The 
results are shown in figures 2.4.2.5- 2.4.2.7ABC. 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
1 NKE<NKE+Kdneg 1 NKE<NKE+Kdneg 1 NKE<NKE+Kdneg 
1 NKE=NKE+Kdneg 2 NKE=NKE+Kdneg 1 NKE=NKE+Kdneg 
1 NKE>NKE+Kdneg 0 NKE>NKE+Kdneg 1 NKE>NKE+Kdneg 
Table 2.4.2.5: The compared results of Dual Luciferase Assays after transfection of 10 T ½ 
fibroblasts. NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal 
control vector, reflects the transfection efficiency. Ratio F/R: normalized reporter activity. 
Kdneg: negative control shRNA-GFP. 
 






















The results shown in figure 2.4.2.5 demonstrate that the expression of the short hairpin RNA 
negative control plasmid does not influence any of the luciferase reporters. The distribution of 
NKE24< NKE24+Kdneg, NKE24= NKE24+Kdneg, and NKE24> NKE24+Kdneg is equal in 
the firefly as well as in the ratio F/R data. The data from renilla luciferase show 67% of equal 
renilla luciferase activity in presence of NKE24 and NKE24+Kdneg, which resembles equal 
transfection efficiencies. The “crosstalk” of GFP and the luciferase signals, which is discussed 
above, was not observed here. 
2.4.2.6 The influence of short hairpin RNA negative control on desmin and 
luciferase reporters 
The pshRNA-GFP negative control was transfected into 10T ½ fibroblasts to prove that this 
short hairpin RNA neither targets desmin, nor results in changed activity of the nkx 2.5 
pro::luc reporter (NKE24). To prove that pshRNA-GFP negative control does not interfere 
with the reporter activity is the basis for subsequent emperiments with short hairpin RNAs, 
which target the desmin mRNA. 
Firefly luciferase (4) Renilla luciferase (4) Ratio F/R (4) 
1 N+Des<N+Des+Kdneg 0 N+Des<N+Des+Kdneg 0 N+Des<N+Des+Kdneg 
3 N+Des=N+Des+Kdneg 3 N+Des=N+Des+Kdneg 4 N+Des=N+Des+Kdneg 
0 N+Des>N+Des+Kdneg 1 N+Des>N+Des+Kdneg 0 N+Des>N+Des+Kdneg 
Table 2.4.2.6: Shows the compared luciferase reporter activities from NKE24, which is co-
expressed with the short hairpin RNA negative control (Kdneg), with desmin and without 
desmin. N(KE24): nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal 
control vector, reflects the transfection efficiency. Ratio F/R: normalized reporter activity. 
Des: ectopic expression of desmin from pBK-RSVcDesmin. 
 
Figure 2.4.2.6: Depicts the results shown above in circular diagrams. 
The co-expression of pshRNA-GFP negative control (Kdneg) with desmin from pBK-
RSVcDesmin and the NKE24 (nkx 2.5 pro::luc) reporter revealed no significant change in the 



















   79 
2.4.2.7 The influence of the knock down of desmin at RNA level on the 
luciferase reporters 
The short hairpin RNA-GFP plasmids from SA Bioscience target desmin mRNA, as it is 
demonstrated in figure 2.4.1. Semi-quantitative real time PCR, as described in chapter 2.4.7, 
was included to demonstrate successful knock down. The knock down of desmin mRNA was 
included to test the impact of the knock down on the expression of the luciferase reporters. If 
desmin acts as an activator of transcription, its knock down at mRNA level should result in 
decreased expression of the nkx 2.5 pro::luciferase reporter. In contrast, the knock down of 
desmin at mRNA level by RNAi should lead to increased reporter activity of the nkx 2.5 
pro::luc, if desmin is an inhibitor of transcription. 
A) Short hairpin RNA clone 1 
Firefly luciferase (2) Renilla luciferase (2) Ratio F/R (2) 
0 NKE24< NKE24+Kd1 0 NKE24< NKE24+Kd1 0 NKE24< NKE24+Kd1 
2 NKE24= NKE24+Kd1 2 NKE24= NKE24+Kd1 2 NKE24= NKE24+Kd1 
0 NKE24> NKE24+Kd1 0 NKE24> NKE24+Kd1 0 NKE24> NKE24+Kd1 
Table 2.4.2.7.A1: The compared activities of the luciferase reporters with the short hairpin 
RNA clone 1 (Kd1) and without the shRNA clone 1. NKE24: nkx 2.5 pro::luc reporter. 
Renilla luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. 
Ratio F/R: normalized reporter activity.  
 
 
Figure 2.4.2.7.A1: The relative difference in luciferase activities under the influence of the 
shRNA clone 1.  
Two replicates of this transfection set up are too little to draw any serious conclusion. Besides 
that, the data from this transfections indicate that the co-expression of pshRNA-GFP clone 1 
(Kd1) does not influence the luciferase reporter activity at all. If desmin was able to activate 
the nkx 2.5 promoter , we would have expected that the luciferase reporter activity decreases, 
upon the co-expression of the short hairpin RNA.  
 
Firefly luciferase (2) Renilla luciferase (2) Ratio F/R (2) 
1 N+Des< N+Des+Kd1 0 N+Des<N+Des+Kd1 2 N+Des<N+Des+Kd1 
1 N+Des= N+Des+Kd1 1 N+Des=N+Des+Kd1 0 N+Des=N+Des+Kd1 




















Table 2.4.2.7.A2: Shows the compared activities of the luciferase reporters in combination 
with desmin and under the influence of the shRNA clone 1(Kd1). N(KE24): nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. Des: ectopic expression of desmin from 
pBK-RSVcDesmin. 
 
Figure 2.4.2.7.A2: Depicts the relative difference in luciferase activities under the influence 
of desmin and the shRNA clone 1. 
This experimental set up was only used twice, so the results are not really significant. Besides 
the insignificance due to the low number of replicates, the data shows that there is no 
influence on the reporter activities of both luciferases. The renilla reporter data shows that the 
efficiency of transfection was slightly greater in the transfections without the pshRNA-GFP 
clone 1 (Kd1).The normalized reporter values (ratio F/R) demonstrate the consequence of the 
deviation of transfection efficiency, as two 50:50 results finally changed to a 100% result 
(NKE+Des< NKE+Des+Kd1). The data indicates that the knock down of desmin at mRNA 
level might increase the reporter signal. The mean value of increase in reporter activity is 1.89 
with a standart deviation of 0.04.  
B) Short hairpin RNA clone 3 
Firefly luciferase (2) Renilla luciferase (2) Ratio F/R (2) 
0 NKE24< NKE24+Kd3 0 NKE24< NKE24+Kd3 0 NKE24< NKE24+Kd3 
2 NKE24= NKE24+Kd3 2 NKE24= NKE24+Kd3 2 NKE24= NKE24+Kd3 
0 NKE24> NKE24+Kd3 0 NKE24> NKE24+Kd3 0 NKE24> NKE24+Kd3 
Table 2.4.2.7B: Shows the compared activities of the luciferase reporters alone or in 
combination with the shRNA clone 3(Kd3). NKE24: nkx 2.5 pro::luc reporter. Renilla 
luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. Ratio 
F/R: normalized reporter activity.  
 
Figure 2.4.2.7B: Depicts the relative difference in luciferase activities under the influence of 



































   81 
In the 10T ½ fibroblasts, which do not express desmin, the co-expression of pshRNA-GFP 
clone 3 (Kd3) does not influence the luciferase reporter activity. Concomitant, the knock 
down of desmin at mRNA level, which is anyway absent in 10T ½ fibroblasts , does not 
change the reporter signal significantly. 
Firefly luciferase (2) Renilla luciferase (2) Ration F/R (2) 
0 N+Des< N+Des+Kd3 0 N+Des< N+Des+Kd3 2 N+Des< N+Des+Kd3 
2 N+Des= N+Des+Kd3 0 N+Des= N+Des+Kd3 0 N+Des= N+Des+Kd3 
0 N+Des> N+Des+Kd3 2 N+Des> N+Des+Kd3 0 N+Des> N+Des+Kd3 
Table 2.4.2.7B: Shows the compared activities of the luciferase reporters in combination with 
desmin and under the influence of the shRNA clone 3(Kd3). N(KE24): nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. Des: ectopic expression of desmin from 
pBK-RSVcDesmin. 
 
Figure 2.4.2.7B: Depicts the relative difference in luciferase activities under the influence of 
desmin and the shRNA clone 3. 
 
At the level of the firefly luciferase alone, the co-expression of the pshRNA-GFP clone 3 
(Kd3) with desmin from pBK-RSV-cDesmin and the nkx 2.5 pro::luc reporter (NKE24) seems 
to leave the reporter activity unchanged. In contrast, the activity of the renilla luciferase is 
lower when the pshRNA-GFP clone 3 is co-expressed. This reflects a sudden decrease in the 
efficiency of the transfection. However, the mean value of decrease in renilla reporter activity 
from co-transfection of pshRNA-GFP clone 3 and pBK-RSVcDesmin compared to NKE24 
and pBK-RSVcDesmin alone was 3.49 with a standart deviation of 1.1. From the experiment, 
which is presented here, it is impossible to draw any conclusions from this observation. This 
set up can not elucidate if the decrease in renilla reporter results from decrease in transfection 
efficiency or from an effect, which is promoted by the co-expression of pBK-RSVcDesmin. 
The Dual Luciferase Assay system is designed to rely on the normalization of the first 
reporter, which is controlled by a regulatory element of choice, to the second, which is the 
renilla luciferase downstream of the thymidine kinase (TK) promoter. To evaluate the reporter 
activity, the values can not be separated. The normalized values of reporter activity (ratio F/R) 
indicate that the co-expression of the pshRNA-GFP clone 3 “increased” the luciferase reporter 




















luciferase reporter activity was 3.15 with a standart deviation of 0.03. Here it seems 
appropriate to mention that in different reporter studies it was observed that reporter vectors, 
especially their promoters, might interfere with each other (Farr et al. 1992). The pshRNA-
GFP clones express the hMGFP from a CytoMegaloVirus (CMV) promoter, which is known 
as one of the strongest promoter elements. In contrast to this theory, the same effect of 
promoter crosstalk would have occured in the co-expression of pshRNA-GFP negative 
control, which was not the case. So in conclusion, desmin seems to act as an inhibitory 
molecule on the nkx 2.5 promoter in 10T ½ fibroblasts. This is demonstrated by the increase 
in luciferase reporter activity upon co-expression of short hairpin RNA clone 3, which targets 
desmin at mRNA level.  
C) Short hairpin RNA clone 4 
Firefly luciferase (4) Renilla luciferase (4) Ratio F/R (4) 
0 NKE24< NKE24+Kd4 0 NKE24< NKE24+Kd4 0 NKE24< NKE24+Kd4 
0 NKE24= NKE24+Kd4 0 NKE24= NKE24+Kd4 4 NKE24= NKE24+Kd4 
4 NKE24> NKE24+Kd4 4 NKE24> NKE24+Kd4 0 NKE24> NKE24+Kd4 
Table 2.4.2.7C: The compared activities of the luciferase reporters from NKE24 and phRL-
TK upon the co-expression of the short hairpin RNA clone 4(Kd4). NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. 
 
 
Figure 2.4.2.7C: The relative difference in luciferase activities under the influence of the 
shRNA clone 4. 
 
The firefly luciferase activity was found greater from NKE24 alone than in combination with 
pshRNA-GFP clone 4. The reporter activity from renilla luciferase shows that the transfection 
efficiency was greater from NKE24 transfections than in combination with pshRNA-GFP 
clone 4. In consequence, the normalized reporter activity (ratio F/R) demonstrates that the 
knock down of desmin at mRNA level does not influence the luciferase reporters. As the 10 T 
½ fibroblasts do not express desmin, this result fulfils our expectations. A knock down of a 
genes mRNA, which is not expressed, should result in unchanged reporter activity, as it is 
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Firefly luciferase (6) Renilla luciferase (6) Ratio F/R (6) 
3 N+Des< N+Des+Kd4 2 N+Des< N+Des+Kd4 3 N+Des< N+Des+Kd4 
3 N+Des= N+Des+Kd4 3 N+Des= N+Des+Kd4 3 N+Des= N+Des+Kd4 
0 N+Des> N+Des+Kd4 1 N+Des> N+Des+Kd4 0 N+Des> N+Des+Kd4 
Table 2.4.2.7C: The compared activities of the luciferase reporters in combination with 
desmin and under the influence of the short hairpin RNA clone 4(Kd4). N(KE24): nkx 2.5 
pro::luc reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the 
transfection efficiency. Ratio F/R: normalized reporter activity. Des: ectopic expression of 
desmin from pBK-RSVcDesmin. 
 
Figure 2.4.2.7C: The relative difference in luciferase activities under the influence of desmin 
co-expression and simultaneous desmin mRNA-targeting by the shRNA clone 4 (Kd4). 
The results from the transfection of 10T ½ fibroblasts with the short hairpin RNA-GFP clone 
4 (Kd4), in NKE24 and pBK-RSV-cDesmin co-expression background revealed that the 
knock down of desmin lead to increased reporter activity in 50% of the compared samples. As 
the knock down of desmin leads to increase in reporter activity from nkx 2.5 pro::luc, desmin 
might act inhibitory on the nkx 2.5 promoter in 10T ½ fibroblasts. The renilla luciferase 
depicts the influence of this plasmid combination on the transfection efficiency. The values 
are relatively balanced, except for a slightly greater transfection efficiency when pshRNA-
GFP clone 4 was co-transfected. This is for sure not a specific effect. The results of the firefly 
reporter normalized to the renilla reporter (ratio F/R) resembles the result from the firefly raw 
data. It indicates that desmin might act inhibitory on the nkx 2.5 promoter, because the knock 
down of desmin at mRNA level lead to increased nkx 2.5 pro::luc reporter activity. The mean 
increase in reporter activity was 2-fold with a standard deviation of 0.43.  
The finding that desmin might act inhibitory on the nkx 2.5 promoter, seems to be in 
conflict with the theory that desmin expression positively influences heart relevant genes and 
TFs (Hofner et al. 2007, Höllrigl et al. 2007). The underlying mechanism of desmins 
interference with genomic regulatory elements, for sure does not fit in a black-white scheme, 
which means that it might be both an inhibitor and an activator, depending on the situation in 
the cell and its state of development. However, the 50% of data with increased reporter 
activity from desmin knock down is opposed by another 50% of equality in reporter activity 



















2.4.3 Luciferase assays of transfected C2C12 myoblasts 
Undifferentiated C2C12 myoblast naturally express desmin. The level of desmin expression is 
further increased when the C2C12 myoblasts are driven into differentiation by the addition of 
5-10% horse serum to the growth medium. Upon the activation of differentiation these cells 
form myotubes. For the transfection and later use in Dual Luciferase Assay the C2C12 were 
used undifferentiated. 
2.4.3.1 The nkx 2.5 promoter drives luciferase reporter expression 
To test if the nkx 2.5 pro::luc reporter plasmid (NKE24) results in greater reporter activity 
than it is derived from the promoter-less pGL3b in C2C12 myoblasts, the C2C12 myoblasts 
were transfected with these plasmids in different approaches. The luciferase reporter activity 
was assayed in the Dual Luciferase Reporter Assay (Promega) 48 hrs after transfection. 
Firefly luciferase (∑ 12) Renilla luciferase (∑ 12) Ratio F/R (∑ 12) 
7 pGL3b< NKE24 1 pGL3b< NKE24 8 pGL3b< NKE24 
3 pGL3b= NKE24 7 pGL3b= NKE24 2 pGL3b= NKE24 
2 pGL3b> NKE24 4 pGL3b> NKE24 2 pGL3b> NKE24 
Table 2.4.3.1: Shows the results of the reporter activities of the promoter-less pGL3b vector 
and the nkx 2.5 promoter-driven luciferase expression (NKE24) compared to each other. 
NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control vector, 
reflects the transfection efficiency. Ratio F/R: normalized reporter activity. 
   
 
Figure 2.4.3.1: Shows the results of the luciferase reporter activities in circular diagrams. 
 
The results from C2C12 myoblast transfection with either pGL3b or NKE24 show that the 
nkx 2.5 promoter is able to activate the expression of the firefly luciferase reporter. The 
activity of the renilla luciferase co-reporter from phRL-TK, served to assess the individual 
efficiency of transfection and is not influenced significantly by the expression of each reporter 
plasmid, as it is demonstrated by the large portion of pGL3b= NKE24. The normalized values 
of reporter activity (Ratio F/R) demonstrate that in 67% of the samples the nkx 2.5 promoter 
succeded to drive the expression of the firefly luciferase reporter. The increase in firefly 
luciferase reporter activity from nkx 2.5 pro::luc (NKE24) was about 25-fold (mean value) 
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2.4.3.2 The influence of desmin expression on nkx 2.5 promoter-driven 
luciferase reporter 
Although desmin is already expressed by C2C12 myoblast, it was included in the transfection 
series, to see if this ectopic expression leads to surprising effects. 
Firefly luciferase (∑3) Renilla luciferase (∑3) Ratio F/R (∑3) 
1 NKE24< NKE24+Des 2  NKE24< NKE24+Des 0 NKE24< NKE24+Des 
1 NKE24= NKE24+Des 0  NKE24= NKE24+Des 1 NKE24= NKE24+Des 
1 NKE24> NKE24+Des 1  NKE24> NKE24+Des 2 NKE24> NKE24+Des 
Table 2.4.3.2: The results of the luciferase activities from nkx 2.5 promoter-driven reporter 
(NKE24) compared to luciferase reporter activity from the same vector in co-expression with 
desmin. NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control 
vector, reflects the transfection efficiency. Ratio F/R: normalized reporter activity. Des: 
ectopic expression of desmin from pBK-RSVcDesmin. 
 
Figure 2.4.3.2: Show circular diagrams of the results of nkx 2.5 promoter-driven reporter 
activities, compared to the co-expression with desmin. 
Indeed the ectopic expression of desmin from pBK-RSVcDesmin led to a surprising result. 
While the raw data from the firefly luciferase reporter does not show any effect of desmin co-
expression on the reporter, the normalized reporter signals (Ratio F/R) indicate that desmin 
might inhibit the luciferase reporter downstream of the nkx 2.5 promoter. The luciferase 
reporter activity is decreased when desmin is co-expressed. The mean value of decrease is 9-
fold with a standard deviation of 12. Despite the great standard deviation, the observed 9-fold 
decrease in reporter activity upon co-expression of desmin is compared to the other results a 
relatively clear and strong effect. The degree of reliability of the apparent repression of the 
luciferase reporter by desmin will be demonstrated by  desmin knock down at mRNA level by 
pshRNA-GFP. The knock down of desmin then should result in increased luciferase activity. 
2.4.3.3 The influence of a short hairpin RNA negative control on the luciferase 
reporters  
To test if the short hairpin RNA-GFP negative control serves as an adequate negative control, 





















myoblasts. The luciferase reporter activity was assayed in the Dual Luciferase Assay System 
(Promega) 48 hours after transfection. 
Firefly luciferase (5) Renilla luciferase (5) Ratio F/R (5) 
1 NKE<NKE+Kdneg 1 NKE<NKE+Kdneg 1 NKE<NKE+Kdneg 
1 NKE=NKE+Kdneg 1 NKE=NKE+Kdneg 4 NKE=NKE+Kdneg 
3 NKE>NKE+Kdneg 3 NKE>NKE+Kdneg 0 NKE>NKE+Kdneg 
Table 2.4.3.3: The compared luciferase reporter activities from NKE24 expression alone and 
in combination with a negative control shRNA (Kdneg). NKE24: nkx 2.5 pro::luc reporter. 
Renilla luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. 
Ratio F/R: normalized reporter activity. 
 
 
Figure 2.4.3.3: The results from comparison of the luciferase reporter activities of NKE24 
alone and in combination with pshRNA-GFP negative control, shown as circular diagrams. 
In this experiment the pshRNA-GFP negative control plasmid was shown to leave the 
luciferase reporters uninfluenced. Therefore, it is proven to be a satisfying negative control for 
subsequent knock down of desmin at mRNA level by pshRNA-GFP clones 1-4. 
2.4.3.4 The influence of short hairpin RNA negative control and desmin and 
luciferase reporters 
The independence of the luciferase reporters from pshRNA-GFP negative control was also 
tested under co-expression of desmin in C2C12 myoblasts. Unfortunately, this test was only 
done in duplicates, which is too little to show significant results. Anyway, the data is shown 
for completeness of the reporter assay data. 
Firefly luciferase (2) Renilla luciferase (2) Ratio F/R (2) 
1 N+Des<N+Des+Kdneg 0 N+Des<N+Des+Kdneg 1 N+Des<N+Des+Kdneg 
0 N+Des=N+Des+Kdneg 1 N+Des=N+Des+Kdneg 1 N+Des=N+Des+Kdneg 
1 N+Des>N+Des+Kdneg 1 N+Des>N+Des+Kdneg 0 N+Des>N+Des+Kdneg 
Table 2.4.3.4: Shows the compared luciferase reporter activities from NKE24, which is co-
expressed with desmin from pBK-RSVcDesmin, without or in combination with a negative 
control shRNA (Kdneg). NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK 
internal control vector, reflects the transfection efficiency. Ratio F/R: normalized reporter 
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Figure 2.4.3.4: Depicts the results shown above in circular diagrams. 
This set up was only repeated twice, so the results are not significant.  
2.4.3.5 The influence of desmin knock down on the luciferase reporters 
A) Short hairpin RNA clone 1 
 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
1 NKE24< NKE24+Kd1 1 NKE24< NKE24+Kd1 1 NKE24< NKE24+Kd1 
0 NKE24= NKE24+Kd1 0 NKE24= NKE24+Kd1 2 NKE24= NKE24+Kd1 
2 NKE24> NKE24+Kd1 2 NKE24> NKE24+Kd1 0 NKE24> NKE24+Kd1 
Table 2.4.3.5A: Shows the compared activities of the luciferase reporters from NKE24 and 
phRL-TK alone or in combination with the shRNA clone 1 (Kd1). NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. 
 
 
Figure 2.4.3.5A: Depicts the relative difference in luciferase activities under the influence of 
the shRNA clone 1.  
Unfortunately, the presented set up was only done in triplicate. If the great deviation from 
previous experiments is taken into account, a triplicate of one experiment might be to little to 
be statistically relevant. Despite this, the normalized results from this reporter assays show 
that the knock down of desmin at mRNA level does not change the reporter activity. 
Therefore, this knock down could not proove the theory that desmin is acting as a repressor on 
the nkx 2.5 promoter. The 33% of the results, which show that the knock down resulted in 
increased reporter activity is below the limit of significance.  
In later semi-quantitative real time PCR with cDNA from transfected C2C12 myoblasts, it 



































time of RNA extraction 48 hours after the transfection, as it is shown in figure 2.4.7AB. 
Concommitantly, the knock down is incomplete when the Dual Luciferase Assay is performed 
48 hours after transfection. The results from the semi-quantitative real time PCR, which 
unfortunately was done after the reporter assays, indicates that in C2C12 myoblasts, which 
naturally express desmin, the timing and or the degree of the knock down is insufficient to 
abolish desmin mRNA from the targeted cells. In parallel the effect of desmin knock down is 
not fully developed at the time when the reporter assay is performed. Most probably, resident 
desmin subunits are still acting on the system, while the newly transcribed desmin mRNA is 
decayed more or less incomplete. Unfortunately, it was missed to assess the degree of desmin 
mRNA knock down in extensive real time PCR experiments.  
If the results from semi-quantitative real time PCR, which are shown and described in 
chapter 2.4.7, are taken into account, the 33% of results, which show increased reporter 
activity upon desmin mRNA knock down, maybe the best result, which is possible under 
conditions of incomplete knock down. 
However, the only conclusion, which can be drawn from the results of this reporter assay, 
is that desmin does not act as an activator on the nkx 2.5 promoter in C2C12 myoblasts. 
B) Short hairpin RNA clone 2 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
0 NKE24< NKE24+Kd2 0 NKE24< NKE24+Kd2 1 NKE24< NKE24+Kd2 
0 NKE24= NKE24+Kd2 0 NKE24= NKE24+Kd2 1 NKE24= NKE24+Kd2 
3 NKE24> NKE24+Kd2 3 NKE24> NKE24+Kd2 1 NKE24> NKE24+Kd2 
Table 2.4.3.5B: The compared activities of the luciferase reporters under the influence of the 
short hairpin RNA clone 2(Kd2). NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from 




Figure 2.4.3.5B: The relative difference in luciferase activities under the influence of 
pshRNA-GFP clone 2. 
At the level of the firefly luciferase, the knock down of desmin at mRNA level seems to 
reduce the reporter activity. The renilla luciferase reflects that the transfection efficiency was 
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luciferase activity might be a consequence of lower transfection efficiency. However, the 
normalized result shows that the knock down of desmin at mRNA level by pshRNA-GFP 
clone 2 does not influence the luciferase reporter activity in C2C12, which is reflected by a 
1:1:1 distribution of smaller:equal: greater reporter activity, as shown in figure 2.4.3.5B.  
C) Short hairpin RNA clone 3 
 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
0 NKE24< NKE24+Kd3 0 NKE24< NKE24+Kd3 1 NKE24< NKE24+Kd3 
0 NKE24= NKE24+Kd3 1 NKE24= NKE24+Kd3 2 NKE24= NKE24+Kd3 
3 NKE24> NKE24+Kd3 2 NKE24> NKE24+Kd3 0 NKE24> NKE24+Kd3 
Table 2.4.3.5C: The compared activities of the luciferase reporters from NKE24 and phRL-
TK alone or in combination with shRNA clone 3 (Kd3). NKE24: nkx 2.5 pro::luc reporter. 
Renilla luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. 
Ratio F/R: normalized reporter activity. 
 
 
Figure 2.4.3.5C: The relative difference in luciferase activities under the influence of the 
shRNA clone 3. 
As it was already before observed from other transfections, the efficiency-or at least the 
renilla luciferase activity, which reflects the transfection efficiency, is lower in the presence of 
pshRNA-GFP (clone 3). However, the normalized reporter activity shows that the knock 
down of desmin at mRNA level does not influence the luciferase reporter activity 
significantly, because 67% (two samples!) show equal reporter activity from NKE24 alone 
and in combination with pshRNA-GFP clone 3. As it is demonstrated by results, which were 
shown previously, a triplicate of one experiment seems to be too little to be statistically 
relevant. In addition to that, as it is also mentioned in chapter 2.4.3.5A, the knock down of 
desmin mRNA in C2C12 by the pshRNA-GFP plasmids was shown to be incomplete in semi-
quantitative real time PCR (chapter 2.4.7). In consequence, the effect of the knock down is 
not reflected unambiguously in the data. Due to the incompleteness of the knock down, we 
have to assume that already slight tendencies, which deviate from statistical distribution of 
1:1:1 or from 100% equality in reporter signal, are the most significant results, which we can 




















GFP clone 1, which is described in chapter 2.4.3.5A, the results from knock down by 
pshRNA-GFP clone 3 show 67% of equal results from NKE24 (nkx 2.5 pro::luc) alone and in 
combination with pshRNA-GFP clone 3 (NKE24= NKE24+Kd3), whereas 33% of the results 
show that the luciferase reporter activity decreased upon the knock down of desmin at mRNA 
level. If the incompleteness of the knock down is taken into account, the 33% of the results, 
which reflect a decrease in reporter activity upon desmin knock down, demonstrate that 
desmin might act inhibitory on the nkx 2.5 promoter.  
D) Short hairpin RNA clone 4 
C2C12 myoblasts, which naturally express desmin, were transfected with the nkx 2.5 pro::luc 
reporter alone or combined with a desmin targeting shRNA (Kd4). 
Firefly luciferase (9) Renilla luciferase (9) Ratio F/R (∑9) 
2 NKE24< NKE24+Kd4 2 NKE24< NKE24+Kd4 2 NKE24< NKE24+Kd4 
1 NKE24= NKE24+Kd4 2 NKE24= NKE24+Kd4 5 NKE24= NKE24+Kd4 
6 NKE24> NKE24+Kd4 5 NKE24> NKE24+Kd4 2 NKE24> NKE24+Kd4 
Table 2.4.3.5D: Shows the compared activities of the luciferase reporters from NKE24 and 
phRL-TK alone or in combination with shRNA clone 4 (Kd4). NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. 
 
 
Figure 2.4.3.5D: Depicts the relative difference in luciferase activities under the influence of 
the shRNA clone 4. 
The results from co-expression of pshRNA-GFP clone4 show that the knock down of desmin 
does not influence the luciferase reporter significantly. 
 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
0 N+Des< N+Des+Kd4 0 N+Des< N+Des+Kd4 2 N+Des< N+Des+Kd4 
0 N+Des= N+Des+Kd4 0 N+Des= N+Des+Kd4 1 N+Des= N+Des+Kd4 
3 N+Des> N+Des+Kd4 3 N+Des> N+Des+Kd4 0 N+Des> N+Des+Kd4 
Table 2.4.3.5D: The comparison of the luciferase reporters under ectopic desmin expression 
from pBK-RSVcDesmin alone or in combination with short hairpin RNA clone 4(Kd4). 
N(KE24): nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control 
vector, reflects the transfection efficiency. Ratio F/R: normalized reporter activity. Des: 
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Figure 2.4.3.5D: Depicts the relative difference in luciferase activities under the influence of 
desmin and the shRNA clone 4. 
 
When desmin is co-expressed with the nkx 2.5 pro::luc (NKE24) reporter, the simultaneous 
knock down of desmin by pshRNA-GFP clone 4-expression, the luciferase activity increases 
in 67% (two samples) upon the knock down. The mean value of increase is 5.76-fold with a 
standard deviation of 3.4. The observed increase in luciferase reporter activity from nkx 2.5 
pro::luc (NKE24) upon the knock down of desmin, suggests that desmin acts inhibitory on the 
nkx 2.5 promoter.  
On one hand, this interpretation of the result should be handled with care, because in 
the manual of the Dual Luciferase Reporter Assay (DLR-Promega) it is documented that „it is 
important to realize that trans effects between promoters on co-transfected plasmids can 
potentially affect reporter gene expression“ (Farr and Roman, 1992; DLR-manual III.B 
“Important considerations in co-transfection experiments”). The expression of GFP from 
pshRNA-GFP is controlled by a CMV (CytoMegaloVirus) promoter. This type of promoter is 
very strong and might over rule the normal mechanisms of transgene expression. To exclude 
the chance of promoter interference, another study is needed, in which the CMV promoter is 
transfected on a separate plasmid, without the short hairpin RNA sequence.  
On the other hand, such a “trans” effect was not observed from any other transfection 
of the shRNA-GFP clones, which carry all the same CMV-promoter to drive GFP expression. 
Therefore, it is more likely that the revealed increase in reporter activity upon desmin knock 
down and simultaneous ectopic expression of desmin suggests an inhibitory role of the 
intermediate filament protein at the nkx 2.5 promoter.   
2.4.4 Luciferase assays of transfected primary cardiomyocytes  
Primary cardiomyocytes (pCMC) were prepared from newborn BalbC and Black6 mice and 
used for transfection one day after isolation without further subculture. From fluorescence 
microscopy of transfected pCMC we know that only a very small subset of cardiac cells is 
susceptible to transfection. The cells were screened for transfection efficiency 24 to 48 hours 




















microscopy. The Dual Luciferase Assays were performed 48 hours after transfection with the 
same cells. 
2.4.4.1 The nkx 2.5 promoter drives luciferase expression in primary 
cardiomyocytes 
 
Firefly luciferase (∑ 11) Renilla luciferase (∑ 12) Ratio F/R (∑ 11) 
11 pGL3b< NKE24 10 pGL3b< NKE24  9 pGL3b< NKE24 
  0 pGL3b= NKE24   1 pGL3b= NKE24  1 pGL3b= NKE24 
  0 pGL3b> NKE24   1 pGL3b> NKE24  1 pGL3b> NKE24 
Table 2.4.4.1: The results of the reporter activities of the promoter-less pGL3b vector and the 
nkx 2.5 promoter-driven luciferase expression (NKE24), in comparison. 
NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control vector, 
reflects the transfection efficiency. Ratio F/R: normalized reporter activity.   
 
Figure 2.4.4.1: The results of the luciferase reporter activities in circular diagrams.  
Again it was successfully proven that the nkx 2.5 promoter is able to promote the firefly 
luciferase reporter expression. Interestingly, from the renilla luciferase activity we see that the 
transfection efficiency was disproportionally greater from NKE24 transfections. However, 
based on the normalized reporter values (ratio F/R) we found in 82% of the primary 
cardiomyocytes increased luciferase reporter expression after nkx 2.5 pro::luc (NKE24) 
transfection. The mean value of increase in reporter activity upon NKE24 transfection was12-
fold with a standard deviation of 9.5. Once a peak of a 29-fold activation was observed, 
compared to the promoter-less pGL3b. The lowest observed activation was 1.8-fold. This 
large deviation in the results led to the great standard deviation, which overshadows the 
reliability of the results.  
2.4.4.2 The expression of pshRNA negative control might elicit side effects in 
transfected cardiomyocytes 
A) pGL3b and pshRNA-GFP negative control 
Primary cardiomyocytes were isolated from newborn mice and transfected with the promoter-
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(Kdneg). This experiment was included to show that the random scrambled sequence of the 
pshRNA-GFP negative control plasmids does not influence the luciferase reporters, which 
could not be demonstrated unambiguously. 
Firefly luciferase (4) Renilla luciferase (4) Ratio F/R (4) 
1 pGL3b< pGL3b+Kdneg 2 pGL3b< pGL3b+Kdneg 1 pGL3b< pGL3b+Kdneg 
3 pGL3b= pGL3b+Kdneg 2 pGL3b= pGL3b+Kdneg 1 pGL3b= pGL3b+Kdneg 
0 pGL3b> pGL3b+Kdneg 0 pGL3b> pGL3b+Kdneg 2 pGL3b> pGL3b+Kdneg 
Table 2.4.4.2: Compared results of reporter assays from transfected primary cardiomyocytes 




Figure 2.4.4.2: Shows the results of the luciferase reporter activities in circular diagrams. 
As we expected, the expression of the pshRNA-GFP negative control does not significantly 
influence the firefly luciferase activity. Despite the insignificance, in 50% of the results we 
found that the reporter activity was 3.7-fold greater without the addition of pshRNA-GFP 
negative control (Kdneg) with a standard deviation of 2.8. This result is somewhat similar to 
the results from the desmin targeting short hairpin clones in C2C12 myoblasts. Although, the 
result is below the limit of significance, it might indicate that the short hairpin RNA negative 
control found some off-target in the pCMC and subsequently leads to reduced reporter 
activity after co-expression.  
B) NKE24 and pshRNA-GFP negative control 
Primary cardiomyocytes (pCMC) were isolated from newborn mice, as described in chapter 
4.1.7. The pCMC were subjected to transfection with the nkx 2.5 pro::luc reporter plasmid 
(NKE24) alone or in combination with a short hairpin RNA-GFP negative control plasmid 
(Kdneg), which expresses a random scrambled hairpin RNA sequence. The luciferase reporter 
activities were assayed in a Dual Luciferase Assay (Promega) 48 hours after transfection. The 
reporter activities from NKE24 transfected cells were compared to the reporter activities from 
cells transfected with NKE24 and pshRNA-GFP negative control. As the different 




















summarized as “smaller” (NKE24< NKE24+Kdneg), “equal” (NKE24= NKE24+Kdneg), and 
“greater” (NKE24> NKE24+Kdneg) and listed in the table below. 
Firefly luciferase (11) Renilla luciferase (11) Ratio F/R (11) 
0 NKE<NKE+Kdneg 5 NKE<NKE+Kdneg 0 NKE<NKE+Kdneg 
5 NKE=NKE+Kdneg 3 NKE=NKE+Kdneg 3 NKE=NKE+Kdneg 
6 NKE>NKE+Kdneg 3 NKE>NKE+Kdneg 8 NKE>NKE+Kdneg 
Table 2.4.4.3: Shows the compared luciferase reporter activities from NKE24 expression 
alone or in combination with a negative control shRNA (Kdneg). NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity.  
 
 
Figure 2.4.4.3: Depicts the results, which are shown above as circular diagrams. 
The transfections of NKE24 and NKE24 in combination with the pshRNA-GFP negative 
control (Kdneg) are supposed to show balanced fractions of the three optional results (< 
smaller, = equal, or > greater). Although from firefly luciferase a great portion of the results 
shows that NKE24 and NKE24+Kdneg (pshRNA-GFP negative control) give equal reporter 
activity, the normalized results (ratio F/R) demonstrate that the combination with pshRNA-
GFP negative control reduced the luciferase activity in 73%. The decrease in reporter activity 
is 2.5-fold (mean value) with a standard deviation of 0.5. The reduced firefly activity from 
NKE24+Kdneg does not seem to be a consequence of lower transfection efficiency, because 
the data from renilla luciferase show balanced results with a slight tendency to a greater 
efficiency of transfection from the samples with pshRNA-GFP negative control. The greater 
transfection efficiency in the samples, which were transfected with nkx 2.5 pro::luc (NKE24) 
and pshRNA-GFP negative control (Kdneg), should result in the production of more firefly 
luciferase reporter, unless there is an unknown factor, which interferes with one of the 
components.  
In the Nature Cell Biology editorial “Wither RNAi?” (2003; Vol.5 (6): 489-490) the 
use of a scrambled siRNA/shRNA is considered to be of “little benefit”. In addition to that, a 
comparison of the effects of siRNA/shRNA targeting a non-endogenous gene, such as lac Z or 
GFP, and a shRNA, which targets the gene of interest, is stated to be more useful as a 
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The results from co-expression of the pshRNA-GFP negative control implicate that the 
expression of the scrambled sequence of the short hairpin elicits an off-target effect in 
pCMCs. Therefore, the sequence of the short hairpin (as shown in 2.4.1.1A), which is 
transcribed from pshRNA-GFP negative control, was subjected to a BLAST search of the 
mouse genome and nucleotide database (NCBI; http://blast.ncbi.nlm.nih.gov/Blast.cgi ).  The 
search revealed six mRNA sequences of the mouse, which could be targeted by the negative 
control short hairpin RNA sequence due to sequence similarity. The  following mRNA 
sequences were identified as potential targets: 
Name Function 
Bone Marrow kinase in the X-chromosome 
(Bmx) non-receptor tyrosine kinase (Bmx/Etk)  
TNF signalling and cell cycle entry 
(Al-Lamki et al.2009) 
leucine rich repeat protein 1 neuronal (Lrrn1) Myotome specific expression (Haines 
et al.2005); cell affinity and 
compartment segregation in brain 
development (Tossell et al.2011) 
exonuclease 3'-5' domain containing 2 (Exd2) Not available on NCBI database search 
ubiquitin specific peptidase 34 (Usp34) Regulation of axin stability and Wnt/β-
catenin signalling (Lui et al.2011) 
natural cytotoxicity triggering receptor 1 
(Ncr1/NKp46) 
Tumor immunoediting (Elboim et 
al.2010) 
 anthrax toxin receptor 1 (Antxr1/Tem8) Tumor endothelial marker (Carson-
Walter et al.2001) 
The potential consequences of RNAi targeting of these mRNAs by the pshRNA-GFP negativ 
control in transfected pCMC are unknown. As the potential targeting of the listed mRNAs 
was not verified by real time PCR, the mechanism behind the decrease in reporter activity 
upon co-expression of pshRNA-GFP negative control remains elusive. 
2.4.4.3 The influence of the knock down of desmin at RNA level on the 
luciferase reporters 
To elucidate desmins potential to interact with the nkx 2.5 promoter in fully differentiated 
primary cardiomyocytes, the nkx 2.5 pro::luc reporter plasmid (NKE24) was transfected alone 
and in combination with a short hairpin RNA-expressing plasmid, which serves to target 
desmin at mRNA level. If desmin does not only bind to the nkx 2.5 promoter, but also 
interferes with its activation, the knock down is expected to result in changed reporter activity 
after transfection into pCMC, which were isolated from newborn mice. 
A) Short hairpin RNA clone 4 
Firefly luciferase (11) Renilla luciferase (11) Ratio F/R (11) 
0 NKE24< NKE24+Kd4 5 NKE24< NKE24+Kd4  0 NKE24< NKE24+Kd4 
7 NKE24= NKE24+Kd4 4 NKE24= NKE24+Kd4  5 NKE24= NKE24+Kd4 
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4 NKE24> NKE24+Kd4 2 NKE24> NKE24+Kd4  6 NKE24> NKE24+Kd4 
Table 2.4.4.3A: Shows the compared activities of the luciferase reporters after transfection 
with nkx 2.5 pro::luc (NKE24) alone or in combination with the short hairpin RNA clone 4 
(Kd4). Renilla luciferase from phRL-TK internal control vector. Ratio F/R: normalized 
reporter activity, which corrects deviation from difference in transfection efficiency.  
 
 
Figure 2.4.4.3A: The relative difference in luciferase activities upon the co-expression of the 
desmin targeting shRNA clone 4 (Kd4). 
The normalized values of luciferase reporter activity reflect a 55%: 45% ratio of 
NKE24>NKE24+Kd4 : NKE24=NKE24+Kd4. So a little less than the half of the the results 
reflect unchanged reporter activity upon the co-expression of pshRNA-GFP clone 4 (Kd4). 
The other half (55%) shows a decrease in reporter activity when pshRNA-GFP clone 4 is co-
expressed. The mean value of decrease is about 4-fold with a standard deviation of 2.85. 
Despite the fact that 55% is not a convincingly significant result, the data suggest that desmin 
might act as activator on the nkx 2.5 promoter in pCMC. This result is in contrast to the 
results from the reporter assays with 10T ½ fibroblasts as well as with C2C12 myoblasts, in 
which the simultaneous co-expression and knock down of desmin revealed increased reporter 
activity, and therefore suggests that desmin acts inhibitory on the nkx 2.5 promoter. 
B) Short hairpin RNA clone 1 and clone 4 combined 
To enhance the effect of desmin knock down on the nkx 2.5 pro::luc reporter, pCMC were 
transfected with two different pshRNA_GFP clones (Kd1+4). 
Firefly luciferase (3) Renilla luciferase (3) Ratio F/R (3) 
2 N< N+Kd1+Kd4 2 N< N+Kd1+Kd4 0 N< N+Kd1+Kd4 
0 N= N+Kd1+Kd4 1 N= N+Kd1+Kd4 0 N= N+Kd1+Kd4 
1 N> N+Kd1+Kd4 0 N> N+Kd1+Kd4 3 N> N+Kd1+Kd4 
Table 2.4.4.3B: Shows the compared activities of the luciferase reporters from pCMC, which 
were transfected with NKE24 alone or in combination with the shRNA clones 1+4. N(KE24): 
nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-TK internal control vector, reflects 
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Figure 2.4.4.3B: Depicts the relative difference in luciferase activities upon co-expression of 
two different shRNA clones. 
The data from the reporter assay of primary cardiomyocytes after the transfection with 
NKE24 or NKE24 in combination with pshRNA-GFP clones 1+4 shows at the level of the 
firefly luciferase that in 67% of the samples the reporter activity increased upon the co-
expression of the pshRNA-GFP clones 1+4. This increase in reporter activity after the knock 
down of desmin might be interpreted in the way that desmin acts as inhibitor on the nkx 2.5 
promoter. This interpretation is contradicted by the results from the normalized values of 
reporter activity (ratio F/R). The ratio F/R shows 100% of NKE24> NKE24+Kd1+Kd4. The 
mean value of decrease was 1.76-fold with a standard deviation of 0.08. The decrease in 
reporter activity allows for the suspicion that desmin might act as a very weak activator at the 
nkx 2.5 promoter or alternative as a “permissive factor”, which binds to the nkx 2.5 promoter 
to substitute another molecule. Once more the results from the reporter assays with 
transfected pCMC contradict the findings from the same study in 10T ½ fibroblasts and in 
C2C12 myoblasts. Upon simultaneous ectopic expression of desmin and knock down of 
desmin at mRNA level, the reporter activity from nkx 2.5 pro::luc (NKE24) increased and 
therefore desmin seems to be rather inhibitory to the nkx 2.5 promoter in 10T ½  fibroblasts 
and C2C12 myoblasts.  
2.4.5 Summarized results of luciferase assays from transfected fibroblasts and 
myoblasts 
The transfections of 10T ½ fibroblasts and C2C12 myoblasts revealed similar results from 
Dual Luciferase Assays. Therefore, in this chapter the data from 10T ½ fibroblasts and C2C12 
myoblasts are summarized with respect to the reporter plasmids, which were used in 
transfection. This was done to achieve more significant results and greater sample quantitiy, 
especially from the transfections, which were only done in duplicates in the different cell 
types. The results from transfected primary cardiomyocytes are not included, because they 




















2.4.5.1 The nkx 2.5 promoter drives reporter expression 
The luciferase reporter activities from 10T ½ fibroblasts and C2C12 myoblasts, which are 
shown in chapters 2.4.2 and 2.4.3, are summarized in the following table.  
Firefly luciferase (∑25) Renilla luciferase (∑ 25) Ratio F/R (∑ 25) 
20 pGL3b< NKE24 9 pGL3b< NKE24 19 pGL3b< NKE24 
  3 pGL3b= NKE24 8 pGL3b= NKE24   4 pGL3b= NKE24 
  2 pGL3b> NKE24 8 pGL3b> NKE24   2 pGL3b> NKE24 
Table 2.4.5.1: The compared reporter activities of the promoter-less pGL3b and the nkx 2.5 
pro::luc reporter (NKE24). Renilla luciferase: from phRL-TK internal control vector, reflects 
the transfection efficiency. Ratio F/R: normalized reporter activity.  
 
 
Figure 2.4.5.1: Shows the results of the luciferase reporter activities in circular diagrams.  
The summarized results of transfected 10T ½ fibroblasts and C2C12 myoblasts confirm that 
the nkx 2.5 promoter upstream of the firefly luciferase gene (NKE24) drives the expression of 
the firefly luciferase reporter. The mean value of the summarized increase in reporter activity 
is 29-fold with a standard deviation of 82.9. The great standard deviation implicates that the 
summary of the results from the two different cell types might be inappropriate. 
2.4.5.2 The influence of ectopic desmin expression  
A) on luciferase activity from promoter-less pGL3b (negative control)  
Firefly luciferase (13) Renilla luciferase (13) Ratio F/R (13) 
  0 pGL3b< pGL3b+Des 3 pGL3b< pGL3b+Des 5 pGL3b< pGL3b+Des 
11 pGL3b= pGL3b+Des 6 pGL3b= pGL3b+Des 3 pGL3b= pGL3b+Des 
  2 pGL3b> pGL3b+Des 4 pGL3b> pGL3b+Des 5 pGL3b> pGL3b+Des 
Table 2.4.5.2A: Shows the results of the luciferase reporter activities from the promoter-less 
pGL3b vector upon desmin co-expression. Renilla luciferase: from phRL-TK internal control 
vector, reflects the transfection efficiency. Ratio F/R: normalized reporter activity. Des: 





















   99 
 
Figure 2.4.5.2A: Shows the results of the luciferase reporter activities in circular diagrams. 
As expected, the co-expression of desmin with the promoter-less pGL3b firefly luciferase 
reporter plasmid does not change the luciferase reporter activities significantly.    
B) The influence of ectopic desmin expression on luciferase reporter 
downstream of the nkx 2.5 promoter 
To assess the influence of desmin on the nkx 2.5 promoter the NKE24 reporter plasmid was 
transfected into 10T ½ fibroblasts and C2C12 alone or in combination with the desmin 
expression vector pBK-RSV-cDesmin, as it is described in chapter 2.4.2 and 2.4.3. The 
results, which are shown here, reflect a summary of the previously shown results, in order to 
increase the sample quantity and statistical relevance. 
Firefly luciferase (∑18) Renilla luciferase (∑18) Ratio F/R (∑18) 
  2 NKE24< NKE24+Des   2 NKE24< NKE24+Des   2 NKE24< NKE24+Des 
  6 NKE24= NKE24+Des   6  NKE24= NKE24+Des 11 NKE24= NKE24+Des 
10 NKE24> NKE24+Des 10  NKE24> NKE24+Des   5 NKE24> NKE24+Des 
Table 2.4.5.2B: Shows the results of the activities from nkx 2.5 promoter-driven luciferase 
reporter (NKE24) compared to NKE24 in combination with desmin. NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. Des: ectopic expression of desmin from 
pBK-RSVcDesmin. 
 
Figure 2.4.5.2B: Show circular diagrams of the results of nkx 2.5 promoter-driven reporter 
activities, compared to the co-expression with desmin. 
The ectopic expression of desmin from pBK-RSV-cDesmin does not lead to a significant 









































fibroblasts and C2C12 myoblasts. The majority (61%) of the samples (N18) revealed that the 
luciferase reporter activity is not influenced by the ectopic expression of desmin.  
C) The influence of ectopic desmin expression on the MCE reporter plasmid 
 
Firefly luciferase (4) Renilla luciferase (8) Ration F/R (4) 
0 MCE<MCE+Des 1 MCE<MCE+Des 0 MCE<MCE+Des 
1 MCE=MCE+Des 0 MCE=MCE+Des 4 MCE=MCE+Des 
3 MCE>MCE+Des 7 MCE>MCE+Des 0 MCE>MCE+Des 
Table 2.4.5.2C: Comparison of luciferase reporter activities. MCE: minimal cardiac 
enhancer sequence upstream of nkx 2.5 promoter and firefly luciferase gene. Des: ectopic 
expression of desmin from pBK-RSV-cDesmin. 
 
 
Figure 2.4.5.2C: Shows circular diagrams of the results shown above. 
The expression of desmin does not significantly change the luciferase reporter activity. 
Unfortunately, the sample quantity is too small to be statistically significant. 
2.4.5.3 Cloned minimal cardiac enhancer fails to increase reporter activity  
Firefly luciferase (∑5) Renilla luciferase (∑5) Ratio F/R (∑5) 
1 NKE24 < MCE 0 NKE24 < MCE 1 NKE24 < MCE 
3 NKE24 = MCE 3 NKE24 = MCE 3 NKE24 = MCE 
1 NKE24 > MCE  2 NKE24 > MCE 1 NKE24 > MCE 
Table 2.4.5.3: Shows a comparison of the results from NKE24 and MCE transfections. 
NKE24: nkx 2.5 pro::luc reporter. MCE: mce::nkx2.5 pro::lucRenilla luciferase: from phRL-




Figure 2.4.5.3: Shows the compared emergence of increased (<), unchanged (=), and 
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The expression of the luciferase reporter failed to increase from the cloned sequence of the 
minimal cardiac enhancer, compared to NKE24 (nkx 2.5 pro::luc reporter). The cloned 
sequence of the minimal cardiac enhancer from the MCE plasmid was not sufficient to 
increase the reporter activity. This might be due to several reasons. The first is that the 
minimal cardiac enhancer (Lien et al. 1999) might fail to induce the nkx 2.5 promoter. The 
second reason may be that the cloned sequence of the MCE contains additional base pairs 
compared to the published version, as it is shown in figure 2.2.5C. Unfortunately it was 
impossible to find out if these base pairs derive from a polymorphic region or if they derive 
from mistakes in the PCR, because the respective sequence of the C3H mouse genome is not 
available in the NCBI database. The GATA-binding sites within the MCE sequence, which 
were shown to be vital for the proper function of the minimal cardiac enhancer (Lien et 
al.1999), were not affected in the cloned sequence.The third reason for the failure of the 
minimal cardiac enhancer sequence to increase the luciferase reporter activity might be that 
the interaction of the enhancer sequence with a promoter needs alignment of the two 
regulatory elements. The arrangement of the minimal cardiac enhancer (MCE) within the 
context of a plasmid might be too tight to enable the alignment of the enhancer element and 
the promoter. For another enhancer element (µ) a need for precise alignment of regulatory 
sites was reported to be vital for enhancer activation (Nikolajczyk et al.1996). Similarily, 
precise spatial arrangement might be crucial to the activation of the minimal cardiac enhancer. 
In the study from Lien and colleagues transgenic mice were used as a model to explore the 
boundaries and the function of the minimal cardiac enhancer. When transgenic mice are 
generated by homologous recombination the sequence is incorporated site specific and 
therefore, the sequence remains in the context of the genome. In contrast, when reporter 
studies are done with plasmids in transfected cells, the lack of the proper spatial arrangement 
of the sequences, which are the subject of the study, might lead to complete loss of function of 
the respective element. The underlying mechanisms of activation of enhancer elements in 
consequence of precise spatial arrangement range from protein binding and complex 
formation to DNA bending (flexure) and to altered DNA conformation. 
2.4.5.4 The influence of a negative control shRNA on the luciferase reporters  
10T ½ fibroblasts and C2C12 myoblasts were transfected with the nkx 2.5 pro::luc reporter 
(NKE24) and the internal control phRL-TK (renilla luciferase), as usual. Additionally, a 
negative control shRNA plasmid (pshRNA-GFP) was co-transfected to demonstrate that any 
observed effect from the later knock down of desmin at mRNA level by shRNA is specific. 
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The use of a scrambled negative control shRNA is discussed in more detail in chapter 2.4.4.2. 
The negative control short hairpin RNA-GFP from pshRNA-GFP was co-transfected to 
demonstrate that it leaves the activities of the firefly and the renilla luciferase unchanged. 
Firefly luciferase (∑8) Renilla luciferase (∑8) Ratio F/R (∑8) 
2 NKE<NKE+Kdneg 2 NKE<NKE+Kdneg 2 NKE<NKE+Kdneg 
2 NKE=NKE+Kdneg 3 NKE=NKE+Kdneg 5 NKE=NKE+Kdneg 
4 NKE>NKE+Kdneg 3 NKE>NKE+Kdneg 1 NKE>NKE+Kdneg 
Table 2.4.5.4: The comparison of luciferase reporter activities from NKE24 expression alone 
or in combination with a negative control shRNA (Kdneg). NKE24: nkx 2.5 pro::luc reporter. 
Renilla luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. 
Ratio F/R: normalized reporter activity. 
 
Figure 2.4.5.4: Depicts the results, which are shown above as circular diagrams. 
Here, it is shown that the negative control shRNA-GFP does not interfere with the reporter 
activity of neither firefly luciferase from NKE24, nor renilla luciferase from phRL-TK. The 
result clearly demonstrates the absence of any off-target effect of the random scrambled RNA 
sequence, which is expressed from the negative control pshRNA-GFP.   
2.4.5.5 The influence of ectopic desmin expression and negative control shRNA  
Firefly luciferase (6) Renilla luciferase (6) Ratio F/R (6) 
2 N+Des<N+Des+Kdneg 0 N+Des<N+Des+Kdneg 1 N+Des<N+Des+Kdneg 
3 N+Des=N+Des+Kdneg 4 N+Des=N+Des+Kdneg 5 N+Des=N+Des+Kdneg 
1 N+Des>N+Des+Kdneg 2 N+Des>N+Des+Kdneg 0 N+Des>N+Des+Kdneg 
Table 2.4.5.5: The compared luciferase reporter activities from nkx 2.5 pro::luc (N) and 
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Figure 2.4.5.5: The compared luciferase reporter activities in circular diagrams. NKE: nkx 
2.5 pro::luc, Des: ectopic desmin expression from pBK-RSVcDesmin, Kdneg: negative 
control shRNA-GFP. 
In 10T ½ fibroblasts and C2C12 myoblasts the negative control shRNA does not influence the 
luciferase reporter. 
2.4.5.6 The influence of desmin knock down on the luciferase reporters 
In this part of luciferase assay results, the effect of desmin knock down at mRNA level by 
pshRNA-GFP clones in 10T ½ fibroblasts and C2C12 myoblasts is discussed. The results 
derive from the transfections of 10T ½ fibroblasts and C2C12 myoblasts, which are discussed 
in chapters 2.4.2 and 2.4.3. The following data represents a summary of luciferase reporter 
assay results of these two cell types. 
A) Short hairpin RNA clone 1 
Firefly luciferase (5) Renilla luciferase (10) Ratio F/R (5) 
1 NKE24< NKE24+Kd1 1 NKE24< NKE24+Kd1 1 NKE24< NKE24+Kd1 
2 NKE24= NKE24+Kd1 2 NKE24= NKE24+Kd1 4 NKE24= NKE24+Kd1 
2 NKE24> NKE24+Kd1 2 NKE24> NKE24+Kd1 0 NKE24> NKE24+Kd1 
Table 2.4.5.6A: Shows the compared activities of the luciferase reporters from NKE24 and 
phRL-TK alone or combined with a desmin targeting shRNA (Kd1). NKE24: nkx 2.5 pro::luc 
reporter. Renilla luciferase: from phRL-TK internal control vector, reflects the transfection 
efficiency. Ratio F/R: normalized reporter activity. 
 
Figure 2.4.5.6A: Depicts the relative difference in luciferase activities under the influence of 
the shRNA clone 1.  
 
The summarized results of transfections of 10T ½ fibroblasts and C2C12 myoblasts 
demonstrate that the knock down of desmin at mRNA level by pshRNA-GFP clone 1 (siRNA 
mechanism) failed to change the luciferase reporter activity signficantly.  
B) Short hairpin RNA clone 3 
Firefly luciferase (5) Renilla luciferase (5) Ratio F/R (5) 
0 NKE24< NKE24+Kd3 0 NKE24< NKE24+Kd3 1 NKE24< NKE24+Kd3 
2 NKE24= NKE24+Kd3 3 NKE24= NKE24+Kd3 4 NKE24= NKE24+Kd3 






















Table 2.4.5.6B: Shows the compared activities of the luciferase reporters under the influence 
of the shRNA clone 3(Kd3). NKE24: nkx 2.5 pro::luc reporter. Renilla luciferase: from phRL-




Figure 2.4.5.6B: Depicts the relative difference in luciferase activities under the influence of 
desmin and the shRNA clone 3. 
The results from the co-expression of pshRNA-GFP clone 3 resemble the data from pshRNA 
clone 1. The knock down of desmin left the reporter activity unchanged. 
C) Short hairpin RNA clone 4 
Firefly luciferase (∑13) Renilla luciferase (∑13) Ratio F/R (∑13) 
  2 NKE24< NKE24+Kd4  2 NKE24< NKE24+Kd4 2 NKE24< NKE24+Kd4 
  1 NKE24= NKE24+Kd4 2 NKE24= NKE24+Kd4 9 NKE24= NKE24+Kd4 
10 NKE24> NKE24+Kd4 9 NKE24> NKE24+Kd4 2 NKE24> NKE24+Kd4 
Table 2.4.5.6C: Shows the compared activities of the luciferase reporters alone or in 
combination with the short hairpin RNA clone 4(Kd4). NKE24: nkx 2.5 pro::luc reporter. 
Renilla luciferase: from phRL-TK internal control vector, reflects the transfection efficiency. 
Ratio F/R: normalized reporter activity.  
 
 
Figure 2.4.5.6C: Depicts the relative difference in luciferase activities under the influence of 
the shRNA clone 4. 
The knock down of desmin at mRNA level by a siRNA mechanism (pshRNA-GFP clone 4) 
does not change the luciferase reporter activity significantly. The result, which is shown here, 
resembles the result from the co-expression of a negative control pshRNA-GFP. The 
normalized reporter activities demonstrate that the knock down of desmin at mRNA level 
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indicates that desmin does not act on the nkx 2.5 promoter, although the intermediate filament 
protein binds to this regulatory element, as it was found in ChIP experiments.     
D) Short hairpin RNA clone 4 and desmin 
Firefly luciferase (∑9) Renilla luciferase (∑9) Ratio F/R (∑9) 
3 N+Des< N+Des+Kd4 2 N+Des< N+Des+Kd4 5 N+Des< N+Des+Kd4 
3 N+Des= N+Des+Kd4 3 N+Des= N+Des+Kd4 4 N+Des= N+Des+Kd4 
3 N+Des> N+Des+Kd4 4 N+Des> N+Des+Kd4 0 N+Des> N+Des+Kd4 
Table 2.4.5.6D: Compared luciferase reporter activities are summarized as smaller (<), 
equal (=), or greater (>). N (NKE24): nkx 2.5 pro::luc reporter. Kd4: desmin targeting 
pshRNA-GFP clone 4. 
 
Figure 2.4.5.6D: The compared reporter activities depicted in circular diagrams. NKE24: 
nkx 2.5 pro::luc reporter, Des: pBK-RSV-cDesmin expression vector, Kd4: desmin targeting 
pshRNA-GFP clone4. 
When desmin is expressed ectopically from pBK-RSVcDesmin and knocked down at mRNA 
level by shRNA (pshRNA-GFP) simultaneously, the luciferase reporter activity increases, 
compared to the ectopic expression of desmin alone. The mean value of reporter increase 
upon desmin knock down was 3.5-fold with a standard deviation of 2.7. (peak increase: 8-
fold). The increase in reporter activity from desmin knock down was only observed when 
desmin is expressed ectopically.  
2.4.6 Results of the luciferase assays 
To elucidate why desmin binds to the nkx 2.5 promoter and the minimal cardiac enhancer 
sequence, two different types of reporter plasmids, which carry the respective regulatory 
elements in cis, were engaged. A third plasmid, which carried the MCE sequence in trans 
without reporter gene, was included.  
First, the NKE24 vector was proven to increase the firefly luciferase reporter activity 
via the nkx 2.5 promoter. In all three transfected cell types the expression of NKE24 (nkx 2.5 
pro::luc) resulted in increased reporter activity compared to the promoter-less pGL3b.  
Second, the minimal cardiac enhancer sequence (Lien et al.1999) was cloned upstream 






















promoter and the minimal cardiac enhancer, but also interferes with reporter activity 
downstream of these well characterized regulatory elements. Unfortunately, the cloned MCE 
sequence was found to be unable to significantly increase the reporter expression from the 
firefly reporter vector. There may be several reasons for the failure of reporter enhancement. 
The first reason might be that the cloned sequence contains additional base pairs compared to 
the published sequence (Lien et al.1999). It is unclear if these bases came from a 
polymorphism within this region or from an error in the PCR. The possibility of a 
polymorphism arises from the fact that C3H mouse gDNA was used for cloning. Lien and 
colleagues were apparently exploring B6C3 gDNA. The second reason may be that the 
distance of the MCE sequence and the nkx 2.5 promoter is too short. Therefore, the MCEcis 
vector was cloned.  
The MCE-cis vector contains the MCE sequence at a maximum possible distance to 
the nkx 2.5 pro::luc reporter. The reporter assays with MCE-cis revealed that the cloned 
sequence of the minimal cardiac enhancer fails to increase the luciferase reporter activity. 
Probably the results would have been different if the vector was aligned before transfection. 
The third reason for the failure of the MCE-cis vector to enhance the reporter activity of 
downstream firefly luciferase gene might be found in the fact that the genomic context is 
missing in the plasmid. In literature a theory is stated that the enhancer needs to align with the 
promoter elements. The precise spatial alignment of an enhancer was shown to be critical to 
the proper function of the enhancer (Nikolajczyk et al.1996). The concert of transcription 
factor (TF) binding needs a certain and apparently invariable arrangement of binding sites for 
proper complex formation. The TF-complex formation might further lead to DNA flexure and 
subsequent alteration of DNA conformation (Nikolajczyk et al.1996). Therefore, the lack of 
the genomic context within a reporter plasmid may be responsible for the failure of the MCE-
cis to enhance the reporter activity. In the study of the minimal cardiac enhancer, Lien and 
colleagues used transgenic mice to explore the function and the boundaries of this regulatory 
element. Within transgenic mice, the MCE sequence remains in a genomic context, because 
homologous recombination is needed to establish a certain genotype in-vivo. Therefore, the 
ability of the MCE sequence to function in a reporter plasmid needs to be studied in more 
detail.  
Third, to eliminate the chance that changed reporter activities result from a possible 
trans effect (Farr et al.1992) of the minimal cardiac enhancer, we tried to clone the MCE-
trans vector. Unfortunately, the efforts to clone the minimal cardiac enhancer sequence into a 
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pBluescriptKS-backbone without luciferase reporter or any other additional regulating 
element remained unsuccessful.  
The major task of this thesis was to elucidate desmins ability to interact with the nkx 
2.5 promoter. Therefore, desmin was ectopically expressed after transfection of 10T ½ 
fibroblasts and C2C12 myoblasts. An nkx 2.5 pro::luc reporter (NKE24) was co-transfected to 
assess the influence of desmin on the nkx 2.5 promoter.  Subsequent Dual Luciferase Assays 
(Promega) revealed that ectopic desmin expression does not significantly change the activity 
of the luciferase reporter.  
It remains elusive why desmin binds to the nkx 2.5 promoter, as it was found in ChIP 
experiments (chapter 2.1).  Concomitantly with the failure of desmin to change the luciferase 
reporter activity, the knock down of desmin at mRNA level from the expression of the 
shRNA-GFP plasmids failed to significantly change the reporter activity. 
In contrast the simultaneous ectopic expression and knock down of desmin at mRNA 
level leads to increased reporter activity in the Dual Luciferase Assays (Promega) in 10T ½ 
fibroblasts and C2C12 myoblasts. In the discussion of the reporter assay results from 10T ½ 
fibroblasts after desmin targeting at mRNA level (2.4.2.7C), it is shown that the shRNA does 
not influence the reporter activity, as it is demonstrated by 100% equality in reporter activity 
with and without desmin knock down. This is in line with the fact that 10T ½ fibroblasts do 
not express desmin naturally. In contrast, when desmin is ectopically expressed during 
simultaneous knock down in 10T ½ fibroblasts the results reflect equal activity and increased 
reporter activity in a 50:50 ratio. Although not significant, the mean value of increase reporter 
activity in 10T ½ was 2-fold with a standard deviation of 0.43.  
In C2C12 myoblasts, which naturally express desmin, the knock down of desmin lead 
to 56% of equal reporter activity. In contrast, when desmin is ectopically expressed and 
simultaneously knocked down in C2C12 myoblasts, the reporter activity increased in 67% of 
the samples. The mean value of incease in reporter activity in C2C12 was 5.76-fold with a 
standard deviation of 3.4. In summary, the results from 10T ½ fibroblasts and C2C12 
myoblasts, therefore suggest an inhibitory action of ectopically expressed desmin on the nkx 
2.5 promoter. In contrast the co-transfection of pBK-RSVcDesmin and the luciferase reporter 
vector into 10T ½ fibroblasts revealed that desmin fails to change reporter activity 
significantly. As we did not expect to find such great difference in the results from natural and 
ectopical desmin expression, it was omitted to increase sample quantities of C2C12 myoblasts 
with ectopically expressed desmin levels. We rather expected to find changed reporter activity 
upon the knock down of naturally expressed desmin. In addition to that, we expected to see 
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changed luciferase reporter activity from transfected 10T ½ fibroblasts, which were forced to 
ectopic desmin expression, compared to nkx 2.5 pro::luc reporter (NKE24) controls. The fact 
that only ectopic desmin expression showed significant results in reporter assays was rather 
surprising and makes conclusive interpretation difficult. 
 The reporter assays with transfected primary cardiomyocytes (pCMC) revealed a 
result, which is the opposite from what was observed in 10T ½ fibroblasts and C2C12 
myoblasts. As fully differentiated pCMC naturally express relatively large amounts of 
desmin, these cells were never subjected to ectopic desmin expression. In pCMC reporter 
assays we relied on the effect of shRNA, which targets desmin at mRNA level, and therefore 
was expected to reveal significant results. The knock down of desmin in pCMC, which were 
transfected with the nkx 2.5 pro::luc reporter (NKE24) revealed in 55% of the samples a mean 
4-fold decrease in luciferase reporter activity with a standard deviation of 2.85. So in pCMC 
the results from knock down of desmin at mRNA level suggest that desmin might act as a 
very weak and potentially conditional activator on the nkx 2.5 promoter. The intermediate 
filament protein desmin might rather be a “permissive” factor on the nkx 2.5 promoter in 
pCMC and in contrast a “non-permissive” factor in 10T ½ fibroblasts and C2C12 myoblasts, 
than a transcription factor (TF), which actively interferes with the activity of the nkx 2.5 
promoter. It might serve as a binding site for TFs, which subsequently induce activation or 
repression of the nkx 2.5 promoter. As the levels of desmin expression are relatively low in 
10T ½ fibroblasts and C2C12 myoblasts compared to pCMC, the proposed role for desmin as 
a co-factor in the regulation of heart relevant gene expression would fit to the process of 
intermediate filament assembly. The subunits of the intermediate filament type III-protein 
desmin bind to the nkx 2.5 promoter and the minimal cardiac enhancer, as it was demonstrated 
in ChIP experiments, at the early onset of expression and act “non-permissive” on these 
genomic regulatory elements, until the onset of intermediate filament assembly. With the 
progress of intermediate filament assembly, desmin subunits are sequestered from the nucleus 
to fullfill their role in the maintenance of the structural integrity of muscle cells, due to greater 
affinity of intermediate filament protein subunits to each other than to DNA. The sequestering 
of desmin from the nucleus to cytoplasmic IF assembly is demonstrated by the disappearance 
of desmin binding to the nkx 2.5 promoter and the minimal cardiac enhancer at day 9 of 
development in des+/+ EBs and at day 8 in des+/+/ect EBs in ChIP experiments. 
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2.4.7 Semi-quantitative Real Time PCR 
To demonstrate the effects of desmin targeting at mRNA level by shRNA (pshRNA) on the 
expression levels of desmin, transfected cells were harvested for subsequent RNA isolation 48 
hours after transfection. The RNA was isolated with the QIAGEN RNeasy kit. The genomic 
DNA was digested with DNaseI. Thereafter, the samples were tested for residual gDNA in a 
PCR with primers, which are specific for the housekeeping gene glycerinealdehyde-3-
phosphat-dehydrogenase (GAPDH). After the samples were proven to be free of gDNA, the 
residual mRNA was reversely transcribed with Superscript II reverse transcriptase from 
Invitrogen and oligo-dT primers. The cDNA was used to set up another GAPDH-PCR to 
equilibrate the cDNA concentration in the samples. 
Thereafter, a PCR with primers, which are specific for desmin, was run under the following 
conditions: 
Temperature Duration Cycles 
95°C 5 min  
95°C 1 min x 22 
52°C 30 sec x 22 
72°C 45 sec x 22 
72°C 1 min 30 sec  
4°C Infinitely  
 
Figure 2.4.7.1: Semi-quantitative real-time PCR. Samples from transfected 10T ½ fibroblasts 
and C2C12 myoblasts. Vectors were used as indicated in the picture. 
NKE24: nkx 2.5 pro::luc reporter, Kd4: shRNA plasmid clone4 (pshRNA),  
GAPDH: housekeeping gene for glycerinealdehyde-3-phosphat-dehydrogenase serves to 
equilibrate [cDNA]; pGL3b: promoter-less firefly luciferase reporter plasmid. Desmin (Des): 




The figure 2.4.7.1 demonstrates the absence of desmin mRNA in 10T ½ fibroblasts and 
successful expression of desmin in 10T ½ after transfection with pBK-RSVcDesmin. The 
levels of ectopically expressed desmin in 10T ½ fibroblasts are not affected by the negative 
control shRNA, whereas the targeting of desmin by shRNA (Kd4) resulted in complete knock 
down of ectopically expressed desmin in 10T ½ fibroblasts. The semi-quantative RT PCR 
with C2C12 cDNA demonstrates that desmin is expressed naturally in untransfected C2C12 
myoblasts. In addition to that, it demonstrates that the knock down of desmin at mRNA level 
by pshRNA-GFP (Kd4) is incomplete in C2C12 myoblasts (NKE24+Kd4). Moreover, this 
semi-quantitative RT PCR failed to detect changes in the levels of desmin expression upon 
ectopic expression. Either the levels of naturally expressed desmin are already saturated, so 
that ectopic expression of desmin fails to further increase the expression level, or the semi-
quantitative real time PCR is simply too insensitive to monitor changes in the levels of desmin 
expression. In the cDNA of transfected C2C12 myoblast there is no evident difference in the 
levels of natural desmin expression compared to the ectopic expression of desmin from pBK-
RSVcDesmin and compared to the knock down of desmin mRNA. The results from the semi-
quantitative real time PCR indicate that the timing of desmin knock down in C2C12 
myoblasts might be inappropriate. In consequence, this indicates that the reliability of the 
results from Dual Luciferase Assays with the C2C12 myoblasts should be questioned. Due to 
the fact that the knock down of desmin was obviously incomplete we can only expect effects 
in the reporter assay, which slightly miss the furrow of significance. Furthermore, the semi-
quantitative RT PCR demonstrates that the expression of additional desmin could not elevate 
the levels of desmin expression in C2C12 myoblasts. Neither the knock down of desmin at 
mRNA level nor its rescue could be verified in the present RT PCR. As a consequence for this 
thesis the whole chapter on Dual Luciferase Assays was interpreted according to this, in the 
way that increase or decrease in luciferase reporter activity was indicated even if reporter 
activity was changed only insignificantly. To finally elucidate desmins ability to interfere with 
regulatory DNA elements during development, the knock down of desmin and its rescue by 
the co-expression of desmin from pBK-RSVcDesmin should be verified in a more sensitive 
approach like a Light Cycler Real Time PCR (Roche) before reporter activity may be assayed. 
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Figure 2.4.7.2: Semi-quantitative real time PCR. RNA was isolated from C2C12 myoblasts 48 
hours after transfection. Vectors were used as indicated. pGL3b: promoter-less firefly 
luciferase reporter plasmid. NKE24: nkx 2.5 pro::luc reporter plasmid, Desmin (Des): from 
the pBK-RSV-cDesmin vector. Kdneg: negative control shRNA, Kd4: desmin targeting 
shRNA. MCE-cis: mce::nkx 2.5 pro::luc reporter.  
In Figure 2.4.7.2 the results of a different semi-quantitative real time PCR (RT PCR) is 
depicted. It shows the natural expression level of desmin in C2C12 myoblasts in the first three 
samples (pGL3b, NKE24, and NKE24+Kdneg). The fourth lane shows the knock down of 
desmin at mRNA level by pshRNA-GFP clone 4. Here the knock down became more 
apparent than in figure 2.4.7.1. The level of desmin mRNA appears slightly reduced when 
compared to the first three lanes. The ectopic expression of desmin from the pBK-
RSVcDesmin is visible as a weak increase in signal intensity in lane 5 (NKE24+Des). 
Unfortunately, this increase is not remarkable when compared to the natural levels of desmin 
expression (e.g lane 3: NKE24+Kdneg). Moreover, the “knock down and rescue” sample in 
lane 7 (NKE24+Des+Kd4) shows greater level of desmin expression than in the samples, in 
which desmin was expressed ectopically (e.g. lanes 5: NKE24+Des and 6: 
NKE24+Des+Kdneg). This also demonstrates that the timing of desmin expression, its knock 
down and rescue in the transfection and reporter assay study might be inappropriate to reveal 
more significant results.  
2.4.8 Fluorescence microscopy reveals levels of transfection efficiency  
The shRNA plasmids, which code for a desmin-targeting short hairpin RNA or a negative 
control shRNA, co-express a green fluorescent protein (hMGFP). The expression of hMGFP 
enables tracking of transfected cells in fluorescence microscopy, and therefore to visualize the 
transfection efficiency.  
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Figure 2.4.8.1: Shows C2C12 myoblasts after the transfection with pshRNA-GFP clone 4, 
which targets murine desmin mRNA. Left: viable C2C12 cells (20x) in phase contrast. Right: 
fluorescence image of the same cells(20x). GFP-fluorescence represents successfully 
transfected (pshRNA-GFP) cells. Transfection efficiency ranged from ~10-15%. 
 
    
Figure 2.4.8.2: Transfected primary cardiomyocytes (pCMC) in phase contrast microscopy 
(left) and in fluorescence microscopy (right). The fluorescence results from the transfection of 
pshRNA-GFP clone 4, which targets the murine desmin mRNA. Transfection efficiency of 
pCMC: ~5% 
2.4.9 Primary cardiocytes represent a heterogenous population 
To assess the consequences of desmin knock down, transfected pCMC were subjected to 
immunofluorescence staining. Therefore, primary cardiomyocytes were transfected with 
plasmids, which express shRNA variants (pshRNA). The pshRNA-GFP clone 4 serves to 
specifically knock down the mRNA of the desmin gene in target cells, by mechanisms of 
RNA interference (RNAi). The negative control shRNA was included to explore co-
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localization of desmin-staining in successfully transfected cells (GFP+). Similarily to the Dual 
Luciferase Assays and semi-quantitative RT PCR, transfected cells were fixed two days after 
transfection. The fixed cells were stained with desmin-specific mouse monoclonal antibodies, 
and a secondary Texas red-conjugated antibody. This enables to visualize the desmin protein 
in the red channel of the Zeiss confocal laser scanning microscope, while the GF protein is 
visualized in the green channel.  
   
A)                                             B)                                            C) 
Figure 2.4.9.1: Immunofluorescence microscopy of pCMC with antiDesmin antibody and 
detection of GFP. 
A) untransfected pCMC, Red: desmin monoclonal mouse AB. DAPI (blue): nucleus. 
B) transfected pCMCs (pshRNA-GFP clone 4). Green: GFP+ from successful transfection 
with desmin targeting shRNA-GFP. Red: desmin monoclonal mous AB. Blue: DAPI stainig of 
the nuclei. 
C) transfected pCMCs. Green: GFP+ (pshRNA-GFP clone 4), red: desmin specific 
monoclonal antibody, DAPI (blue): nuclei. 
Figure 2.4.9.1A shows a fixed primary cardiomyocyte, positively stained for desmin (red). 
The intermediate filament type III protein is mostly located to the cytoplasm and more 
condensed around the nucleus (blue). Figure 2.4.9.1B shows fixed pCMCs, which are either 
successfully transfected (GFP+) or desmin positive (red). It remains unclear if the introduction 
of desmin targeting shRNA leads to RNAi-mediated protein decay, or if in advance only 
desmin negative pCMCs are susceptible to transfection. To examine the effect of desmin 
knock down at mRNA level on the levels of pre-existing protein (e.g. RNAi-mediated protein 
decay), a series of western blot studies need to be done. 
However, the immunofluorescence staining of transfected pCMC demonstrates that 
primary cells represent a very heterogenous population of cells, in which only some are 
susceptible to genetic manipulation.  
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A)                                                B) 
Figure 2.4.9.2: Transfected pCMCs. 
Green: GFP positive, Red: desmin positive immunofluorescence staining, Blue (DAPI): nuclei 
A) transfected with desmin targeting pshRNA-GFP clone 4. 
B) transfected with a negative control pshRNA-GFP.  
Figure 2.4.9.2AB demonstrates the observed heterogeneity of pCMC with respect to the 
susceptibility of individual cells to transfection. Interestingly, in virtually all the samples of 
fixed pCMC after transfection, we only found large cardiac fibroblasts to be successfully 
transfected (GFP positive). The desmin positive cells (red) were usually smaller. Two 
exceptions were found in all examined samples.  The exceptions are shown in figure 2.4.9.1B 
and 2.4.9.3 on the left. In both pictures des+ and GFP+ neighbouring cells appear in similar 
size and shape.  
It seems that not all of the cell types, which are present in a cardiac tissue, are 
susceptible to transfection. This observation is in line with the very low transfection 
efficiency we obtained from the primary cardiomyocytes (~5%).  
Unfortunately, the transfections of the negative control shRNA failed to reveal a single 
des+/GFP+ cell, although the negative control shRNA (pshRNA-GFP) codes for a scrambled 
short hairpin RNA sequence, which does not target desmin mRNA. In Dual Luciferase Assays 
(Promega) of transfected pCMCs we found evidence that the negative control shRNA elicits 
off-target effects. In subsequent search of the NCBI nucleotide database six potential targets 
were identified. Still it remains elusive if the GFP expression over rules the desmin staining or 
interferes with its structure in a way that masks the epitopes for desmin-specific antibody 
binding or if desmin is simply not expressed uniformely in all cell types of the cardiac tissue. 
However, it is remarkable that even after the transfection with the negative control, the cells 
were either GFP positive, or desmin positive. 
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Figure 2.4.9.3: transfected Primary cardiocytes (pshRNA-GFP clone4). Red: desmin-specific 
staining from monoclonal mouse antibodies and secondary texas red (TR) antibody. Green: 
GFP+, DAPI (blue): nuclei. 
Unfortunately, in none of the specimens a co-localization of GFP (successful transfection) and 
desmin-texas red staining was found. This leads to the suspicion that it is only a special subset 
of primary cardiocytes, which is susceptible to transfection. More precisely, the cardiac 
muscle cells may be too specialized and too sensitive to be susceptible to transfection and 
therefore, to produce a short hairpin RNA. In a cell type of that importantance in the organism 
there might be at least one mechanism to suppress any attack from foreign DNA or RNA. In 
addition to that, it is very unlikely that the short hairpin RNAs are able to act on pre-existing 
desmin protein, or even on large quantities of desmin mRNA, as the semi-quantitative Real 
Time PCR of the transfected samples revealed (chapter 2.4.7). So in summary, the primary 
cardiomyocytes represent a model, which is not ideal for transfection and subsequent reporter 





3. Material  
3.1. Chemicals for molecular biology 
 
Acetic acid Merck, D 
Acrylamide BioRad, USA 
Agarose, Biozyme LE Biozyme, D 
Ampicillin Sigma, USA 
BCIP=5’Brom-4’Chlor-3’Indoylphosphat Diagnostic Chemicals Limited, D 
Bovine Serum Albumin Roth, D 
ß-Mercaptoethanol Loba Feinchemie, A 
Bis N,N’-Methylenbisacrylamide BioRad, USA 
Brompheolblue Sigma, USA 
Coomassie Brilliant Blue R250 Merck, D 
DAPI Sigma, USA 
Dabco Sigma, USA 
dNTPs MBI Fermentas, Lithuania 
Dimethylsulfoxid (DMSO) Acros, B 
Dimethylformamid Fluka, CH 
Dithiothreitol (DTT) Acros, B 
Ethanol Merck, D 
Ethidiumbromide Fluka, CH 
EDTA Acros, B 
EGTA Acros, B 
Formaldehyde Merck, D 
Glycerin Merck, D 
Hydrochloric acid (HCl) Acros, B 
Kanamycin Sigma; USA 
Lumiglo® cell signaling, D 
Methanol Merck, D 
MgCl2 MBI Fermentas, Lithuania 
Mineraloil Sigma, USA 
Mowiol 2-88 Hoechst, D 
Nitrotetrazolium Blue Chloride (NBT) Fluka, CH 
NEB Buffers New England Biolabs, USA 
PCR-buffer without MgCl2 MBI Fermentas, Lithuania 
Phenylmethansulfonylfluoride (PMSF) Flucka, CH 
Ponceau-S Sigma, USA 
Protease inhibitor complete mini Roche, CH 
Reverse Transcriptase Buffer Invitrogen, USA 
Saponin Roth, D 
SDS BioRad, USA 
Sodiumchloride Salinen Austria, A 
Sodiumhydrogencarbonate LifeTechnologies, USA 
Tris Base LifeTechnologies, USA 
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T4-Ligase Buffer Promega, USA 
3.2. Chemicals for tissue culture 
ß-Mercaptoethanol Loba, A 
Ampothericin B Invitrogen, USA 
D-Glucose Acros, B 
DMEM powder LifeTechnologies;USA 
DMSO (Dimethylsulfoxide) Sigma, USA 
Fetal Bovine Serum (FBS) HyClone, USA 
        Gibco, USA 
        Sigma, USA 
Gelatine Difco, USA 
L-(+)-Glutamin Acros, B 
Mitomycin C Acros, B 
Natriumhydrongencarbonate LifeTechnologies, USA 
Penicillin G Kaliumsalz Merck, D 
Streptomycin Sigma, USA  
3.3 Enzymes 
 
CIP (Calf Intestine Phosphatase) NewEnglandBiolabs, USA  
Collagenase Gibco, USA 
DNAse I, RNase free Roche, D 
Pancreatin Worthington, USA 
Pfu-Polymerase Fermentas, Lithuania 
Restriction Enzymes NewEnglandBiolabs, USA 
RNaseOUT® LifeTechnologies, USA 
Superscript®II RNase Reverse Transcriptase LifeTechnologies, USA 
Taq DNA Polymerase MBI Fermentas, Lithuania 
Trypsin LifeTechnologies, USA 
T4 DNA Ligase Promega, USA 
3.4 Antibodies 
Anti-Desmin (mouse) monoclonal (epitope approx: AA 325-372), Sigma (ProdNr.D1033) 
Anti-Histone H3 (rabbit), Abcam (ProdNr.: ab1791) 
Anti-cMyc (mouse), from the group of E.Ogris 
Anti-Vimentin (mouse), Abcam 
donkey anti-rabbit TexasRed-conjugated  
primary pre-immune serum from rabbits, from the group of C.Seiser  
goat anti-mouse FITC-conjugated 
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3.5 PCR primers 
Primer name Sequence
nkx2-5 promoter 1 fwd 5’-CTCTGTTTGCTTTCTCGCCA-3’ 52°C 245 bp
nkx2-5 promoter 1 rev 5’-ATTGGAGACAGGCAGCGTTA-3’ 52°C
nkx2-5 promoter 2 fwd 5'-GGCGTTGTTGAAGATAAAGC-3' 48°C 275 bp
nkx2-5 promoter 2 rev 5'-GCCTTTTAAAGACTTGGTGC-3' 48°C
min.card.enh 1 fwd 5'-GAGATAAGATGACATACCAGA-3' 349 bp
min.card.enh 1 rev 5'-ATTAGTGTGAACACAACACT-3' 57,8°C
min.card.enh 2 fwd 5'-TTATCTTCCCCGGAGGAAAT-3' 51,9°C 327 bp
min.card.enh 2 rev 5'-GCAGACACTCAAGCCCTTAA-3'
MCE1107 2 fwd 5´-CGACAGGAAACTCGGAGCTA-3´ 60°C 121 bp
MCE1107 2 rev 5´-CTCTGCTGTGTGGCCTTGTA-3´ 60°C
nkx2.5ProSG fwd 5´-TAAAGAAACCCCCACAGGTCA-3´ 55°C 166 bp
nkx2.5ProSG rev 5´-TGTCAAGAAAAAGGAAGAAAACTC-3´ 53°C
nkx2-5 distal 1 fwd 5´-AGATTCCCAGCAGTCCGTA-3´ 54,5°C ~340 bp
nkx2-5 distal 1 rev 5´-CAAGAGTCACTGCCCGAA-3´ 54,5°C
nkx2-5 distal 2 fwd 5´-GACATTGTGCATCTTAGCA-3´ 54,5°C ~440 bp
nkx2-5 distal 2 rev 5´-TTCCACACTGCTGACCTG-3´ 54,5°C
nkx2-5 proximal 1 fwd 5´-GTCCCAGAACAACTGTCT-3´ 54,5°C ~270 bp
nkx2-5 proximal 1 rev 5´-CCAGCCAGACACACTCAA-3´ 54,5°C
nkx2-5 proximal 2 fwd 5´-CTCACTCTGTCCTGTTTCCT-3´ 54,5°C ~400 bp
nkx2-5 proximal 2 rev 5´-GAGTCCTGTTAAGTGAATCGG-3´ 54,5°C
GAPDH fwd 5´-CGTCTTCACCACCATGGAGA-3´ 55°C ~300 bp
GAPDH rev 5´-CGGCCATCACGCCACAGTTT-3´ 55°C
Dra III fwd 5’-TAATCACGTAGTGTCTGGGTCCTAATGC-3’ 63°C 510 bp
Not I rev 5’-TATTCGCCGGCCGCTCAAGGTGCACATGA-3’ 63°C
MCEtrans fwd 5’-GATAGGGTTGAGTGTTGTTCCAGTTT-3’ 66°C 1066 bp
MCEtrans rev 5’-ATTACCGCCTTTGAGTGAGCTGATA-3’ 66°C
Sal I fwd 5’-TAATGTCGACTCTGGGTCCTAATGC-3’ 56,5°C ~ 510 bp
Sal I rev 5’-TATTGTCGACTCAAGGTGCACATGA-3’ 56,5°C
MCEcis fwd 5’-TATGTTTCAGGTTCAGGGGGAGGTG-3’ 57°C ~ 681 bp
MCEcis rev 5’-TAAGTGCGGCGACGATAGTCATGC-3’ 57°C






pGL3b  Promega  Basic FF (w/o promoter), AmpR 
(Luc.Assay) 
pUC18 ATCC LacZ, AmpR (Transfection/DNA 
balance) 
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NKE24 
Based on pGL3b (Promega), cloned 
and kindly provided by K.Yutzey 
from Cincinnati, USA. 




Based on NKE24, cloned by C.Fuchs 
(2007) MCE (Lien et al.; 1999) 




Based on NKE24, cloned by 
S.Gawlas in cooperation with 
C.Fuchs in 2007. 
MCE- nkx 2.5 promoter-FF ; AmpR 
(Luc.Assay) 
MCEcis Based on NKE24, MCE cloned at 
max. possible distance by S.Gawlas 
in 2008 
nkx2.5 promoter-FF….-MCE (at 
max.distance) AmpR  (Luc.Assay) 
MCEtrans Based on pBluescriptKS from 
Stratagene, cloned by S.Gawlas in 
2008  




Backbone from Stratagene, 
(Sonja Puz diploma thesis 1999) 
(Hofner et al.2007). 
RSV promoter-cDNA of desmin; 
KanR 
(expression/transfection/Luc.Assay) 




group of Prof.G.Wiche, backbone 
pEGFP-C1(Clontech) 




SA Biosciences, (hMGFP backbone) U1 promoter-short hairpin RNA 




Abbreviations: FF (firefly luciferase gene), RL (renilla reniformis luciferase), AmpR 
(ampicillin resistance gene), LacZ (β-Galactosidase gene for blue-white screening), MCE 
(minimal cardiac enhancer; Lien et al. 1999), RSV (Rous-Sarcoma Virus promoter, relatively 
strong promoter), HSV-TK (Herpes simplex virus-thymidine kinase promoter, provides low 
to moderate levels of (renilla luciferase expression), CMV (CytoMegaloVirus promoter, a 
very strong promoter), GFP (gene for green fluorescent protein), KanR (Kanamycin resistance 
gene) 
 
Figure 3.6.1: Shows a map of pGL3b 
(Promega). 
 
Figure 3.6.2: Shows a map of pUC18.
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Figure 3.6.7: Shows a map of the pshRNA 
(SA Biosciences).
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3.7 Kits 
RNeasy® Mini Kit Qiagen, D 
QIAGEN Endotoxin free Maxi Plasmid Prep Qiagen, D 
QIAquick Gel extraction Kit Qiagen, D 
Wizard® Plus SV Minipreps DNA Purification System Promega, USA 
PureYieldTM Plasmid Midiprep System Promega, USA 
Dual Luciferase® Reporter System Promega, USA 
3.8 Bacterial strains 
E.coli TOP10 
E.coli XL-1 
3.9 Material for bacterial culture 
3.9.1 LB medium 
For one liter of LB-medium for bacterial culture, 10g Sodium Chloride, 10g Tryptone, and 5g 
yeast extract are mixed in a beaker and dissolved in one liter of distilled water. The pH is 
adjusted to 7 and aliquoted to 500ml glass bottles. Then the LB-medium is sterilized by 
autoclaving at 120°C at 1,4bar steam pressure for at least 20 minutes. 
3.9.2 LB-agar plates 
To produce LB-agar plates, 7.5g agarose (1.5%) is added to a 500ml bottle of LB-medium, 
before autoclaving. One 500ml bottle contains enough volume to produce twenty 10cm plates. 
After autoclaving, the LB-agar medium is either directly used to pour the plates, or it may be 
stored at 4°C until use. In case the LB-agar is not directly used, the agarose must be melted in 
a microwave at 180 watt for 30 minutes. 
Thereafter or after autoclaving, the LB-medium must be allowed to cool down to about 50°C 
before antibiotics may be added (e.g. 0.08g Ampicillin). To ensure proper distribution, gently 
shake the media. The LB-agar is poured into 10cm plates for bacterial culture under (semi-) 
sterile conditions. The agar needs about one hour at room temperature to solidify. Thereafter, 
the plates are stored at 4°C in the cold room. Before use, the plates have to be dried and 
heated to room temperature under (semi-) sterile conditions. 
  
122 
3.10 Material for cell culture 
Glass bottles 
Used empty glass bottles are filled with a dash of hypochlorite and tap water. To destroy all 
potentially contaminating agents, the bottles are left with the hypochlorite for 10 minutes. 
Thereafter, the bottles are rinsed until no chlorine smell is left. 
The bottles are rinsed, filled with milli pore water and are left for 24hrs. On the next day the 
bottles are dried and autoclaved at 121°C and 1bar steam pressure for at least 20 minutes. 
Glass pipettes 
After use, the pipettes are stored in quivers, containing hypochlorite and tap water, to prevent 
them from running dry, while they are still dirty. A dirty pipette, which dried out would be 
almost impossible to clean, when detergent must not be used. 
The glass pipettes are rinsed in tap water in a special quiver for at least two hours. Overnight 
they are incubated in milli pore water. On next day they are dried at 80°C, plugged. To 
sterilize the glass pipettes, they are baked at 180°C for 8hrs (dry sterilization). These pipettes 
and bottles are exclusively used for cell culture. They must not be mixed up with normal 
detergent treated bottles and pipettes. 
In addition to that, single use plastic ware, like 10cm dishes, cell lifters and pipette tips are 
needed. 
3.11 Cell lines 
All cell lines are from murine origin. 
Embryonic 
Stem Cells 
Des +/+ (AB2.2) wild type ESC isolated by Allan Bradley from 
129Sv mice (Soriano et al;1991) 
 Des+/+desect (DC6) Constitutively overexpressing desmin 
Produced by Sonja Putz in 1999 (diploma 
thesis)   
 Des-/-   desmin knocked out by Georg Weitzer 
(Weitzer et al.;1995) 
 Desmin∆1-48/∆1-48 (1B44) N-terminally truncated version of  desmin is 
ectopically expressed (Höllrigl et al.;2002) 
primary Cardiomyocytes Isolated from newborn mice (BalbC and B6) 
Fibroblasts 10T 1/2  Murine embryonic fibroblast line (do not 
express desmin)  
 C2C12 Murine myoblasts (muscle pre-cursor cells), 
express desmin 
 SNL 76/7 Transgenic mouse embryonic fibroblast STO 
feeder cell line (McMahon and Bradley;1990) 
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4. Methods 
4.1 Tissue culture 
In general, working should be absolutely sterile. To maintain murine embryonic stem cells 
(ESC), the glassware (pipettes and bottles) must be completely free of washing detergents and 
the cells need to be fed every 24 hours. Whenever water is included in a TC protocol, it is 
sterile (autoclaved > 20minutes at 121°C and 1bar steam pressure) water from a MilliPore 
Synergy® Ultrapure Water System. The water from this system is deionized (optimal 18.2 
MegaOhm) and free of any (bacterial) toxin.  
4.1.1 Media and solutions for tissue culture 
Water 
sterile (autoclaved > 20minutes at 121°C and 1bar steam pressure) water from a MilliPore 
Synergy® Ultrapure Water System. 
10x Phosphate Buffered Saline 
NaCl 80  g  
KCl   2  g 
Na2HPO4 . 7 H2O 10.72 g 
KH2PO4   2 g  
 
The ingredients are dissolved in 800ml MilliPore water, pH is adjusted to 7.2 using saturated 
Na2HPO4. Afterwards, the solution is filled to 1 liter (MilliPore) and sterile filtered (Nalgene 
Filter , Nalgene membrane; 0.22µm pore size)  
100x Glutamine-Penicilline-Streptomycine 
NaCl    4.25 g 
Penicilline   1.5 g 
Streptomycine   2.5 g 
L-(+)-Glutamine 14.6 g 
 
Ingredients are dissolved in 500ml MilliPore water. 
Sterile filtered, aliquoted in 50ml Falcon tubes, and stored at -20°C for longer periods. The 
currently used GPS stock is stored at 4°C after thawing.  
β-Mercaptoethanol   
 1x PBS  200 ml  
β -Mercaptoethanol  144 µl 
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Ιn ESC culture, β-ME is used to disarm free radicals in the nutrition media. Free radicals may 
be generated during exposure to oxygen, CO2, or just during the cellular metabolism. Before 
use, the solution is sterile filtered, aliquoted and stored at -20°C until use. 
Trypsin/EDTA 
NaCl  3.5 g 
D-Glucose  0.5 g 
Na2HPO4. 7H2O  0.09 g 
KCl  0.185 g 
KH2PO4  0.12 g 
EDTA  0.2 g 
Trypsin (Gibco)  1.25 g 
TrisBase  1.5 g 
 
The ingredients are dissolved in 450ml MilliPore water, pH is adjusted to 7.6 (with 
concentrated HCl), and the solution is filled to a final volume of 500ml. Before use, it is 
sterile filtered, aliquoted and stored at -20°C.  
1% Gelatine Solution 
To prepare this 10x stock solution, 10 g gelatine (Difco) are dissolved in 1l MilliPore water  
and sterile filtrated or autoclaved. 
A 0.1 % gelatine solution is used to cover plates with collagen matrix to facilitate attachment 
of ESC, “feeder cells” or embryoid bodies (EBs). 
Dulbeco´s Modified Eagle Medium 
 To prepare 5 l of DMEM medium, half a can of powdered high glucose DMEM (Gibco) and 
18.5 g NaHCO3 are dissolved in 4.5 l milli pore water. After pH-adjustment to pH 7.4, the 
solution is expanded with MilliPore water to a final volume of 5 liters and is sterile filtered, 
through a Nalgene filter membrane with 0.22 µm pore size, into cell culture bottles.  From 
each sterile filtered bottle of DMEM a small aliquote is incubated at 37°C over night, to see if 
sterilization was successful.  
Cell culture Media  
Name Composition Purpose 
M10Gi 10% FCS (Gibco), 1% GPS, 
DMEM 
Fibroblast culture 
M15Hi 15% FCS (High Clone), 1% 
GPS, 1% β-ME, DMEM 
ESC culture 
M15Si 15% FCS (Sigma), 1% GPS, EB culture 
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1% β-ME, DMEM 
M4Si 4% FCS (Sigma), 1% GPS, 
DMEM 
Cardiomyocyte culture  
2x Freezing Medium 20% FCS according to cell 
type, 20% DMSO, 60% 
DMEM 
Freezing of all cell types 
 
2x Freezing Medium 
The freezing medium contains dimethylsulfoxide (DMSO), which is an amphophilic 
substance that prevents the formation of (big) ice crystals during a freezing procedure. If 
DMSO is omitted, the ice crystals can grow during the freezing procedure and will harm the 
membranes and the organelles of the cells. The freezing medium always should be prepared 
freshly, as DMSO is sensitive to light and oxygen.  
Before cells are frozen, freshly prepared 2x FM is added 1:1 to the cells in culture medium; 
e.g.: 1.2ml 2x FM + 1.2ml cells suspended in the appropiate medium (M10Gi, M15Hi) 
4.1.2 Collagen coating of tissue culture plates 
The tissue culture (TC) plates, which are used to plate feeder cells, to grow EBs, to grow 
primary cardiomyocytes must be freshly covered with 0.1% collagen (gelatin). To cover the 
plates, they are filled with the gelatin solution until the bottom is covered. Then the plates are 
incubated at room temperature (RT) for two hours. Thereafter, the remaining liquid is sucked 
off with a Pasteur pipette, which is connected to a vacuum pump. 
4.1.3 Culture of fibroblasts 
In general for the culture of fibroblasts, TC-plates do not need to be additionally collagen-
coated. The fibroblasts usually manage to adhere to TC plates within few hours. As growth 
medium, M10Gi is used and cells can be split up to 1:8 before they reach confluency. The 
fibroblast cell lines in culture were 10T ½ (an embryonal mouse fibroblast cell line), C2C12 
myoblasts, and SNL 76/7 (fibroblasts which ectopically express Leukemia Inhibitory Factor-
LIF). 
For long term storage, the cell lines are kept in liquid nitrogen (Cp: 77K / < -196°C). 
Therefore, the cells have to be thawed. To remove the cell-containing vials from the liquid 
nitrogen, a protective shield must be worn. Once the cells are out of the liquid nitrogen, the 
thawing procedure should be done quickly. 
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Before the cells are thawed, a beaker, which contains hand-warm water, is prepared. In 
addition, a 1000µl Gilson pipette, a pipette man, a sterile 12ml Falcon tube, a 10cm TC plate 
and M10Gi will be needed.  
The vial, which contains the cells, is thawed in hand warm water. When only a small 
ice core is left, the vial is rinsed with 70% EtOH, dried and flamed. The cell suspension is 
transferred to the sterile 12 ml Falcon and 10 ml M10Gi are added slowly and drop-wise to 
carefully reduce the DMSO concentration. This is necessary to avoid osmotic shock, which 
would be the consequence when nutrition media is added too suddenly to the cells in DSMO-
containing media. The falcon tube, which contains the cell suspension is flamed, tightly 
closed, and centrifuged at room temperature (RT) and 1000 rpm for 7 minutes. The 
supernating medium, which contains DMSO, is sucked off and the cells are resuspended in 
4ml M10Gi. The cell suspension is then transferred to a 10cm TC plate. To catch all cells, the 
falcon tube is washed with another 4ml M10Gi. Alternatively the pellet of cells may be 
resuspended in 8ml M10Gi and cells are then directly plated on a 10cm TC plate. The 
fibroblasts are incubated at 37°C and 5% CO2.  
 To maintain cells in exponential growth phase it is important to split them before 
complete confluency is reached. To split cells, medium is sucked off the plate, the cells are 
washed once with ~ 5ml 1xPBS. Then the PBS is removed, the cells are covered with 1ml 
trypsin /10cm plate. The cells detach during incubation at 37°C for 5-10 minutes. The 
detachment of the cells is controlled in a light microscope (using fourfold magnification). If 
the cells are completely detached, trypsin is inhibited by adding of at least 2 parts of serum-
containing medium (e.g 2ml medium). The fibroblasts can be split up to 1:8 (e.g. 1ml out of 
8ml cell suspension is resuspended in 7ml fresh M10Gi). To achieve an equal distribution of 
the cells on the plate, it is rocked back and forth, left and right. Rotary movements should be 
avoided, as this would lead to the concentration of the cells in the middle of the plate. After 
plating, the incubation of the cells is continued at 37°C and 5% CO2. 
 To protect the cells from senescence, they are frozen as soon as they are no more 
needed in continuous culture. To guarantee that the cells are not harmed during the freezing 
procedure, they are protected by 20% DMSO in the freezing medium. The DMSO is an 
amphophilic substance, which has the ability to prevent the formation of big ice crystals. To 
freeze viable cells, the culture medium of a slightly sub-confluent culture vessel is sucked off. 
Then, the cells are washed once with 1x PBS. To detach the cells, 0.7 ml trypsin is equally 
applied onto a confluent cell layer and is incubated at 37°C and 5% CO2 for 10 minutes. The 
detached cells are resuspended in 2ml M10Gi and are transferred to a sterile 12 ml Falcon 
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tube. Analogical to the thawing procedure, it is important to slowly increase DMSO 
concentration in the cell suspension. If the DMSO -concentration is raised too quickly the 
cells would shrink. Therefore 2.7 ml 2x Freezing medium are added slowly and drop-wise, 
while pivoting the tube. Then 1.8ml of this suspension is aliquoted into cryo-tubes. The cryo-
tubes have to be flamed, to decrease the risk of contamination, before they are closed tightly. 
The tightly closed vials are put into a polystyrene box, which is hermetically sealed. The box 
is put to a -80°C freezer for at least 24hrs (up to several weeks). For long term storage the 
cells should be kept in liqu.N. 
4.1.4 Production of feeder-cells 
The “feeders” are needed to maintain ESC in an undifferentiated state. 
As feeder cells we use mitotically inhibited SNL76/7 cells, which secrete LIF (leukemia 
inhibitory factor) into culture medium. The ESC are plated on these feeder cells. 
One confluent 10cm plate of SNL76/6 fibroblasts is sufficient for at least two 24-well 
plates. The culture medium of SNL76/6 cells is sucked off, but 4ml. Then 80µl mitomycine C 
are added drop-wise and incubated 3-4 hrs at 37°C to achieve complete mitotic arrest. The 
experimentator should wear gloves, when mitomycin C is handled, because it is very toxic to 
cells. The mitomycin C disables mitotic division of any cell type. In the meantime, 24-well 
plates are covered with collagen for two hours. After four hours the medium of the SNL 
fibroblasts, which contains the mitomycin C, is sucked off. Then cells are washed twice with 
1x PBS and 1 ml trypsin is added to achieve detachment of the cells. The plate is then, as 
usual, incubated at 37°C for 10 minutes. The mitotically inhibited fibroblasts are resuspended 
in ~ 5ml M10Gi and transferred to a 50ml falcon tube. To be sure of having transferred all 
cells, the original cell culture plate is washed with an additional volume of 5ml media and the 
suspension is added to the cells in the falcon tube. As even traces of mitomycine C would be 
harmful to the ESC, the toxin has to be removed completely. Therefore the suspension of 
mitotically arrested SNL (“feeders”) is centrifuged at 1000 rpm for 7 minutes, and the 
supernatant (SNT) is sucked off. The pellet of feeder cells is resuspended in 20ml M10Gi and 
the cells are counted in Thoma-chamber (number of cells in all squares x 10.000 = 
number/ml). 
The concentration of the cells in the suspension is adjusted/ or rather diluted to 1.5-
1.75 x 105 cells per ml. Thereafter the cell suspension is plated onto the collagen covered TC- 
plates: for a 6-well plate 2ml cell suspension are needed; for a 24-well plate: 1ml; for a 48-
well plate: 0.5 ml; for a 96-well plate 0.2 ml. Before the ESC are plated on top, the feeders 
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must be incubated at 37°C over night, to ensure attachment to the plate. The feeders can be 
kept for two weeks, but they should be fed at least once a week. 
4.1.5 Maintenance of embryonic stem cells (ESC) 
To maintain ESC in an undifferented state, they need to be grown on a layer of “feeder cells”. 
In addition to that, the ESC must be fed every 24hrs (1.5 ml M15 Hi) for two reasons. First, 
they have a high turnover rate and need a lot of nutrients. Second, it is necessary to exchange 
the nutrition medium every 24hrs, to avoid accumulation of signaling factors from 
neighboring cells. Likewise important is that ESC must be split as soon as they reach 
confluency, otherwise they would begin to differentiate. 
The ESC are kept in liquid nitrogen until they are needed. To thaw the ESC, one 
follows the general procedure as is was described above for the fibroblast. The only difference 
is, that the “feeder-wells” must be pre-fed with ~1ml M15 Hi two hours before the ESC are 
thawed. The pre-feeding is critical to maintain the ESC in an undifferentiated state, because 
the nutrition medium will be enriched with LIF in the meantime. The thawing procedure itself 
is the same as with fibroblasts: The vial, which contains the ESC, is thawed in hand-warm 
water until only a small ice core is left. Then the ESC suspension, which contains DMSO, is 
transferred to a sterile 12ml falcon tube. To reduce the DMSO-concentration, 10ml M15Hi 
are added slowly and drop-wise. Then the ESC suspension is centrifuged at 1000 rpm for 7 
minutes. After the centrifugation, the cells are resuspended in 1ml M15Hi taken from the pre-
fed feeder well. To avoid pre-mature differentiation, the ESC are carefully resuspended in the 
LIF-enriched medium. Equally important to the presence of LIF, is that ESC are seeded as 
single cells, because any kind of aggregation would lead to the onset of a differentiation 
process. The ESC are finally seeded into a 24-well for normal maintenance of the cells. The 
plates are incubated as usual at 37°C and 5% CO2.  
To keep the ESC in an undifferentiated state and in the exponential growth phase, it is 
absolutely necessary to split them, before they reach complete confluency. When the ESC 
have to be split, the ESC and the feeder wells, on which ESC will be plated after splitting, 
must be pre-fed two hours before (1.5ml M15Hi/24-well). This ensures that the medium is 
enriched with LIF. After the two hours of pre-feeding, the old medium is sucked off the ESC, 
then the ESC are washed TWICE with 1xPBS. To detach and separate the cells from each 
other, they are treated with 200µl trypsin and are incubated at 37°C and 5 % CO2 for 20 
minutes. The detachment is controlled in a light microscope. When the cells are detached, 1ml 
M15Hi from a pre-fed feeder well is used to inactivate the trypsin. To plate the ESC as single 
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cells they have to be resuspended thoroughly and to be split 1:3 for maintenance (e.g. transfer 
400µl per 24-well). 
To ensure the transfer of all cells, the old well can be washed with another 1ml fresh 
M15Hi and is distributed to the new well(s) in equal amounts. Thorough resuspension is 
crucial to prevent ESC from differentiation. The ESC only may be kept in an undifferentiated 
state if they are seeded as single cells. For full attachment of ESC on top of the “feeder layer” 
it is necessary to incubate the plate at least over night at 37°C and 5% CO2. 
4.1.6 Generation of embryoid bodies  
The embryoid body (EB) model of in-vitro ESC differentiation enables the generation of all 
cell types, which are obtained from the three germ layers. 
The day before the generation of the EBs, the ESCs should be split 1:2, to obtain them 
in optimal condition. Prepare autoclaved Millipore water and an automatic pipette. 
On day 0, the ESCs are pre-fed two to four hours with M15Si. Later, to get rid of the feeder 
cells, they will be pre-adsorbed to a collagen-coated 6-well. Therefore, a 6-well plate is coated 
with collagen and left for two hours. After 2-4 hours, the medium is sucked off the pre-fed 
cells. Then the cells are washed twice with 1x PBS. To detach ESCs from each other and the 
feeders, they are incubated with 200µl trypsin per 24-well at 37°C for 20 minutes. In the 
meantime the collagen is sucked off the plate for pre-adsorption. The detached cells are then 
resuspended in 800µl M15Si. The feeders are pre-absorbed on the coated 6-well plate. To 
ensure that all cells are transferred it is recommended to wash after with 1ml M15Si. The 
feeder cells are pre-adsorbed for 1hr on the collagen-coated 6-well. The attachment of the 
fibroblasts is monitored in a light microscope. The pre-adsorption is fine when huge 
fibroblasts stick to the bottom of the plate and the smaller and round ESC are still in 
suspension. The cell suspension is transferred to a sterile 50ml Falcon. Before the cells are 
counted in a Thoma-chamber, the cell suspension is diluted in M15Si to a volume of 20ml. 
The cell density is adjusted to 4x104 (±2000) cells per ml. To calculate the amount of the cell 
suspension, which is necessary for the experiment, we assume that about 100 EBs fit to one 
10cm plate. Each EB is made up by a drop of 20µl of the [4x104 cells/ml] suspension. 
Therefore, about 2ml ESC suspension will be needed per plate. To prevent the EBs from 
drying out, during the first 4 days of incubation as hanging drops, they must be provided with 
a humid environment. The droplets of 20µl cell suspension are set in the lid of petri-dishes, 
which are filled with sterile, autoclaved, Millipore water. An automatic pipette is used to drop 
about 100 times 20 µl of the cell suspension into lid of the petri-dishes. Each drop contains 
about 800 cells. The formation of EBs is happening during a continuous incubation at 37°C 
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and 5% CO2 for 4.5 days. This allows for the attachment of the ESC to each other in a snow-
ball like manner. In the meantime, some of the ESCs develop to cells of the primitive 
endoderm, the visceral and the parietal endoderm. At day 4.5 the EBs are gently rinsed to 
collagen-covered TC-plates using at least 6.5 ml M15Si. Then, to enable the attachment of the 
EBs to the bottom of the TC-plates, the plates are incubated for at least 24 hrs. 
 
Feeding protocol for EBs 
The nutrition medium is not changed completely, because it is enriched (“conditioned”) with 
EB-derived factors, which influence the further differentiation. 
Day 0-4.5 800 ESC in 20µl  
Day 4.5 Rinse with ~6.5 ml M15Si  
Days 7 and 10 3ml conditioned medium+8ml fresh M15Si 
Days 13,16,19, and 22 4ml cond.med.+ 10 ml fresh M15Si 
Days 25, 28 and 31  5 ml cond.med. + 12 ml fresh M15Si 
 
   
Fig.4.1.6A: day 4.5 WT EB   Fig.4.1.6B: day 5 WT EB  Fig.4.1.6C: day 7 WT EB 
(20x)    (10x)      ( 4x) 
Note the bubbles of visceral endoderm; the cells at the borders of EBs belong to parietal 




Fig.4.1.6D: Comparison of an early egg 
cylinder stage embryo with an embryoid 
body. Note the lack of a real 
trophectoderm in the embryoid body 
model. (cross sections)
4.1.7 Isolation of primary cardiomyocytes from neonatal mice 
The hearts of neonatal mice (BalbC and Black6) are prepared and placed in 1x PBS. Then the 
hearts are cut into very small pieces with sterile scissors. To clean the tissue, the pieces are 
spun at 1000rpm for two minutes. The supernatant is removed and 1ml of a 
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pancreatin/collagenase mixture is added to digest the connective tissue. The digestion is 
incubated shaking at 37°C for 15 minutes. Thereafter, the cells are spun at 1000rpm for two 
minutes, the supernatant is removed, and another 1ml of fresh Pancreatin/Collagenase mixture 
is added. This second digestion at 37°C shaking is continued until a homogenous appearance 
is achieved (5-10 minutes). To get rid of the cell debris, the cells are spun at 1000rpm for two 
minutes. The supernatant is removed and the cardiac cells are resuspended in M4Si culture 
medium. 
To get rid of the cardiac fibroblasts, the cell suspension is pre-adsorbed on collagen 
coated tissue culture plates for two to three hours. Finally the supernatant, which contains the 
enriched cardiomyocyte population, is plated onto new collagen coated tissue culture plates. 
The cardiomyocytes are cultured at 37°C and 5% CO2. The culture medium has to be renewed 
after 24 hours to remove the remaining cell debris. The media has to be changed every three 
to four days. 
Pancreatin/Collagenase enzyme mix 
0.4 ml Pancreatin (Gibco) 
5 mg Collagenase (Worthington) 
9.6 ml 1x PBS 
4.1.8 Transient transfection of eukaryotic cells 
4.1.8a Calcium-phosphate Transfection  
Material: Exponentially growing eukaryotic cells (e.g.10 T ½ fibroblasts) 
      Complete medium (M10Gi)  
      Purified Plasmid DNA (10 µg per 6 well)  
      2,5 M CaCl2  (30µl) 
      2x HEPES-buffered saline  
      1x PBS (Phosphate-buffered saline)  
2,5M CaCl2:  183.7 g CaCl2 • 2H2O is dissolved in 500ml Millipore water, is sterile 
filtered through a nitrocellulose filter, and is stored at -20°C in 10ml aliquots. 
2x HEPES-buffered saline(HeBS) solution : 
  16.4g NaCl [0.28M final] 
  11.9g HEPES (2-4-(2-Hydroxyethyl)-1-piperazinyl)-ethansulfonic acid) 
  0.21g Na2HPO4 [1.5mM final] 
The ingredients are dissolved in 800ml Millipore water. The pH is adjusted to 7.05 (- 7.12 
max.) with 5N NaOH. The solution is sterilized by filtration. The precipitation potential is 
tested by mixing 0.5 ml 2x HeBS and 0.5 ml CaCl2. The two solutions are combined and 
vortexted. A fine precipitate should form. The precipitate appears cloudy and white in an 
eppendorf tube or opalescent under the light microscope. If the precipitation failed, the pH has 
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to be checked (optimal range pH 7.05-7.12). The pH is absolutely critical for the transfection 
efficiency and the viability of the cells.   
At the day of the transfection, the optimal cell density for a 6 well is 5x105. Therefore, 
exponentially growing cells (e.g.10T ½) are plated to 6 wells in a density of approximately 
2.5x105 on the day before transfection. In the next morning, the cells are pre-fed with 2ml 
M10Gi. Then, the transfection reagents are heated to room temperature to guarantee for the 
proper formation of precipitate. For the transfection of each 6 well, 10 µg of transfection 
grade plasmid DNA is mixed in sterile Millipore water to a final volume of 256.5µl. To keep 
the amount of transfected DNA steady in all the different experiments, it is necessary to 
divide the total DNA concentration of 10µg, if there is more than one plasmid to be 
transfected. Then, 13.5µl 2M CaCl2 is added to reach a total volume of 270µl. In parallel, the 
same volume of 2xHeBS (270µl) per 6 well is aliquoted to sterile 12ml falcon tubes or 2 ml 
Eppendorf tubes. The mixture of plasmid DNA and CaCl2 is resuspended and added dropwise 
to one HeBS-aliquote, while it is vortexed simultaneously. The simultaneous vortexing 
prevents formation of complexes that would be too large for the uptake by the cells. The 
vortexing therefore increases the efficiency of the transfection. The complete transfection mix 
is allowed to sit at room temperature for at least 30 minutes. Thereafter, the transfection 
solutions are vortexed again and are added to the cells slowly and drop-wise. To evenly 
distribute precipitate all over the cell layer, the medium is carefully resuspended. The plates 
are incubated at 37°C and 5% CO2 over night. 
An additional step of a DMSO-shock may be useful to enhance the efficiency of the 
transfection, but this also may kill sensitive cells. The DSMO-shock is performed after the 
incubation of the cells with the transfection reagents (this could be from 2hrs after the 
transfection to the next morning). Therefore, 10% DMSO in PBS is prepared freshly (2ml per 
6well). The transfection medium is removed from cells the shock solution (10% DMSO in 
PBS) is added to the cells and incubated at RT for up to 2.5 minutes. The DMSO is removed, 
the cells are washed twice with 1x PBS and are fed with regular growth medium (M10Gi in 
case of fibroblasts). 
Due to the great variations in the transfection efficiency that arise from the Calcium-
Phosphate method, an alternative transfection reagent was also used. 
4.1.8b Lipofectamine 2000 (Invitrogen) Transfection 
When Lipofectamine 2000 is used as a transfection reagent, one has to follow the principle of 
keeping the DNA amount constant in all the different experiments. Actually, this is important 
independently from the method and the transfection reagent. 
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In “lipofection”, less DNA is needed, compared to the calcium phosphate method of 
transfection. Therefore, only 4µg DNA per 6 well are diluted in DMEM without serum or 
antibiotics to a final volume of 250µl. Then, 12µl of lipofectamine 2000 are diluted in DMEM 
without serum or antibiotics to a total volume of 250µl. Then the diluted DNA and the 
lipofectamine in DMEM are combined. This mixture is incubated at room temperature for 30 
minutes. After 30 minutes, the lipofection mix is added to the pre-fed cells. Then the 
lipofected cells are incubated at 37°C and 5% CO2 for four hours. Thereafter, the cells are 
washed with 1xPBS and fed with regular growth medium. 
4.1.9 Immunofluorescence staining 
The immunofluorescence staining is a method to localize proteins or any other antigen. It 
relies on proper fixation of the cells to retain cellular distribution of the antigen and to 
preserve the morphology of the cell. After fixation, the cells are exposed to a primary 
antibody, which is directed against the protein of interest. To ensure for the accessibility of 
the epitopes of the antigen, the cells are also exposed to permeabilizing reagents. The primary 
antibody is then bound by a species specific secondary antibody, which binds its Fc-portion. 
The secondary antibody is conjugated to a fluorophore, which is excited by a certain 
wavelength of laser light. This enables the visualization of defined structures within a cell. 
First, the cells have to be fixed. The choice of the fixation reagent depends on the cell type 
and the antibodies, which will be used. One fixation reagent is ice-cold (-20°C) 96% ethanol. 
To fix cells with 96% EtOH, media is sucked off the culture plate and the cells are washed 
twice with ice-cold 1x PBS. The ice-cold PBS should not be directly applied onto the cells, 
but rather led down the wall of the culture plate. After the washing, the cells are fixed with an 
appropriate volume (2ml for a 6 well) of ice-cold 96% EtOH. The EtOH must be added 
slowly, because alcohol leads to de-hydration of cellular structures. Then the fixed cells are 
incubated at –20°C for 20 minutes. Thereafter, the cells are slowly re-hydrated by adding 
sterile distilled water to the 96% EtOH to receive 70% EtOH (800µl for a 6 well). If the water 
is not added slowly, the cells would burst due to osmotic forces. Then the culture plate is 
sealed with parafilm and is incubated at –20°C for 10 minutes. Afterwards, the culture plate 
with the fixed cells and the 70% EtOH may be kept at 4°C for a few weeks if it is sealed 
tightly. The fixation with EtOH is said to be potentially harmful to fine cellular structures, 
because the alcohol dehydrates the cells. On one hand, this dehydration may destroy the 
epitope, which should be bound by the specific antibody. On the other hand, EtOH fixation at 
the same time serves for permebilization of the cell, and therefore might increase the 
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accessibility of the epitope. In general, when the fixation reagent is chosen, one should follow 
the advice of the manufacturer of the antibody.  
Another fixation reagent is 2% formaldehyde in PBS. To fix cells with 2% formaldehyde in 
PBS, the medium is aspirated and replaced by formaldehyde fixative (2ml per 6 well). The 
fixative is incubated at room temperature for 10 minutes. Then the cells are washed twice 
with 1xPBs. The culture plate is sealed with parafilm and may be stored at 4°C over night. 
Here to permeabilize the cells, a solution of 0.1% saponin in 1xPBS is used (140µl 10% 
saponin in 14ml 1xPBS). Saponin is used as a mild permeabilizing reagent. The saponin 
solution is incubated shaking at room temperature for 20 minutes. Thereafter, the cells are 
washed 1x TBS/ 0.1% Triton x-100. If EtOH fixation was used, the saponin permeabilization 
and the TBS washing steps are not compulsory. To block unspecific binding, the cells are 
incubated at room temperature with 1xPBS and 10% fetal calf serum (FCS) for 20 minutes. 
In the meantime, the primary antibodies are diluted according to the manufacturer’s protocol 
usually in 1xPBS (here in PBS/ 0.1% saponin/10% FCS; e.g. antiDesmin 1:40, antiHistone 
H3 1:500). To reduce background staining, it is recommended to centrifuge the mixtures at 
full speed in a table top centrifuge for five minutes, to bring down aggregates of antibody. 
Then a 60µl drop of this antibody containing solution is placed in the lid of the culture plate. 
With forceps the coverslips are lifted from the plate and excess liquid is blotted on a Kim-
wipe, by touching it with the edge of the cover slip. The cover slips are inverted and laid onto 
the drop with the cells facing the antibody solution. The culture plate is emptied and rinsed 
with tap water and distilled water, and then turned into a humid chamber, by filling the wells 
with humid paper towels (if available, a humid chamber is used). Then the coverslips are 
incubated with the primary antibody at room temperature in the humid chamber for about 1.5 
hours. Before the incubation with the secondary antibodies, the coverslips are inverted again 
and placed back to their original wells, where they are washed three times with a 0.1% Triton 
x solution in 1x TBS. Then the species-specific secondary antibodies are diluted (e.g. 1:200; 
usually 1:100- 1:500 in 0.1% saponin/10% FCS in PBS) and centrifuged at full speed at room 
temperature for 5 minutes to pellet aggregated antibodies. The secondary antibodies are 
incubated at room temperature in the dark in a humid chamber for about one hour. To 
counter-stain the nuclei, a DAPI staining is included. Therefore, DAPI (Hoechst) is diluted 
between 1:2500 and 1:5000 in 1x PBS. After the incubation with the secondary antibody, the 
coverslips are washed three times with PBS (EtOH fixed) or twice with 0.1% Triton x in TBS 
and a third time in regular PBS for 10 minutes each. To the EtOH fixed cover-slips the DAPI 
counter-stain may be included in the first washing step with PBS. To the formaldehyde fixed 
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cover slips, the DAPI is added to the third washing step with PBS. The coverslips are 
incubated with DAPI at room temperature in the dark for five minutes. Then the samples are 
washed three times with 1x PBS at room temperature for 5 minutes. Finally the stained cover 
slips are fixed to microscope slides. Therefore, the mounting medium Mowiol is pre-heated to 
65°C and 40µl are laid to a clean microscope slide. The coverslips are laid on the slides, with 
the cell-side facing the mouting medium. The Mowiol is dried at room temperature over 
night. On the next day the edges of the cover slips are sealed with nail polish. 
10x Tris Buffered Saline (TBS) 
  500 mM Tris. HCl (pH 7.4)  
1500 mM NaCl 
10% Saponin in 1x PBS 
dissolve 1g Saponin in 10ml PBS, aliquote to Eppies (500µl) and store at -20°C. 
2% Formaldehyde in PBS 
2ml 37% Formaldehyde are diluted in 35ml 1x PBS. 
100 ml 0.1% Triton X in TBS 
100 µl Trition X-100 in 100ml 1x TBS 
 
Mowiol 2-88 
6    g Glycerol 
2.6 g Mowiol 2-88 (Hoechst) 
5 %  DABCO 
6 ml dH2O 
 
The ingredients are mixed and are stired for two hours until all components are dissolved. 
Then 12 ml 0.2 M Tris/HCl pH 8.5 are added. The solution is heated to 50°C for 10 minutes. 
Then the solution is centrifuged at room temperature and 5000 rpm for 15 minutes. The 
solution is aliquoted and stored at -20°C.  
4.1.10 The use of a Zeiss confocal laser scanning microscope 
The system is turned on at a main switch. The LSM 510 meta program is started in expert 
mode. The lasers, which are needed to excite the fluorophores, are turned on. To excite DAPI 
staining a wavelength of 405nm (UV) is needed. To excite FITC labelled samples, an argon 2 
laser is needed. This laser is most sensitive and has to be set on standby to pre-heat, before it 
is turned on. To excite Texas Red stained samples, a wavelength of 561nm is needed. 
Thereafter, the microscope has to be configured for its scanning method. There is the option 
to choose single or multitracking. The use of the multitracking mode is of advantage, because 
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it scans the signals from the different channels one after the other. This minimizes the chance 
of detecting wrong signals from “bleeding” of other fluorophores. Then the tracks have to be 
defined individually. The exciting laser is chosen, then HFT and mirrors are chosen. Finally 
the filters have to be chosen: A “long pass” filter allows wavelengths greater than 420nm to 
pass, whereas all wavelengths shorter than this are deflected. A “band pass” filter allows a 
defined wavelength to pass and deflects others. Therefore, it is important to know, which 
wavelength is emitted by the used fluorophore. An example for the set up to detect FITC 
would be to set the HFT to 488nm, a BP filter to 505-550. A setting for TR detection: laser 
561nm on, detector 530nm. To adjust the channels, the size of the pinhole is set to 1, which is 
the setting to see a confocal picture. It is not recommended to change the detector gain or the 
amplifier gain, because both work by photo-multipliers, which would also increase all 
background noise. It is better to start with the detector set to 750, then if necessary to increase 
the laser power. 
To turn off the laser microscope, the 561nm laser must be turned off in the “makro”, 
because there is a software bug. If the next microscope user is coming not before one hour, 
the argon laser is switched to the standby mode. If the system may be shut down, all lasers are 
turned off in the laser menu. Now, the argon laser shows “cooling”. It is most important to 
wait until it says “connected” and not to turn off the system before the laser is cooled. After 
that, the LSM-meta program may be closed (exit), the computer may be shut down and the 
main switch is turned off.   
4.2 Molecular biology methods 
4.2.1 mRNA isolation (Quiagen RNeasy®) 
The mRNA is isolated from eukaryotic cells, which are washed twice with 1x PBS. Then the 
cells are overlaid with 1xPBS and scraped off the culture surface by either using a cell scraper 
or a gilson pipette tip. The loosened cells are resuspended and transferred to 1,5ml eppies. 
The suspension is centrifuged at full speed and 4°C for 5 minutes. Thereafter, the supernatant 
is sucked off, and the pellets are resuspended in 600µl buffer RLT and 6µl β-
mercaptoethanol. Then, the suspension is transferred to the QIA-shredder column and is 
centrifuged at full speed and RT for 2 minutes. The flow-through is collected and mixed with 
the same volume of 70% RNase-free ethanol. This suspension is put on an RNA-binding 
column in two steps, each 600µl. The column is centrifuged at full speed and RT for 15 
seconds and the flow-through is discarded. The column, which has bound the RNA, is washed 
twice with buffer RW1. The flow-through is discarded. Then, the column is washed twice 
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with 500µl of buffer RPE and centrifuged at full speed and RT for 15 seconds. After the 
second wash the column with bound RNA is centrifuged again at full speed and RT for 15 
seconds to remove all residual washing liquid. Finally, the column is added to a new eppi, and 
the RNA is eluted with 40µl RNase-free water by centrifugation at full speed and RT for one 
minute. To remove possible DNA-contamination, 3,75µl DNase I buffer and 3,75µl DNase I 
(Fermentas) is added and incubated at RT (or 37°C) for 30 minutes. To inactivate the DNase, 
the RNA suspension is incubated with 3,75µl EDTA at 65°C for 10 minutes. Thereafter, the 
RNA is stored at -80°C until reverse transcription. Before reverse transcription, the RNA has 
to be checked for contamination with gDNA. Therefore, a PCR with primers, which are 
specific for a eukaryotic housekeeping gene(e.g.: GAPDH; glyceraldehyde-3-phosphate 
dehydrogenase) is performed. The sequences of primers are listed in chapter 3.5.  
The following table shows the conditions for a GAPDH PCR: 
Temperature Time Cycles 
94°C  1 minute  
94°C  45 seconds 30 (29 repetitions) 
55°C  45 seconds 30 (29 repetitions) 
72°C  1 minute 30 (29 repetitions) 
72°C  4 minutes  
4°C Infinitely  
The results of the GAPDH-PCR is analysed on a 1,5% agarose gel. A negative control and a 
positive control should be included, to be sure that there is no gDNA contamination in the 
RNA samples. If no gDNA contamination was found, the mRNA is reverse transcribed into 
cDNA.  
4.2.2 Reverse transcription of mRNA 
The master mix for each reverse transcription reaction is set up as the following: 
10   µl  5x RT buffer 
  5   µl 0.1 M DTT 
  1.5µl RNA out 
  2   µl 10mM dNTPs 
 
1µl of oligo dTTT-primer is added to each mRNA-solution and is incubated at 70°C for 10 
minutes. Thereafter the mixture is cooled on ice for 3 minutes. After the cooling the mRNA 
mixture is centrifuged at full speed and RT for 15 seconds to collect condensed liquids. Then, 
18,5µl of the RT-PCR mix is added to each mRNA solution. The RT-mixes are incubated at 
42°C for 2 minutes then 1µl of reverse transcriptase enzyme is added. To reverse transcribe 
the mRNA, the mixes are incubated at 42°C for 50 minutes, followed by incubation at 70°C 
for 15 minutes. The reverse transcribed mRNA, which is now cDNA, is cooled on ice for 5 
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minutes and finally centrifuged at full speed and RT for 2 minutes. The cDNA is stored at –
80°C until use, or –20°C. For semi-quantitative RT-PCR it is necessary to balance the levels 
of total cDNA. Therefore, a PCR is set up with primers, which are specific for a house 
keeping gene, like GAPDH. The result of this PCR is used to balance the concentration of the 
template cDNAs. 
4.2.3 Polymerase chain reaction 
The PCR is a standard laboratory method to selectively amplify target DNA. It is rapid and 
versatile, but one of the limitations of a PCR is that some information about the target 
sequence needs to be known. This information is needed to design the primers or amplimers. 
The primers are specific for the target sequence and usually consist of 15 to 25 nucleotides. 
They serve as the priming unit, which enables the DNA polymerase in presence of 
deoxyribonucleotide triphosphate units (dNTPs) to elongate the template DNA. The template 
DNA is melted at 94°C, so that the separated DNA strands are available for the binding of the 
complementary primers (annealing). Thereafter, the PCR reaction mix is heated to 72°C, 
which is the working temperature of the commonly used DNA polymerase of Thermus 
aquaticus a thermophile bacterium. The Taq-DNA polymerase then adds the dNTPs 
according to the sequence on the complementary DNA strand, the target DNA is extended and 
amplified. After 15 to 30 rounds of heating and cooling of the PCR mix, the reaction is 
stopped by cooling to 4°C, the target DNA was selectively amplified. The product of a PCR is 
usually analysed in an agarose gel electrophoresis.  
The following table shows the conditions of a typical PCR: 
Temperature Time Cycles 
94°C (DNA melting)  1 minute  
94°C (melting)  45 seconds 14 to 29 repetitions 
55°C ( primer annealing)  45 seconds 14 to 29 repetitions 
72°C (extension by pol)  1 minute 14 to 29 repetitions 
72°C (final extension)  4 minutes  
4°C (cooling) Infinitely  
 
4.2.4 Analysis of PCR products in agarose gel electrophoresis 
To prepare an analytic 1% agarose gel (7cm x 12cm) for electrophoresis, 1g agarose 
(electrophoresis grade) is heated in 100ml 1xTBE buffer in a microwave oven at full power 
for about two minutes.  
For a preparative gel it is better to use 1xTAE buffer.  
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Table 4.2.4: shows the range of efficient DNA separation on agarose gel. 
Agarose % [w/v]  Range of efficient separation of linear DNA 
0.3% 5- 60 kb 
0.6% 1- 20 kb 
0.7% 0.8- 10 kb 
0.9% 0.5- 7 kb 
1.2% 0.4- 6 kb 
1.5% 0.2- 3 kb 
2% 0.1- 2 kb 
4.2.5 DNA isolation  
To isolate gDNA from (embryonic stem) cells, the cells are washed twice with room 
temperature 1xPBS. Then the cells are detached from the culture plate by applying 200µl of 
trypsin (EDTA) at 37°C for 20 minutes. In the meantime, the lysis buffer is prepared as the 
following: 10mM Tris pH 7,4 ; 10mM EDTA ; 300mM NaCl ; 0.4% SDS ; 200ng /ml 
proteinase K. The lysis buffer is added in 10 times more volume than the volume of the 
trypsin, directly to the trypsin treated cells. The cells are briefly resuspended in lysis buffer 
and then transferred to a 2ml eppi. The lysis proceeds at 55°C over night. On the next day the 
lysate is cleared from protein by phenol-chloroform-isopropanol extraction. Therefore, 500µl 
PCI is added and the suspension is vortexed to mix. Then the suspension is centrifuged in a 
table top centrifuge at full speed and 4°C for 10 minutes. The supernatant is transferred to a 
new Eppendorf tube and PCI extraction is repeated. After the second transfer of the 
supernatant (the aqueous phase), it is divided into two and precipitated with room temperature 
isopropanol. To achieve successful precipitation it is necessary to use at least twice the 
volume of the supernatant. The precipitate is spun down in a centrifuge at full speed at 4°C 
for 30 minutes. The supernatant is carefully discarded and the DNA pellet is washed with 
70% ethanol. After the centrifugation, the supernatant again is carefully discarded and the 
pellet is allowed to air-dry. The DNA pellet is allowed to dissolve in 100µl TE buffer over 
night at 4°C. 
4.2.6 Chromatin Immuno Precipitation 
The ChIP is a technique to confirm physical interaction of a protein of interest (POI) and a 
genomic DNA (gDNA) region of interest (ROI). It is based on cross-linking of residual 
proteins to gDNA, and purification in the presence of antibodies, which are specific for the 
POI. The analysis of the ChIP results is achieved by PCRs with primers, which are specific 
for the region of interest. 
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ChIP Stocks Solutions 
Chemicals Amount  pH adjustment Solvent Volume 
1M Tris pH 8,1 12.1 g  HCl ddH2O 100ml 
1M Tris pH 6,5  12.1 g HCl ddH2O 100ml 
1M Tris pH 7,5 12.1 g HCl ddH20 100ml 
1M HEPES  pH 7.9 23.8 g  2M NaOH ddH2O 100ml 
0.5M EGTA pH 7.5 19.0 g 2M NaOH ddH2O 100ml  
0.5M EDTA pH 7.5 18.6 g 2M NaOH ddH2O 100ml 
3M NaOAc  pH 5.2 24.6 g HCl ddH2O 100ml 
10% TritonX-100 20 ml  ddH2O 200ml 
10% NP-40 20 ml  ddH2O 200ml 
10% SDS 20 ml  ddH20 200ml 
1M LiCl 16.96 g  ddH2O 400ml 
1M Tris pH 8 48.4 g  ddH2O 400ml 
4M NaCl 23.36 g  ddH2O 400ml 
10% NaDoc 10 ml  ddH2O 100ml 
ChIP Buffers 
Wash-Buffer I (400ml) Lysis Buffer (desired vol.) 
10ml  10% Triton X-100 10% SDS 
8ml    0.5M EDTA pH 7.5 10mM EDTA pH 7.5 
400µl 0.5M EGTA pH 7.5 50mM Tris pH 8 
4ml 1M HEPES pH 7.9 Proteinase Inhibitor ( Roche, Complete) 
1 tablet dissolved in sterile Millipore 
water = 50x stock  
ddH20 ad 400ml  0.1mM PhenylMethanSulfonylFlourid 
(MW 174.19g/mol ; solved in 
Isopropanol; 10µl from 1000x stock) 
Wash-Buffer II (400ml) Hi-Salt Buffer (400ml) 
20ml    4M NaCl 50ml 4M NaCl 
800µl   0.5M EDTA pH 7.5 20ml 1M Tris pH 8 
400ml  0.5M EGTA pH 7.5 4ml 10% SDS 
4ml      1  M HEPES pH 7.9 40ml 10% NP-40 
ddH2O ad 400ml ddH2O ad 400ml  
Dilution Buffer (400ml) LiCl Buffer (400ml) 
400µl   10% SDS 100ml 1M LiCl 
44ml    10% Triton X-100 20ml   1M Tris pH 8 
960µl   0.5M EDTA pH 7.5 20ml   10% NaDoc 
6.68ml 1M Tris pH 8.1 40ml   10% NP-40 
16.7ml 4M NaCl  ddH2O ad 400ml  
ddH2O ad 400ml  Elution Buffer ( 5ml)  
RIPA Buffer (400ml) 1ml   10% SDS 
15ml 4M NaCl 0.5ml 1M NaHCO3 
20ml 1M Tris pH 8.1 50µl   1M DTT 
4ml   10% SDS TE Buffer (400ml) 
20ml 10% NaDoc 4ml     1M Tris pH 8  
40ml 10% NP-40 800µl 0.5M EDTA  
ddH2O ad 400ml ddH2O ad 400ml  
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Preparation of Protein-A-coupled Sepharose beads 
Before use, the protein-A sepharose beads have to be prepared, washed and blocked. About 
0.1g protein-A sepharose beads, which equals to three times the tip of a small spatula, is put 
into a 2ml eppi. Then 1ml TE buffer is added and the beads are allowed to soak at room 
temperature for one hour. Then the beads are centrifuged in a table top centrifuge at 1000 rpm 
and at room temperature for 3 minutes. The supernatant is taken off cautiously and the beads 
are washed three times with 1ml TE buffer in the same way as described. To avoid unspecific 
binding of DNA or protein to the beads, they have to be blocked. For 100µl beads, a blocking 
solution is prepared as the following: combine 2µl herring or salmon sperm [10mg/ml TE], 
with 10µl BSA [10mg/ml], with 5µl of a 2% sodium azide solution, and with 84µl TE buffer. 
The protein-A sepharose beads are overlaid with one volume of blocking solution and blocked 
shaking at 4°C for two hours. Thereafter, the beads are washed and overlaid with the same 
volume of TE buffer. 
ChIP procedure 
Day 1 
To crosslink residual protein to chromatin, 54µl 37% formaldehyde per 2ml culture medium 
(270µl/10ml) are added into culture wells and incubated in a fume hood at RT for 20 minutes. 
To sequester the formaldehyde, 100µl 2.5 M glycine is added and incubated shaking at RT for 
5 minutes. The culture medium containing formaldehyde and glycine is aspirated and the cell 
layers are washed twice with ice-cold 1xPBS. The cells are harvested in 2ml 1xPBS. 
Therefore, a 1000µl gilson pipette is used to scratch and to resuspend the fixed, harvested 
cells in PBS. The yield is transfered to a sterile 12 ml falcon tube and is centrifuged 1200rpm 
at 4°C in a table top centrifuge for 5 minutes. To avoid loss of POI through degradation, 
200µl of a solution of 50x Roche Complete Protease Inhibitor (PI) in sterile Millipore water 
and 10µl of a 1000x PMSF in isopropanol solution are added to 10ml WASH I buffer in the 
mean time. The supernatant (SN) is sucked off, the pelleted cells are washed with WASH I 
buffer by resuspending them in 1ml Wash buffer I and adding of another 4ml. Then the cells 
are incubated on ice for 10 minutes. The same procedure is repeated with WASH II buffer: 
The suspension is centrifuged, SN is aspired, the pellet is resuspended in WASH II +PI+ 
PMSF and incubated on ice for 10 minutes. Thereafter the suspension is centrifuged 1200 rpm 
at 4°C for 5 minutes. The supernating wash II is sucked off, the pellet is resuspended in 500µl 
lysis buffer (+PI+PMSF) and incubated at 4°C over night.   
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Day 2 
5ml Elution Buffer are prepared according to the formula listed above. To fragment chromatin 
(genomic DNA of the cells), a sonicator is used. The lysate is sonicated 5 times at 90% dot 
cycle, 45% output for 15 seconds with a cooling step on ice between each cycle for 30 
seconds. To clear the suspension from unwanted membrane proteins, the sonicated lysate is 
centrifuged at full speed (14krpm) in an Eppendorf centrifuge at 4°C for 10min. The cleared 
SN is transfered to a new Eppendorf tube. To estimate the concentration of protein in the 
sample, the optical density at a wavelength of 280nm is measured in a NanoDrop photometer. 
Therefore, the samples are diluted 1:50 in lysis buffer before measurement of  OD280 (protein 
concentration) in the NanoDrop photometer. First of all a so called “input” sample is 
prepared. The input sample serves to check if sonication was sufficient. In addition to that, the 
input sample serves as internal control: In following PCRs, the DNA content of all other 
samples will be compared to the DNA content in the input sample. Sufficient sonication is 
essential for a successful ChIP. As “sufficient sonication” is considered a mean length of 
sonicated gDNA fragments of 400-600 bp. Otherwise, in later PCR analysis false positive 
signals may occur, if chromatin fragments are too long. The ChIP is based on several 
purification steps of DNA fragments in the presence of IgG antibodies, which are specific for 
the protein of interest. On the other hand the antibodies bind to protein A coupled sepharose 
beads. ChIP functions because specific antibodies keep DNA fragments with bound protein 
down with the beads, whereas other DNA fragments and proteins remain free in the 
suspension. So if DNA fragments are too long, the protein of interest (POI) may be bound to a 
gDNA sequence far more upstream or downstream, which would give false positive signals in 
the following PCR, even if primers, specific for a certain DNA sequence are used. 
However, for a measured OD280 of 0.1 we take 100µl of sonicated material to set up the input 
sample. (max.possible volume is 140µl) 
To reverse crosslinking of protein and gDNA in the input sample, the sample volume is 
extended to a final volume of 400µl with elution buffer. Thereafter, 20µl 4M NaCl are added 
and the sample is incubated at 65°C 300rpm shaking O/N.  
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Day 3  
Protein in the sample is degraded by proteinase K:  
8µl 0.5 M EDTA, 16µl 1M Tris pH 6.5 and 2µl proteinase K solution [20mg/ml] are added 
and incubated at 55°C 500rpm shaking for one hour. Thereafter, DNA in the sample is 
purified by phenol-chloroform-isopropanol (PCI 25:24:1) extraction. Phenol is always 
handled in a fume hood and gloves should be worn. 600µl PCI are added to input samples. 
The tubes are vortexed to mix and centrifuged at full speed (14krpm) at 4°C for ten minutes. 
The centrifugation is needed to separate the aqueous phase, which contains DNA, from the 
phenol phase, which contains degraded protein. The aqueous phase is transfered to a new eppi 
and is mixed with 800µl –20°C cold 96% Ethanol (EtOH p.a.), 12µl 3M NaOAc, and 1µl 
glycogen [20mg/ml dH2O]. To precipitate the DNA, this solution is incubated at –20°C for 30 
minutes. Following precipitation DNA is pelleted in a centrifuge at full speed at 4°C for 10 
minutes. The SN is discarded and the DNA pellet is washed with 500µl 70% EtOH. As the 
DNA pellet is more loosely attached after the 70% EtOH washing, an additional 
centrifugation step at full speed and 4°C is needed for 5 minutes. The SN is discarded, pellets 
are air dried and allowed to dissolve in 200µl sterile dH2O. While DNA dissolves in dH2O, 
RNA is digested with 1µl RNase A at 37°C and 1200rpm shaking for 30 minutes.  
Before proceeding to sample preparation in presence of antibodies specific for protein of 
interest, the length of sonicated chromatin fragments in the input samples have to be checked 
on a 0.8% agarose gel. 
Fig.4.2.3: Analysis of sonicated chromatin on a 0.8% agarose gel 
 
 
The setup of an immuno-precipitation: for each immuno-precipitation one 100µl aliquote  of 
the sonicated sample is needed. ( if the OD280 is 0.1 100µl). Then 900µl dilution buffer 
(+200µl PI+10µl PMSF/10ml) are added. Thereafter, to pre-clear the sonicated samples, 20µl 
protein A bead suspension is added and incubated vertically shaking at 4°C for one hour. To 
separate the sonicated sample from the beads, which should be loaded unspecifically with 
protein, the vial is centrifuged at 1200rpm at 4°C for 5 minutes. Then the SN is transfered to a 
144 
new eppi and antibodies specific for the protein of interest (POI) are added [4µg per IP]. The 
antibodies are incubated at 4°C in a vertical shaker over night.  
Day 4 
The complexes of antibodies bound to POI are harvested with 30µl protein A beads shaking at 
4°C in a vertical shaker for one hour. The underlying principle is that sepharose beads are 
conjugated to staphylococcus aureus protein A, which binds the Fc-portion of IgG molecules. 
After harvesting, the IPs are centrifuged at 1200rpm at 4°C for 5minutes. Then the SNT is 
removed. The protein A-sepharose beads have POI bound via IgG and their Fc-potion. To get 
rid of unspecific bindings, the beads are washed with 900µl RIPA-buffer and HI salt buffer. 
All the following washing steps consist of vertical shaking at 4°C for ten minutes and 
centrifugation at 1200 rpm and 4°C for five minutes, to collect the beads at the bottom. The 
same washing procedure repeated with 900µl LiCl buffer to get rid of crosslinked RNA. 
Finally the beads were washed twice with 900µl TE-buffer to neutralize and wash away salts.  
Finally to elute DNA-POI-antibody complexes from the beads, the beads are vigorously 
shaked at room temperature in 400µl elution buffer for 30minutes. Afterwards, the suspension 
is centrifuged at 3000rpm at RT for 5minutes. The SN is transfered to a new eppi. The 
crosslinking between DNA and protein is reversed in presence of 20µl 4M NaCl at 65°C 
horizontally shaking at 300rpm over night. 
Day 5 
To degrade proteins, including antibodies and protein of interest, a proteinase K digestion is 
set up. 
Therefore, 8µl 0.5M EDTA, 16µl 1M Tris pH 6.5 and 2µl proteinase K solution [20mg/ml] 
are added to immuno-precipitations (IPs). The degradation occurs during incubation 
horizontally shaking at 55°C for one hour. To remove degraded proteins,  IPs are subjected to 
phenol-chloroform-isopropanol (PCI) extraction with 600µl PCI. The PCI-IP emulsion is 
vortexed to mix. To separate DNA-containing aqueous phase from protein-containing phenol 
phase the samples are centrifuged at 14krpm at 4°C for 10 minutes. The aqueous phase is 
transfered to a new eppi. To collect the DNA, it is precipitated by addition of 600µl –20°C 
96% EtOH, 12µl 3M NaOAc, and 1µl glycogen [20mg/ml]. The samples are kept at –20°C 
for an hour. To pellet the precipitated DNA, the samples are centrifuged at 14krpm at 4°C for 
20 minutes. The supernating EtOH is discarded and pellets are washed with 500µl –20°C 70% 
EtOH to rehydrate DNA. After another 10minutes of centrifugation at 14krpm at 4°C, the SN 
is taken of and the DNA pellets are air-dried. Then, the DNA pellets are allowed to dissolve in 
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200µl nuclease-free dH2O. To get rid of RNA, 1µl RNase A is added and the samples are 
incubated at 37°C for 30 minutes. Finally ChIP samples were stored at –20°C until use for 
PCR. 
ChIP PCRs 
A PCR master mix for ChIP samples differs from common PCR master mixes: per sample 4µl 
less water is added. In contrast to common PCRs where usually the input of DNA template 
does not exceed 1µl, in ChIP PCRs 5µl of antibody-purified ChIP samples are used as 
templates. Therefore, the amount of ddH2O in the master mix is reduced by 4µl per antibody-
purified sample.  
A PCR master mix for 19 samples is prepared as following:  
 1x ChIP PCR MM 19x (-6x 4µl ddH2O) 
DdH2O 38.75 µl 712.25 µl 
10x Taq buffer    5      µl   95      µl 
MgCl2   3      µl   57      µl 
dNTPs (0.1 mM)   1      µl   19      µl 
Primer fwd   0.5   µl     9.5   µl 
Primer rev   0.5   µl     9.5   µl 
Taq Polymerase   0.25 µl (1unit)     4.75 µl 
For input samples 49µl MM+ 1µl template and for antibody-purified ChIP samples 45µl MM 
and 5µl template were used. 
The polymerase-containing MM is laid in sterile 0.5ml PCR tubes, then the templates are 
added, and the PCR is performed in following conditions: 
Temperature Time Cycles 
95    °C 4  min  
50.5 °C (dependent on primers) 4  min  
72    °C     45   sec  
95    °C 1  min 40 
50.5 °C (dependent on primers)     45   sec 40 
72    °C     45   sec 40 
72    °C 4  min  
  4    °C Infinitely  
 
 
Fig.4.2.4: shows a 2% agarose gel to visualize the results of the ChIP PCR (20µl of the PCR 
products)  
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This gel electrophoresis of the ChIP PCR products shows input bands for both of the 
undifferentiated ESC lines, which proves that the region of interest is present in the sonicated 
samples and that the PCR works. In this PCR analysis, the DC6 (desmin overexpressing ESC 
line) shows binding of vimentin (another type 3 IF) and weaker binding of desmin to the 
genomic region of a minimal cardiac enhancer (Lien et al. 1999). As a positive control, we 
use IP samples, which were prepared with histone H3 IgG, because histones usually are 
present non-selectively on chromatin.  
4.3 Cloning 
4.3.1 The Generation of competent E.coli 
To generate competent E.Coli, the bacteria of the selected strain (most often E.coli XL1 blue 
or E.coli TOP 10) are plated to an LB-plate, either directly from a frozen stock or from a 
small volume of a bacterial suspension. On the next day, one colony is picked and used to 
inoculate 1ml of liquid LB medium. After incubation on a horizontal shaker at 37°C for three 
or four hours (or over night), the liquid culture is diluted with 49ml of fresh LB medium in a 
250 ml Erlenmeyer flask. The liquid culture then is incubated at 37°C until it reaches an 
optical densitiy OD600= 0.3-0.6, which usually takes about two to four hours. Then the E.coli 
culture is centrifuged in a 50 ml Falcon tube at 1000 x g and 4°C for 10 minutes. The 
supernatant is removed and the bacterial pellet is resuspended in 5ml TSB. The suspension is 
then incubated on ice for ten minutes. The competent bacteria are then aliquoted (10x0,5ml) 
to pre-cooled (4°C) reaction tubes, with screw lids. Finally, the competent E.coli are shock 
frozen in liquid nitrogen and are stored at -80°C until use in bacterial transformation. 
TSB-Medium 
10% PEG6000 or PEG8000 25.0 g 
5% DMSO 12.5 ml 
10mM MgCl2x6H2O 0.51g 
10mM MgSO4x7H2O 0.62g 
_____________________________________________ 
The solution is filled with LB medium to a final volume of 250ml, is then sterile filtered and 
stored at 4°C. 
4.3.2 Glycerol stocks of bacteria 
For long term storage of transformed bacteria, glycerol stocks are frozen from fresh over night 
liquid cultures under sterile conditions. Therefore, 150µl of sterile 87% glycerol p.a. is laid in 
sterile cryo-vials using tips with cut ends, as glycerol is highly viscous. Then 850µl of an 
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over-night (O/N) liquid bacterial culture is added, resuspended and vials are closed in sterile 
conditions. After shock-freezing in liquid nitrogen (NLIQU) glycerol stocks are stored at -80°C. 
4.3.3 Retrieving plasmids 
4.3.3.1 Wizard® Plus SV Minipreps DNA Purification System 
1-10ml of a bacterial overnight culture is centrifuged in a table top centrifuge at full speed for 
5 minutes. The supernatant is removed and the pellet is resuspended in 250 µl cell 
resuspension solution. Then, 250 µl cell lysis solution is added. To mix, the suspension is 
inverted for four times. To degrade proteins, 10µl alkaline protease is added. To mix, the 
solution is inverted for four times and then incubated at room temperature for five minutes. 
To stop the lysis, 350 µl neutralization solution is added. To mix, the suspension is inverted 
for four times. To pellet unwanted proteins, the suspension is centrifuged in a table top 
centrifuge at full speed for ten minutes. Then, the cleared lysate is decanted into a spin 
column, which is provided with the kit. The DNA is bound to the column by centrifugation at 
full speed for one minute. The flow through is discarded and the column is inserted into a 
collection tube. The column with the DNA bound is then washed with 750 µl wash solution 
(with EtOH added). To wash, the column is centrifuged at full speed for one minute. The flow 
through is discarded. Then, the column is washed again with another 250 µl wash solution 
and is centrifuged at full speed for two minutes. After washing, the spin column is transferred 
to a sterile 1.5 ml Eppendorf tube. It is recommended to mark the sample identity on the wall 
of the tube, because it happens that the tubes are de-capped during the following 
centrifugation. To elute the DNA from the column, 100μl (or 70μl) of nuclease-free water is 
added to the spin column and incubated at room temperature for one minute. Thereafter, the 
DNA is eluted by centrifugation at full speed for one minute. The column may be discarded. 
The concentration of the DNA is measured in a Nanodrop device. Then the DNA is stored at  
-20°C or below. 
4.3.3.2 Promega´s Pure Yield Midi Plasmid Preparation 
This type of plasmid preparation is needed when the plasmid DNA is meant to be sequenced. 
For sequencing relatively high DNA concentrations and high quality is needed. The plasmids, 
which are prepared in this Midi prep kit are also suitable for transfection. 
An over night liquid culture of the selected clones in 50ml LB+amp is centrifuged 
20.000 rotations per minute (rpm) at room temperature (RT) in a Sorval SS34 rotor for 15 
minutes. The supernating LB-medium is aspirated and the pellet is re-suspended in 3ml 
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resuspension solution. After adding 3ml cell lysis solution, it is inverted 5 times to mix. Then 
the solution is incubated at RT for 3min. To stop the lysis, 5ml neutralization solution are 
added. The tube is inverted 5 times to mix and incubated at RT for 3 minutes. To clear the 
lysate, it is centrifuged in a pure yield clearing column 3000rpm in a table top centrifuge for 5 
minutes. For DNA binding, the cleared lysate is poured into a provided column and 
centrifuged 3000 rpm for 3 minutes. To get rid of bacterial toxin, the column is washed with 
5ml endotoxin removal solution and twice with 20ml column wash. Finally, the plasmid DNA 
is eluted with 600µl nuclease-free H2O by centrifugation at 3000 rpm for 5minutes. The 
concentration of the plasmid DNA is measured in a NanoDrop photometer. 
4.3.3.3 QIAGEN Maxi Plasmid Preparation 
For large scale plasmid preparation a liquid starter culture of a single colony of transformed 
E.coli is inoculated in 2ml of LB, which contains the appropriate antibiotic. It is incubated 
shaking at 37°C for two hours. Then the starter culture is used to inoculate a larger over night 
liquid culture in 100ml LB. The large scale liquid culture is incubated shaking at 37°C over 
night. To harvest, the cultures are centrifuged in the next morning at 6000x g at 4°C for 15 
minutes. In the meantime the buffer P3 is pre-cilled to 4°C on ice. The pellet is resuspended 
in 10ml buffer P1. Then 10ml of buffer P2 are added and the solution is inverted for 4-6 times 
to mix. Then the solution is incubated at room temperature (RT) for 5 minutes. Thereafter, 
10ml of chilled buffer P3 are added to stop lysis. The solution, which contains cloudy white 
material, is poured into the barrel of a QIAfilter cartridge, which is provided in the kit. The 
material is allowed to settle for 10 minutes at RT. Then the lysate is filtered into a 50ml 
Falcon tube, by insertion of the plunger. To the filtered lysate, 2,5ml of endotoxin removal 
(ER) buffer is added and incubated on ice for 30 minutes. In the meantime, a QIAGEN-tip 
500 is equilibrated by adding 10ml of buffer QBT, and allowing the column to empty by 
gravity flow. The filtered lysate then is poured into the equilibrated QIAGEN-tip. The 
material is allowed to enter the resin by gravity flow. The column is washed twice by adding 
30ml buffer QC and allowed to empty by gravity flow. Discard the flow through and use a 
new 50ml falcon tube. To elute the DNA from the column, 15ml of buffer QN are added to 
the column. The plasmid DNA now is precipitated by adding 10,5 ml of RT isopropanol to 
the eluate. The suspension is inverted to mix and aliquoted to sterile 1,5 ml Eppendorf tubes. 
These Eppendorf tubes are centrifuged at 15.000 x g at 4°C for 30 minutes. The supernatant is 
carefully decanted or removed with a gilson pipette. The pellets from the different eppies are 
combined in four eppies and washed with 5ml 70% ethanol (RT). After washing, the pellets 
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are centrifuged at 15.000 x g at 4°C for 10 minutes. The supernatant is carefully decanted and 
the pellet is allowed to air-dry for 5 to 10 minutes. The pellet is allowed to dissolve in an 
appropriate volume of sterile endotoxin free water (e.g. 200µl). The DNA concentration is 
measured using a NANODROP device.  
4.3.4 The production of a DNA-insert for cloning 
To produce a DNA-insert for cloning, a polymerase chain reaction is set up with a gDNA 
template (e.g. C3H mouse genomic DNA) and Pyrococcus furiosus polymerase (Pfu pol). The 
Pfu polymerase exhibits 3´5´ exonuclease activity, which means that this enzyme does not 
simply extend a primed DNA-sequence, but it also moves back to correct reading mistakes 
(“proof reading”). Therefore, the Pfu polymerase needs longer extension times in a PCR cycle 
(at least 2 minutes per kilobase). For cloning, the PCR primers are generated to introduce two 
different restriction sites, which are unique within the future plasmid backbone. They serve to 
introduce these restriction sites to the DNA insert, which will be cloned. The backbone 
plasmid and the insert then will be cut with the same restriction enzymes, to generate 
compatible ends for later ligation. 
1x Pfu master mix  
DdH2O (nuclease free) 38 µl 
10x Pfu buffer   5 µl 
10 mM dNTPs    1 µl 
Primer fwd   2 µl 
Primer rev   2 µl 
Pfu polymerase   1 µl 
Template (C3H genomic DNA)   1 µl 
    
Temperature Time  Cycles 
95 °C (melting of gDNA)  4 min  
95 °C (melting)  1 min 30  sec 35 
63 °C (annealing)            45  sec 35 
72 °C (extension)  2 min 30  sec 35 
72 °C (final extension)  5 min  
4   °C (cooling)  Infinitely  
 
The DNA-insert is purified in a preparative agarose gel, which is prepared with 1x TAE 
buffer instead of 1x TBE. 
4.3.5 QIAquick Gel extraction 
Under UV light, the DNA-fragment is excised from the preparative agarose gel with a clean 
and sharp scalpel. To minimize damage from the exposure to the UV light, the excision must 
be done as quick as possible. Then, the size of the gel slize is minimized by removing extra 
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agarose, which does not harbour DNA. Then, the gel slice is weighted in an Eppendorf tube. 
To extract the DNA from the agarose gel, three volumes of buffer QG is added to one volume 
of gel (100mg ~ 100μl). The gel slice is dissolved by incubation at 50°C for ten minutes. If 
the gel slice failed to dissolve completely, the incubation may be extended. While the gel slice 
dissolves, it is vortexed every two to three minutes, to mix and to accelerate the reaction. 
After the gel slice completely dissolved, the color of the suspension must be yellow, which 
indicates that the pH did not change. To precipitate the DNA, one gel volume of isopropanol 
is added to the sample. Then, a QIAquick spin column is added to a provided 2 ml collection 
tube. To bind the DNA to the spin column, the sample is applied to the QIAquick column and 
centrifuged at 13.000 rpm for one minute. The flow-through is discarded. The spin column is 
placed back in the same collection tube and the column is washed with 0.75 ml buffer PE by 
centrifugation at 13.000 rpm for one minute. The flow-through is discarded. To get rid of 
remaining liquid the QIAquick column is centrifuged for one additional minute at 13.000 rpm 
(~17,900g). Before elution of the purified DNA from the QIAquick column, it is put into a 
clean 1.5 ml Eppendorf tube. To elute the DNA, 50μl of buffer EB (10mM Tris-Cl, pH 8.5) or 
nuclease-free ddH2O is added to the center of the QIAquick membrane. Then, the column is 
centrifuged at 13.000 rpm for one minute. Alternatively, to increase the DNA concentration, 
the amount of elution buffer may be reduced (30 µl). In addition to that, it is recommended to 
let the column stand for one minute before the centrifugation. The DNA may be stored at 
+4°C or at –20°C for long term storage.  
4.3.6 The restriction analysis of DNA 
For all restriction digests, the enzymes and corresponding buffers were chosen from New 
England Biolabs. On the website of NEB a program is provided, which assists in finding 
single cutters in a known DNA-sequence (at the NEB tools tab). 
http://www.neb.com/nebecomm/default.asp 
NEBuffer 1: 10mM Bis-Tris-Propane-HCl, 10mM MgCl2, 1mM Dithiothreitol 
NEBuffer 2: 10mM Tris-HCl, 50mM NaCl, 10mM MgCl2, 1mM Dithiothreitol 
NEBuffer 3: 100mM Tris-HCl, 50mM NaCl, 10mM MgCl2,1mM Dithiothreitol  
NEBuffer 4: 50mM Potassium acetate, 20mM Tris-acetate, 10mM Magnesium acetate, 
1mM Dithiothreitol 
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Restriction 
1μg DNA (approx. 10μl of Midiprep DNA) 
2μl of NEB Buffer 10x 
1μl enzyme 1 
1μl enzyme 2 
0.2μl BSA 100x (if necessary) 
ad 20μl with dH2O 
The restriction digests are incubated at 37°C for one to three hours, or at room temperatue 
over night. After the incubation the restriction digest may be stopped by addition of 6x 
loading dye and separation of the DNA fragments in an agarose gel electrophoresis. If the 
restriction was done for cloning, the restriction enzymes need to be heat inactivated at least at 
65°C for 15 minutes. For cloning the digested DNA is subsequently separated on a 1-1.2% 
agarose gel, which was prepared with 1xTAE buffer. The DNA fragments are cut out of the 
gel and are purified, as described in chapter 4.3.5. Alternatively the heat inactivated samples 
may be stored at -20°C until use.  
4.3.7 5’ Dephosphorylation of DNA 
For cloning of a DNA insert into plasmid, it is often necessary to de-phosphorylate the vector 
backbone, to prevent a self re-ligation. This is achieved by the addition of alkaline 
phosphatase (calf intestinal phosphatase, CIP). The CIP catalyzes a removal of the 
5’phosphate groups from DNA. These 5’phosphate groups are used by ligases to re-ligate 
DNA. The future insert DNA is not treated with CIP to enable the ligase to ligate the DNA 
insert and the vector. Therefore, the 5’dephosporylation is an essential strategy to decrease the 
vector background in cloning strategies. 
To 5’dephosphorylate a vector for cloning, it is suspended in 1xNEBuffer 3 (0.5μg/10μl). 
Then 0.5 units CIP per μg vector DNA are added. The suspension is incubated at 37°C for one 
hour. Thereafter, the DNA is purified by gel purification, spin-column purification or phenol 
extraction. The purified vector DNA is used for cloning. 
4.3.8 The ligation of the DNA-insert and a cloning vector 
Usually when a DNA insert will be cloned into a vector, the several different ratios of vector 
and insert are tried out. To convert molar ratios to mass ratios a formula is used: 
ng of vector x kb size of insert x molar ratio of  insert = ng of insert 
kb size of vector     vector 
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Usually ratios of 1:1, 1:2, and 1:3 are tried out.  
To assemble a ligation reaction, the following components are combined in a sterile 
microcentrifuge tube: 
 
Vector DNA        100 ng 
Insert DNA e.g.  17 ng  (1:1) 
Ligase 10x buffer            1 µl 
T4 DNA ligase     0.1- 1 unit 
Nuclease-free water to a final volume of          10 µl    
The reaction mixture is incubated at room temperature for three hours or at 4°C over night, or 
at 15°C for 4-18hours. The time of incubation depends on the restriction enzymes, which 
were used to cut the DNA and on the type of cut they made. While so-called “sticky ends” are 
effectively ligated at room temperature (22°C) for three hours or at incubation between 4°C-
8°C over night, the ligation of so-called “blunt ends” is most efficient at temperatures 
between 15 and 20°C for 4-18 hours (over night). 
4.3.9 The transformation of competent E.coli 
To transform competent E.coli, the bacteria are thawed on ice. Immediately after thawing, 
10µl of ligated vector is added to the suspension of bacteria. A suspension of competent 
bacteria must not be resuspended. Therefore the bottom of the vial is tipped with a finger to 
gently mix. Then, the transformation mix is incubated on ice for 30 minutes. Thereafter, the 
E.coli are heat-shocked in a 42°C heated water bath for 30 seconds and right afterwards put 
back on ice for about 5 minutes. Then, the transformed bacteria are fed with 250µl of 
preheated LB-medium without antibiotics. It is important to use LB-medium without 
antibiotics, because the bacteria need some time to express the antibiotic resistance gene, 
which they just received with the plasmid. The transformed bacteria are then incubated at 
37°C horizontally shaking for 1.5 hours. In the mean time, LB-plates containing an 
appropriate antibiotic (e.g. ampicilin) are dried in a (semi-)sterile environment. To receive 
single colony transformants, 100µl, 50µl, 20µl, and twice 10µl of the transformed E.coli are 
plated. Finally, the plates are incubated at 37°C over night. 
4.3.10 Analysis of the clones 
In the next morning, the plates are examined. The colonies of transformants are counted. The 
plate is stored at 4°C. 
Of the transformed bacterial colonies, some single colonies are selected for mini-preps and 
restriction analysis. The selected clones are picked with a tooth pick and are then plated in 
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separate lines on a recovery plate, which contains an appropriate antibiotic. The same tooth 
pick is used to inoculate a liquid culture in 10ml LB-medium containing the appropriate 
antibiotic (e.g. ampicillin [100µg/ml]). The liquid cultures are incubated for several hours or 
over night. In the next morning, the plasmids of the clones are retrieved with an SV Wizard 
mini prep system from Promega (as described in chapter 4.3.3 Retrieving plasmids). Then, the 
plasmids are digested in a qualitative restriction and are analyzed in an agarose gel 
electrophoresis, as described in chapter 4.3.6 Restriction digest. 
From the clones, which carry the insert in the right orientation, one or two are chosen for 
sequencing at VBC Biotech. Therefore, a plasmid midi preparation should be set up.  
4.4 Dual Luciferase® Reporter System 
The Dual Luciferase Reporter System is a powerful tool to assess information about a 
genomic region of interest. For instance, a putative promoter or enhancer region may be tested 
for its ability to induce the expression of a luciferase reporter gene. Therefore, the genomic 
region of interest must be cloned into a reporter plasmid upstream of the firefly luciferase 
gene. Thereafter, eukaryotic cells are transiently transfected with this reporter plasmid. To 
correct for deviations in the reporter activity, which arise from different transfection 
efficiencies, a phRL-TK internal control reporter is co-transfected. From firefly luciferase 
reporter vector (pGL-variants), a 61kDa monomeric protein is synthesized. The firefly 
reporter protein does not require post-translational processing for enzymatic activity. From 
the renilla luciferase reporter vector (phRL-TK), a 36kDa protein is synthesized. Similar to 
the firefly luciferase, the renilla luciferase does not require post-translational processing for 
enzymatic activity (Promega). After transient transfection, the eukaryotic cells can be tested 
for luciferase activity. As various transfection methods often result in inconstant transfection 
efficiency, phRL-TK an internal control reporter plasmid is included in this reporter system. It 
is co-transfected with the firefly luciferase plasmid and expresses the renilla luciferase gene 
under the control of the Herpes simplex virus (HSV) thymidine kinase (TK) promoter. As a 
result, the activity of the firefly luciferase may be normalized to the activity of the renilla 
luciferase, which reflects the transfection efficiency. This serves to minimize the risk of 
evaluation artefacts, because all transfected wells receive the same amount of the control 
plasmid (phRL-TK). So deviations, which arise from different transfection efficiencies or 
differences in the vitality of the cells, are corrected.  
To assay the reporter activity, eukaryotic cells are transfected with both luciferase 
reporter plasmids (NKE24, which contains the firefly luciferase gene downstream of the nkx 
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2.5 promoter and the phRL, which serves as an internal control). 48 hours after transfection, 
the cells are harvested with passive lysis buffer. According to the protocol from Promega, the 
cell layer is scratched with the tip of a pipette and 1ml of the 1x passive lysis buffer (provided 
by Promega) is applied. To lyse the transfected cells, they are incubated at room temperature 
for 30 minutes. Thereafter, the cells easily can be harvested by resuspension. For the 
luciferase assay, 50µl of the cell lysate is pipetted into a special 96-well reading plate. The 
luciferase catalyzes an oxidative decarboxylation of the luciferase substrate, which is 
provided by Promega in the reaction kit (DLR™). The reaction requires ATP, Mg2+ and O2 
and leads to release of energy in form of photons. Photon emission is achieved through 
oxidation of beetle luciferin via a luciferyl-AMP intermediate that turns over very slow. The 
intensity and stability of the luminescent signal is significantly enhanced by the addition of 
Co-enzyme A (CoA) to the substrate buffer.  
The evaluation of luciferase reporter activity is performed automatically in a Berthold 
Centro plate-reader, with MicroWin software. 
 
Fig.4.4: Luciferases catalyze an oxidative decarboxylation of the substrates shown below. 
The oxidative decarboxylation of the substrates leads to a release of energy in form of 
photons. (oxyluciferin λ 530-635nm; coelenteramide λ 482nm) 
 
5. Appendix 
5.1 References  
I tried to find all owners of copyrights of the illustrations in order to get the permission to 
use them in this thesis. In case still infringement of copy rights emerges, I kindly ask 
you to get in contact with me.   
 
Ich habe mich bemüht, sämtliche Inhaber der Bildrechte ausfindig zu machen und ihre 
Zustimmung zur Verwendung der Bilder in dieser Arbeit eingeholt. Sollte dennoch 
eine Urheberrechtsverletzung bekannt werden, ersuche ich um Meldung bei mir.  
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5.2 Abstract 
On the role of desmin in cardiomyogenesis 
Desmin is a type III intermediate filament protein, which has a well known role in the 
maintenance of the structural integrity within muscle cells. It was shown to be vital in the 
regeneration of muscle in-vivo and in-vitro. Studying the role of desmin during in-vitro 
differentiation in the embryoid body (EB) model revealed that the presence of ectopically 
expressed desmin boosts the differentiation of embryonic stem cells toward a cardiogenic fate 
(Hofner et al.2007), whereas the ectopic expression of an amino-terminally truncated version 
of desmin severely hampers cardiomyogenesis in-vitro. In addition to the boost of 
cardiomyogenesis, which is observed as earlier onset of cardiomyogenesis, the ectopic 
expression of desmin led to significant upregulation of the cardiac-specific TF gene nkx2.5 
and the mesodermal TF gene brachyury. To elucidate the mechanism behind the upregulation 
of the cardiac-specific TF gene nkx 2.5, desmins ability to physically interact with regulatory 
sequences in genomic DNA was assessed in chromatin-immuno-precipitation (ChIP) of in-
vitro differentiated embryonic stem cells (ESC). Desmin binds to the nkx 2.5 promoter at day 
6, 7, 8, and 9 in des+/+ EBs. In des+/+/ect EBs desmin binds to the nkx 2.5 promoter at day 5, 6, 
7, and 8. The fact that desmin binds earlier to the nkx 2.5 promoter when it is ectopically 
expressed compared to des+/+ EBs, is in line with the observed earlier onset of 
cardiomyogenesis in the EB in-vitro differentiation model. Desmin also binds to a minimal 
cardiac enhancer sequence, which is located in the 5’-UTR of the nkx 2.5 gene (Lien et 
al.1999). To test if desmin not only binds to regulatory genomic elements but also modulates 
transcription, luciferase reporter assays were performed with three different cell types (10T ½ 
fibroblasts, C2C12 myoblasts, and primary cardiomyocytes). These cells types differ in their 
natural expression levels of desmin. The luciferase reporter assays revealed that desmin might 
act inhibitory or “non-permissive” on the nkx 2.5 promoter in 10T ½ fibroblasts and C2C12 
myoblasts. In primary cardiomyocytes desmin was rather found to activate the nkx 2.5 




Über die Rolle von Desmin bei der Entwicklung von Herzzellen 
Desmin ist ein Typ III Intermediär Filament Protein, das bisher vorallem für seine Funktion in 
der Erhaltung der zellulären Integrität von Muskelzellen bekannt war. Das Protein ist von 
enormer Bedeutung in der Regeneration von Muskelzellen nach Belastung, wie in vielen in-
vitro und in-vivo Studien gezeigt wurde. Studien über die Rolle von Desmin in der in-vitro 
Differenzierung im “Embryoid body” (EB) Modell zeigen, daß die Anwesenheit von  
überexprimiertem Desmin die Differenzierung von embryonalen Stammzellen (ESC) der 
Maus zu Herzzellen fördert. Im Gegensatz dazu konnte gezeigt werden, daß die Expression 
einer Desmin-variante mit fehlendem Amino-terminus, zu erheblicher Verzögerung der 
Herzzellen-entwicklung führt (Hofner et al.2007). Zusätzlich zu dem beobachteten förder-
lichen Effekt von überexprimiertem Desmin auf die Differenzierung von Stammzellen zu 
Herzzellen wurde gezeigt, daß gleichzeitig die Expression des Herz-spezifischen Tran-
skriptionsfaktor (TF) Gens nkx2.5 und des mesodermalen TF Gens brachyury signifikant 
erhöht wurde. Um weiteren Einblick in die zugrundliegenden Mechanismen dieser Akti-
vierung zu gewinnen, wurde die physische Interaktion von Desmin mit regulatorischen 
Elementen der genomischen DNA mittels Chromatin Immun-Präzipitation (ChIP) getestet. 
Die ChIP Ergebnisse zeigen, daß Desmin Protein an Tag 6, 7, 8 und 9 der EB in-vitro 
Differenzierung an den nkx 2.5 Promoter in des+/+ EBs bindet. In des+/+/ect EBs bindet Desmin 
den nkx 2.5 promoter an Tag 5, 6, 7, and 8. Die Tatsache, daß Desmin früher an den nkx 2.5 
Promoter bindet, wenn es in ESC überexprimiert wird, ist in Übereinstimmung mit der 
Beobachtung der “verfrühten“ Herzzellenentwicklung in EBs. Die Bindung von Desmin 
konnte auch am „Minimal Cardiac Enhancer“ (Lien et al.1999) in der 5’-UTR des nkx 2.5 
Gens nachgewiesen werden.  
Weiters, um zu testen ob Desmin nicht nur genomische regulatorische Elemente 
binden kann, sondern auch ihre Aktivität beeinflusst, wurden Luciferase Reporter Assays in 
drei verschiedenen Zelltypen (10T ½ Fibroblasten, C2C12 Myoblasten, and primäre 
Cardiomyocyten) durchgeführt. Die drei Zelltypen unterscheiden sich durch das Ausmaß ihrer 
natürlichen Desmin Expression. Die Luciferase Reporter Assays ergaben, daß Desmin als 
Inhibitor oder “Aktivierungs-verhindernder“ Faktor auf die Aktivität des nkx 2.5 Promoters in 
10T ½ Fibroblasten und C2C12 Myoblasten wirkt. In Reporter Assays mit primären 
Cardiomyocyten zeigte sich Desmin eher als Aktivator des nkx 2.5 Promoters.   
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